data_1w4f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1w4f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 121.087 0.47 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.63 149.21 5.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.988 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.4 mtm -56.37 158.15 8.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.859 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.4 -24.89 79.05 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.496 2.131 . . . . 0.0 112.332 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 m -91.12 -31.78 16.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 158' ' ' VAL . 43.7 t -68.52 -45.2 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.6 mtp-105 -54.61 -31.82 57.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.62 -38.48 47.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.238 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.539 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.6 t80 -66.41 -48.06 71.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.011 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.23 -45.59 80.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 11.2 ttt85 -54.78 -31.67 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.402 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.36 -39.48 19.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.709 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.4 ' HB3' ' CD1' ' A' ' 167' ' ' LEU . 45.6 mmtt -80.25 9.98 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.605 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.9 8.77 64.84 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.526 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.64 143.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.986 0.422 . . . . 0.0 110.703 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -116.06 129.4 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.912 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 32.1 mm -51.04 -22.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -64.18 -34.38 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.02 0.438 . . . . 0.0 110.429 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.406 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.25 -2.14 58.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.984 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.41 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 7.4 t -115.19 139.08 43.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.9 0.381 . . . . 0.0 111.376 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -98.1 90.72 4.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.576 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.454 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -57.6 134.07 52.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.766 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.35 26.07 9.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.629 0.252 . . . . 0.0 111.009 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -105.13 127.63 9.11 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.156 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.28 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.577 0.227 . . . . 0.0 111.492 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -110.13 30.23 6.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.811 0.338 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 90.08 26.01 25.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.714 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.424 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 31.9 ttm180 -79.48 138.9 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 135' ' ' VAL . 45.7 t -72.07 132.68 33.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 111.425 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.1 mt -105.66 162.5 13.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.756 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -55.74 -31.42 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.99 -37.59 86.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -61.69 -49.98 74.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.664 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.539 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 35.0 mm -52.69 -54.8 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.473 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.88 -38.61 73.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.46 89.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.568 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.406 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 51.6 t-105 -58.4 -57.01 14.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.4 ' CD1' ' HB3' ' A' ' 142' ' ' LYS . 1.9 mt -65.58 -27.35 68.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.066 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.294 -179.81 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.929 0.395 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -161.28 150.39 16.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.344 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.5 mtp -59.98 159.59 19.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.785 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.4 -26.27 82.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.569 2.179 . . . . 0.0 112.157 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 p -91.04 -29.58 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.4 t -70.06 -48.82 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.382 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -54.58 -30.03 53.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -40.07 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.119 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.17 -48.15 71.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.067 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -66.22 -45.35 81.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -54.83 -31.82 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.133 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.49 -37.54 21.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.853 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -84.03 26.1 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.862 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.0 18.71 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.557 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.425 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 54.4 t -112.26 141.06 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.05 0.452 . . . . 0.0 110.944 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -116.21 131.23 57.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.624 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 32.6 mm -50.82 -23.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.628 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.405 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -65.12 -31.96 73.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.932 0.396 . . . . 0.0 110.287 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.5 mt -86.07 -7.66 58.45 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.658 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.3 t -111.08 145.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 120.974 0.416 . . . . 0.0 111.435 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.71 88.48 2.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.197 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.43 137.09 39.71 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.049 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.38 26.06 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.754 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.79 121.76 6.77 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.402 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.52 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' GLY . 17.0 m-80 -114.08 36.86 3.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.18 26.08 34.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.617 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -82.06 142.5 32.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.94 137.95 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.477 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.5 mt -110.41 161.38 15.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.702 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -55.43 -31.8 62.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.774 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -64.61 -38.05 89.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.7 m-20 -62.16 -49.94 73.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.737 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.517 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 37.9 mm -52.69 -55.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.66 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.79 -37.3 68.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.89 92.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.855 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.44 ' CZ2' ' HB3' ' A' ' 148' ' ' LEU . 55.3 t-105 -58.34 -57.1 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -63.34 -31.33 72.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.953 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.21 179.893 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.063 0.458 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -165.53 149.12 8.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.4 mtm -61.8 160.06 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.13 -25.91 72.92 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.651 2.234 . . . . 0.0 112.231 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.5 p -90.97 -31.01 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.038 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.84 -47.35 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.37 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -54.66 -30.09 54.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.462 . . . . 0.0 109.892 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -77.7 -41.12 39.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.165 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.499 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.0 t80 -65.5 -48.17 73.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.02 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.9 -45.44 81.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -54.91 -31.84 60.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.096 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.52 -37.58 21.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.947 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.416 ' HE3' ' CE1' ' A' ' 138' ' ' TYR . 19.1 mmtp -84.13 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.814 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.14 18.61 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.66 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.59 143.66 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.046 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -116.19 131.32 56.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.016 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.7 mm -50.88 -23.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.226 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -63.96 -34.86 78.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.046 0.451 . . . . 0.0 110.469 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.412 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -89.52 -0.07 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.981 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 3.3 t -118.85 113.28 41.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.88 0.372 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.31 105.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.188 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.437 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -66.28 128.87 31.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.753 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 26.08 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.637 0.256 . . . . 0.0 110.96 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.24 126.42 8.08 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.309 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.49 -89.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.09 21.73 14.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.555 0.217 . . . . 0.0 111.464 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 110.61 26.14 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.809 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.2 ttp-105 -85.72 146.94 26.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.425 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 12.5 t -83.61 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.093 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.0 mt -107.87 165.05 11.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.39 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 1.6 tttt -57.5 -34.37 69.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.29 -36.09 82.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.3 m-20 -64.94 -48.65 73.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.499 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 41.5 mm -52.87 -54.79 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.13 -40.81 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.677 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.65 83.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.412 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 45.9 t-105 -58.82 -57.12 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.44 -33.59 76.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.942 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.413 ' CG2' ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.184 0.516 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.411 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -170.11 147.77 3.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.945 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.1 mtm -54.54 148.91 23.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.991 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.77 -26.6 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.659 2.239 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -89.76 -28.18 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.23 -45.86 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.52 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 11.5 mtp-105 -54.67 -32.01 58.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.145 0.498 . . . . 0.0 109.735 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -40.14 41.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.1 t80 -65.67 -48.15 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.12 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.55 -45.08 80.55 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -54.91 -31.94 60.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.022 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -84.42 -38.13 20.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.952 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -83.46 24.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.805 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.38 21.73 20.87 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.497 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.422 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 49.6 t -109.95 142.89 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.907 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -116.1 129.98 56.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.066 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.0 mm -51.73 -21.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.239 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -64.45 -34.45 78.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.405 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.91 -1.11 57.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.928 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -115.1 151.0 16.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 0.6 OUTLIER -111.59 96.59 6.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -67.82 135.31 30.42 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.963 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.33 26.01 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.635 0.255 . . . . 0.0 110.946 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.0 131.14 10.5 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.102 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.04 -87.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.605 0.241 . . . . 0.0 111.375 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.04 29.13 8.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.777 0.323 . . . . 0.0 111.012 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 96.87 18.26 30.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.697 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HA ' ' CG2' ' A' ' 130' ' ' ILE . 3.2 ttm180 -73.0 138.98 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 110.971 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.42 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 31.9 t -71.26 138.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.185 0.517 . . . . 0.0 111.551 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.1 mt -109.84 161.74 15.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.53 -32.44 62.94 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.742 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -64.33 -37.38 87.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.267 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.9 m-20 -62.57 -50.03 72.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.76 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.514 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 33.8 mm -52.74 -55.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.654 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.16 -38.97 71.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.726 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.09 84.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.545 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.41 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 44.8 t-105 -60.19 -57.03 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.422 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.1 mt -64.55 -30.19 71.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.858 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -161.63 149.11 14.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.355 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.37 150.82 62.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.08 -26.81 15.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.526 2.151 . . . . 0.0 112.352 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 -29.64 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.072 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.32 -50.27 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.385 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 10.3 mtt180 -54.64 -30.18 54.33 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -77.67 -39.63 44.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.142 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.515 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 47.5 t80 -66.9 -48.11 69.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.165 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.92 77.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.89 -31.98 60.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.033 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.41 -36.97 22.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.992 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.584 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -82.19 19.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.733 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.5 19.88 49.45 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.977 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.406 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 50.0 t -110.75 143.56 20.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 111.022 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -116.23 130.56 56.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.947 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.6 mm -51.0 -23.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.121 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -63.33 -34.27 77.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.542 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.42 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -86.62 -6.46 58.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.971 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.1 t -107.82 152.33 9.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.88 0.372 . . . . 0.0 111.142 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.85 97.51 7.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.813 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.93 128.77 48.48 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.99 26.02 9.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.697 0.284 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -122.03 150.27 17.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.687 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 47.97 -97.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -114.19 37.02 3.47 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.91 26.09 23.03 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.413 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 34.0 ttm180 -81.97 146.73 29.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 162' ' ' ASP . 40.0 t -81.52 134.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.14 0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.7 mt -105.25 161.32 14.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -55.63 -32.34 63.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.0 -37.51 87.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -62.5 -50.07 72.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.638 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.515 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 37.0 mm -52.66 -54.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.49 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.0 -35.08 68.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.92 95.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.601 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.42 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 47.3 t-105 -58.38 -56.48 21.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.406 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -65.94 -34.95 79.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.993 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.25 179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -166.66 152.81 8.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.318 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.48 151.86 58.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.737 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.42 -27.58 32.18 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.468 2.112 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.9 -29.23 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.365 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 HG13 ' A' ' 158' ' ' VAL . 86.0 t -68.0 -48.55 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -54.63 -29.3 51.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -77.69 -39.91 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.97 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.8 t80 -66.38 -48.02 71.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.05 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.0 -45.32 82.0 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.89 -31.87 60.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.102 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.44 -37.38 21.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.847 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -84.08 23.5 1.04 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.836 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.53 20.92 25.86 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.446 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 49.1 t -109.0 143.53 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.968 0.413 . . . . 0.0 110.943 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.062 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.4 mm -52.31 -21.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.089 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -63.76 -34.29 77.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.05 0.452 . . . . 0.0 110.218 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.412 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.05 -3.92 58.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.867 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.9 t -116.8 129.38 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.322 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.29 94.85 10.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.287 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -59.91 134.83 50.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.011 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.17 25.99 9.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 110.652 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.46 103.94 3.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.965 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.94 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.657 0.265 . . . . 0.0 111.489 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.2 m-80 -95.85 35.18 1.42 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 111.109 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 75.3 26.11 66.81 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.502 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.425 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 27.7 ttm180 -79.24 139.16 37.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.214 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.457 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 38.2 t -74.6 133.79 30.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.199 0.523 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.7 mt -104.8 160.97 14.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.001 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -55.81 -31.55 62.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.97 -37.45 86.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -61.78 -50.0 74.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.593 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.513 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 35.6 mm -52.66 -55.18 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.558 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -55.55 -40.55 72.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.655 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.14 82.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.636 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.412 ' CZ2' ' HB3' ' A' ' 148' ' ' LEU . 41.9 t-105 -59.47 -57.01 14.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.481 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.446 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.1 mt -63.59 -31.56 72.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.939 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.227 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 121.009 0.433 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.428 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -163.92 153.95 14.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.46 160.1 54.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.37 -28.17 83.97 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 112.258 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.1 p -91.13 -29.46 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.92 -48.33 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.448 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 65.5 mtt-85 -54.63 -29.37 51.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.061 0.458 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.71 -41.14 38.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.198 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.608 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 44.3 t80 -66.4 -48.26 70.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.911 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -64.31 -47.18 80.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 16.8 tpt180 -54.97 -31.92 61.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.72 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.69 -38.61 19.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.221 0.534 . . . . 0.0 111.192 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 138' ' ' TYR . 26.6 mmmt -82.38 24.71 0.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.831 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.23 21.88 27.49 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.445 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.417 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 54.6 t -112.33 142.25 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -116.18 129.97 56.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.2 mm -51.39 -22.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -63.98 -34.0 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.987 0.423 . . . . 0.0 110.384 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.96 -4.22 58.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.916 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 5.4 t -113.92 134.98 55.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.107 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.28 93.4 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -57.87 129.37 49.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.586 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 26.09 9.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 0.0 111.1 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.76 140.53 16.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.984 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.41 -91.0 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.462 0.172 . . . . 0.0 111.441 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -114.1 34.38 4.7 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.871 0.367 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 90.0 21.06 40.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.454 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.428 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 41.7 ttm180 -78.36 145.11 35.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.424 HG11 ' HB2' ' A' ' 162' ' ' ASP . 38.5 t -77.18 135.94 25.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.164 0.507 . . . . 0.0 111.322 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.2 mt -107.51 162.04 14.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.006 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -55.66 -32.05 62.89 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.821 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -65.24 -37.33 86.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.5 m-20 -62.77 -50.14 72.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.73 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.54 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 34.7 mm -52.67 -55.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -56.82 -36.58 70.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.545 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.407 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 42.2 t-105 -59.75 -54.84 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.549 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.417 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -68.85 -26.82 65.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.135 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.622 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.405 HG21 ' HG3' ' A' ' 157' ' ' ARG . 28.0 mt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.013 0.435 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.08 146.31 3.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.17 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.69 146.96 79.48 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.71 -24.42 17.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.555 2.17 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 m -91.06 -37.32 13.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.085 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 158' ' ' VAL . 47.9 t -63.44 -44.13 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.65 -30.44 55.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.64 -39.45 45.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.084 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.512 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.9 t80 -66.3 -48.04 71.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.114 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.25 81.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -31.87 60.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.172 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.39 -37.47 21.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.854 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -84.27 25.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.727 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.65 20.72 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.525 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 53.7 t -111.5 143.78 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -116.17 130.21 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.786 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.41 HG22 ' HB ' ' A' ' 158' ' ' VAL . 29.7 mm -49.99 -23.7 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.383 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.41 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.8 OUTLIER -64.3 -37.02 86.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.907 0.384 . . . . 0.0 110.367 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.0 OUTLIER -81.42 -5.63 58.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.642 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.6 t -112.82 137.19 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.332 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.57 100.01 12.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -63.41 126.14 35.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.901 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 26.03 9.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.644 0.259 . . . . 0.0 110.794 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -101.71 122.05 7.43 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.349 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.69 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.6 OUTLIER -106.93 27.47 8.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.761 0.315 . . . . 0.0 111.293 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.52 26.17 21.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.8 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.408 ' HG3' ' HA ' ' A' ' 131' ' ' ALA . 27.3 ttm105 -82.19 151.99 26.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.705 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 135' ' ' VAL . 9.5 t -86.64 136.18 23.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.173 0.511 . . . . 0.0 111.117 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 27.9 mt -107.26 164.45 12.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.48 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -33.18 67.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.45 -36.47 84.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.2 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -63.65 -48.51 76.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.746 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.512 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 36.1 mm -52.9 -54.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.62 -39.2 73.21 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.621 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.4 80.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.529 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 148' ' ' LEU . 52.0 t-105 -60.53 -56.97 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.87 -33.06 75.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.276 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.438 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.046 0.45 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 157' ' ' ARG . . . -168.57 158.12 9.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.314 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.2 154.39 82.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.828 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.32 -27.53 58.05 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.639 2.226 . . . . 0.0 112.35 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -90.02 -32.11 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.07 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.415 HG13 HG13 ' A' ' 158' ' ' VAL . 97.5 t -65.53 -48.06 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.354 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 24.4 mtt180 -54.57 -28.78 48.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -77.67 -39.86 43.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.942 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.503 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.8 t80 -66.83 -48.02 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.059 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 3.4 tpt180 -54.92 -31.99 60.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.054 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.32 -36.62 22.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.067 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.1 OUTLIER -83.61 21.64 1.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.61 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.48 19.78 42.65 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.421 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 49.0 t -110.36 143.05 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.0 110.913 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -116.27 130.19 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.053 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 32.8 mm -52.38 -21.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -63.58 -34.21 77.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.058 0.456 . . . . 0.0 110.25 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.56 -4.16 58.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.859 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.57 139.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.383 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.428 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 3.8 pt20 -102.73 97.48 7.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.355 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.436 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -71.7 143.29 34.99 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.165 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.32 113.76 4.46 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.965 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.95 -85.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.372 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -105.72 37.01 2.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.83 0.347 . . . . 0.0 111.108 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 83.68 26.13 43.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.577 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.438 ' HG3' HG21 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -75.87 136.82 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.749 0.309 . . . . 0.0 111.003 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.429 ' HA ' ' CA ' ' A' ' 151' ' ' GLY . 30.5 t -73.56 132.24 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.105 0.479 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.4 mt -102.87 161.13 14.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.196 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.408 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 3.8 tttt -55.45 -31.7 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.32 -37.83 88.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.0 m-20 -61.66 -50.48 72.33 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.626 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.503 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 31.5 mm -52.79 -54.97 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.43 -39.04 72.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.541 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.22 84.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.634 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.413 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 48.1 t-105 -60.38 -57.08 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.421 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -64.92 -32.52 74.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.934 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.435 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.899 0.38 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.444 ' N ' ' HG3' ' A' ' 157' ' ' ARG . . . -166.94 154.77 9.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.6 mtt -60.47 160.02 20.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.34 -25.78 80.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.462 2.108 . . . . 0.0 112.202 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -30.49 16.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' A' ' 158' ' ' VAL . 76.3 t -68.28 -47.82 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -54.68 -29.89 54.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -77.7 -39.89 43.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.059 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.16 -48.18 71.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.928 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.77 -45.89 80.84 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.81 -31.8 59.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.348 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -84.49 -37.56 21.18 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.923 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HE2' ' CE1' ' A' ' 138' ' ' TYR . 38.5 mmtt -84.58 25.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.728 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 22.05 19.29 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.697 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.435 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 51.1 t -111.18 142.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.001 0.429 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -116.16 130.21 56.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.197 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.0 mm -52.61 -21.26 2.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -64.0 -34.97 79.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 110.094 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.414 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.52 -1.27 57.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.855 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.07 133.39 66.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.88 0.371 . . . . 0.0 111.485 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -95.89 97.31 9.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -71.37 144.03 36.71 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.059 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.75 10.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.334 . . . . 0.0 110.629 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -87.12 107.1 3.22 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.814 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.31 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 111.332 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.8 p30 -99.32 33.26 2.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.343 . . . . 0.0 111.02 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.66 25.96 44.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -76.4 138.72 40.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.717 0.294 . . . . 0.0 111.094 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.418 ' HA ' ' CA ' ' A' ' 151' ' ' GLY . 24.6 t -72.86 137.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 111.19 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -109.42 161.33 15.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.226 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -55.97 -31.06 62.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -65.58 -37.31 86.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -62.38 -50.55 71.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.784 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.508 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 30.0 mm -52.77 -55.0 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.695 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.1 -40.16 73.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.673 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.25 87.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.87 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.414 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 52.3 t-105 -58.94 -57.25 13.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.435 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.1 mt -63.45 -32.33 73.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.039 0.447 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.41 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -169.87 151.26 4.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.4 mtp -58.98 149.64 65.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.87 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.35 -26.62 11.98 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -91.08 -29.23 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 99.5 t -68.09 -51.18 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.421 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 1.8 mtt-85 -54.59 -29.95 53.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -77.68 -38.8 46.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.157 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.527 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 45.8 t80 -67.54 -48.11 67.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.053 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.23 76.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 1.2 tmt_? -54.92 -32.03 60.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.036 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -84.3 -36.68 22.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.059 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.4 OUTLIER -83.47 22.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.678 -179.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.28 20.73 37.41 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.255 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.425 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 51.1 t -112.1 142.83 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -116.14 130.7 56.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.054 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.9 mm -51.49 -23.09 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -63.09 -34.12 76.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.496 . . . . 0.0 110.36 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.411 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.5 -6.71 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.951 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.1 t -110.87 129.62 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.891 0.376 . . . . 0.0 111.322 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.21 92.46 8.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.452 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -57.97 130.35 50.88 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.757 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.44 26.1 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.59 0.233 . . . . 0.0 111.038 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -104.6 125.2 8.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.513 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.82 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -114.08 31.36 6.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 92.62 26.08 18.64 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.721 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.41 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 40.3 ttp180 -81.01 149.61 29.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.045 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.0 t -83.51 135.45 24.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.21 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.5 mt -106.2 160.93 14.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.955 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -55.63 -32.38 63.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.664 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -65.12 -37.28 86.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -62.14 -49.91 73.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.762 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.527 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 34.8 mm -52.69 -55.02 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.524 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -57.35 -36.24 70.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.626 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.98 99.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.646 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.411 ' CZ3' ' O ' ' A' ' 148' ' ' LEU . 54.9 t-105 -57.22 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.482 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -64.21 -31.77 73.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.912 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.404 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.2 mp . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.115 0.484 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.411 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -165.55 149.82 8.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.425 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 1.7 mmt -64.67 154.53 84.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.716 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.72 -33.71 94.47 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.708 2.272 . . . . 0.0 112.531 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.83 -33.21 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.104 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 53.6 t -69.08 -45.76 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.308 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 8.1 mtm180 -54.62 -31.44 57.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -38.81 46.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.078 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.492 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.9 t80 -66.49 -47.91 71.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.94 -45.7 77.01 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.71 -32.08 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.128 178.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.47 -37.58 21.17 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.593 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -81.86 20.39 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.725 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.01 48.73 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.13 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.51 144.3 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 110.941 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -116.28 130.73 56.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.123 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 146' ' ' ILE . 33.4 mm -49.98 -23.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.162 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -63.71 -35.99 82.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.005 0.431 . . . . 0.0 110.545 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.36 -0.52 56.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.093 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.6 t -116.51 131.53 68.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.65 106.14 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -69.0 129.71 24.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.72 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.04 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.608 0.242 . . . . 0.0 111.003 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.91 143.35 17.41 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.894 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt 49.67 -91.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -114.2 22.95 13.32 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.593 0.235 . . . . 0.0 111.444 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 26.05 6.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.759 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HG3' ' HA ' ' A' ' 131' ' ' ALA . 38.3 ttm180 -83.28 143.07 30.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.681 0.276 . . . . 0.0 111.006 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.422 HG13 HG13 ' A' ' 135' ' ' VAL . 13.8 t -78.88 134.79 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 111.112 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 15.2 mt -107.1 165.81 11.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.54 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -34.39 68.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -36.36 83.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.4 m-20 -64.6 -48.57 74.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.75 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.492 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 38.3 mm -52.92 -54.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.575 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -56.85 -38.84 73.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.568 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.69 -38.19 84.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.489 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.413 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 48.6 t-105 -60.03 -57.08 14.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.601 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -32.39 73.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.909 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.983 0.42 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.13 154.61 9.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.166 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 mtp -61.34 151.23 77.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.15 -26.01 24.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.2 . . . . 0.0 112.42 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 p -91.04 -30.36 16.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.409 ' CG1' HG13 ' A' ' 158' ' ' VAL . 58.9 t -67.24 -47.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.533 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 1.4 mtp-105 -54.68 -30.02 54.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 0.0 109.887 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -77.59 -40.39 42.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.198 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.522 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.01 -48.11 72.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.049 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.08 -45.56 80.83 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.82 -31.75 59.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.16 178.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.39 -37.46 21.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.901 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.421 ' HE3' ' CE1' ' A' ' 138' ' ' TYR . 19.0 mmtp -84.3 25.26 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.761 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.09 21.78 18.93 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.532 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.418 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 54.8 t -110.66 142.29 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.902 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.3 mm -51.22 -22.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 -62.7 -33.7 75.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.33 -7.16 57.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.846 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.2 t -111.15 140.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.848 0.356 . . . . 0.0 111.334 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.29 90.8 4.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.4 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -61.64 135.33 47.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.878 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.98 9.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.591 0.234 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.79 127.08 9.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.107 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt 57.02 -86.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.548 0.213 . . . . 0.0 111.509 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.28 29.71 7.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.218 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 94.46 26.12 14.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.416 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 33.9 ttm180 -83.38 137.71 33.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 110.841 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.409 HG13 ' CG1' ' A' ' 135' ' ' VAL . 39.1 t -70.87 138.03 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.191 0.52 . . . . 0.0 111.467 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.2 mt -111.88 162.91 14.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.824 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -56.01 -31.59 63.22 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.42 -36.47 84.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -63.48 -49.97 71.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.673 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.522 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 34.4 mm -52.76 -54.92 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.704 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -55.91 -39.88 72.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.664 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.01 80.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.691 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.41 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 45.2 t-105 -60.74 -57.02 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.574 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.418 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -64.8 -32.51 74.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.314 -179.872 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.033 0.444 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.436 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -165.64 148.88 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.015 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -57.41 159.96 7.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.717 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.84 -25.92 82.12 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.578 2.185 . . . . 0.0 112.248 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -91.05 -29.46 17.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.45 HG13 HG13 ' A' ' 158' ' ' VAL . 62.1 t -70.18 -47.53 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.396 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -54.53 -31.25 55.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.64 -38.76 47.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.213 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.2 t80 -66.77 -48.09 70.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.056 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.31 -45.73 79.33 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -54.88 -31.81 60.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -84.43 -37.6 21.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -83.98 25.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.737 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.43 20.08 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.506 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.427 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 49.4 t -111.48 143.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.984 0.421 . . . . 0.0 110.972 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -116.21 130.85 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.1 mm -52.35 -22.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.121 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mmm-85 -64.11 -33.93 76.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.939 0.399 . . . . 0.0 110.439 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.18 -4.01 59.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.076 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 10.8 t -111.54 146.75 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.878 0.37 . . . . 0.0 111.186 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.4 95.43 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.5 128.6 48.0 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.709 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.16 26.12 9.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 0.0 111.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.81 143.83 18.03 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.001 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 49.28 -91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -114.01 29.9 7.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.741 0.305 . . . . 0.0 111.322 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.68 26.04 12.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.659 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.436 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 38.5 ttm180 -82.63 145.93 29.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.731 0.3 . . . . 0.0 110.905 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.45 HG13 HG13 ' A' ' 135' ' ' VAL . 41.1 t -79.31 134.63 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.275 0.559 . . . . 0.0 111.279 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.6 mt -106.35 162.01 14.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.972 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -31.7 62.38 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -37.76 87.93 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.1 m-20 -62.16 -50.15 72.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.742 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.519 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 34.5 mm -52.73 -54.93 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.639 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.11 -36.01 67.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.661 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.24 90.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.407 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 38.9 t-105 -59.67 -56.71 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.559 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.427 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -64.83 -31.42 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.969 0.414 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.19 154.28 4.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.89 147.63 78.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.695 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.45 -25.53 14.33 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.572 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.7 p -91.01 -28.96 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.66 -47.61 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.468 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.9 mtp180 -54.71 -30.68 56.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -77.63 -39.24 45.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.126 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.5 t80 -66.48 -48.21 70.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.49 -45.47 79.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 3.5 tpt180 -54.8 -31.71 59.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.267 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.47 -38.21 20.41 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.924 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -82.99 26.45 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.885 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.84 22.25 18.54 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.471 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.417 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 54.1 t -111.68 144.01 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 111.044 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -116.29 131.1 57.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.97 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 35.0 mm -52.4 -22.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -64.58 -33.61 76.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.982 0.42 . . . . 0.0 110.421 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.411 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.93 -1.4 57.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.961 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.7 t -114.64 146.11 19.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -104.65 108.5 19.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' CA ' HG21 ' A' ' 158' ' ' VAL . . . -66.96 126.1 25.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.764 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.26 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.716 0.293 . . . . 0.0 111.016 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.23 142.31 17.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.12 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.406 ' CE ' ' HA ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER 49.87 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -114.02 31.72 6.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.69 0.281 . . . . 0.0 111.326 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.13 17.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.721 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -84.29 148.09 26.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.711 0.291 . . . . 0.0 110.742 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.408 HG21 ' CA ' ' A' ' 151' ' ' GLY . 10.1 t -81.63 137.99 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 111.223 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.9 mt -110.35 161.92 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.345 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -55.64 -32.65 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.3 -37.38 87.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.277 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -62.39 -48.5 79.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.701 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.502 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 39.4 mm -52.83 -54.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.502 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.94 -35.29 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.526 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.14 89.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.504 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.411 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 39.9 t-105 -59.93 -57.01 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.417 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -64.81 -32.06 73.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.251 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.908 0.385 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.403 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -169.99 151.2 3.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.31 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.404 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 1.4 mtp -58.27 148.47 62.92 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.12 -25.32 22.58 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.562 2.174 . . . . 0.0 112.506 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.2 m -90.94 -34.0 15.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 92.7 t -62.79 -47.56 92.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.4 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 37.7 mtp85 -54.66 -28.1 44.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.035 0.445 . . . . 0.0 110.002 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -41.57 37.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.928 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.613 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 40.4 t80 -66.3 -48.29 70.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.816 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.15 85.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.95 -32.11 61.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.5 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -84.69 -38.42 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 111.104 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 138' ' ' TYR . 27.0 mmmt -82.19 25.48 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.976 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 23.65 23.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.342 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.65 142.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.06 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -116.24 131.86 56.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.702 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 158' ' ' VAL . 32.9 mm -50.29 -23.77 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.712 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.413 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.4 OUTLIER -66.31 -33.19 75.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.893 0.378 . . . . 0.0 110.377 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.413 ' CD2' ' HG3' ' A' ' 147' ' ' ARG . 1.4 mt -85.52 -1.86 57.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.412 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 5.0 t -115.56 127.21 73.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.81 0.338 . . . . 0.0 111.475 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.01 92.4 7.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.425 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -57.38 129.13 49.03 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.981 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.12 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.727 0.299 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -100.06 117.03 5.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 153' ' ' GLY . 4.1 p30 -101.73 31.31 3.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.62 26.16 43.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.677 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.403 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 43.7 ttm180 -80.13 150.91 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 146' ' ' ILE . 21.9 t -84.67 133.73 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 21.0 mt -106.83 162.41 13.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.66 -33.18 63.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -62.87 -48.48 78.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.785 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.527 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 32.5 mm -52.76 -53.82 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.428 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.74 -38.36 75.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.523 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.84 86.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.412 ' CZ3' ' O ' ' A' ' 148' ' ' LEU . 50.8 t-105 -59.2 -57.06 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.24 -33.68 76.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.229 -179.922 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.006 0.431 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.423 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.2 152.02 7.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.163 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.3 mtp -58.7 160.04 11.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.22 -25.8 81.22 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 m -91.03 -30.92 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.457 HG13 HG13 ' A' ' 158' ' ' VAL . 45.1 t -69.11 -47.15 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.541 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.5 mtp180 -54.61 -31.22 56.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.69 -38.21 47.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.82 -48.09 70.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.077 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.38 -45.42 80.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.77 59.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.285 178.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -84.45 -37.78 20.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.905 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -83.61 25.85 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.728 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.03 21.8 18.53 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.381 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.418 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 55.9 t -111.12 142.42 23.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.009 0.433 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.21 130.47 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.8 mm -50.7 -23.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.16 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtp-105 -63.8 -35.74 81.6 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.7 OUTLIER -85.51 -4.07 59.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 8.6 t -113.46 149.2 15.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 111.241 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -107.29 102.55 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.403 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -62.39 129.73 43.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.0 9.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.712 0.291 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.2 141.57 17.09 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.077 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.61 -91.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -113.98 34.33 4.7 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.735 0.302 . . . . 0.0 111.271 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 89.93 26.09 25.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.763 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.423 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 22.6 ttm180 -82.55 142.63 31.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.854 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.457 HG13 HG13 ' A' ' 135' ' ' VAL . 37.5 t -76.75 133.32 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.231 0.538 . . . . 0.0 111.196 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.3 mt -107.86 163.9 12.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.075 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.45 -32.4 62.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.93 -37.72 88.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -62.18 -50.52 71.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.753 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.523 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 29.9 mm -52.74 -55.04 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.733 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.43 -38.46 69.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.636 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.89 89.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 148' ' ' LEU . 46.1 t-105 -59.16 -57.15 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.418 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.1 mt -64.45 -30.24 71.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.023 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.418 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.21 0.529 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -168.68 143.69 3.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.1 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.416 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 9.9 mmt -55.55 150.28 25.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.45 -29.78 70.43 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.04 -33.46 21.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 93.3 t -66.36 -46.81 86.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.304 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 42.0 mtp180 -54.64 -28.88 50.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.027 0.442 . . . . 0.0 109.867 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -77.67 -41.61 37.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.055 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.48 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.4 t80 -65.2 -47.99 74.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.44 82.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.8 tpt85 -54.71 -31.84 58.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.3 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.46 -37.54 21.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 167' ' ' LEU . 47.6 mmtt -84.14 22.35 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.797 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.3 19.06 31.13 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.594 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.419 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 65.3 t -104.96 143.24 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.3 t0 -116.16 129.09 56.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.934 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 146' ' ' ILE . 35.5 mm -50.66 -22.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.25 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -64.32 -33.71 76.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.99 0.424 . . . . 0.0 110.595 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.409 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.2 OUTLIER -91.37 1.73 56.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 4.0 t -119.09 120.12 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.71 96.23 8.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.4 ' HA2' ' N ' ' A' ' 158' ' ' VAL . . . -68.85 134.78 27.85 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.114 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.18 26.02 9.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 110.695 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.12 112.74 4.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.935 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.2 -85.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 153' ' ' GLY . 69.9 m-80 -97.75 33.66 2.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.769 0.319 . . . . 0.0 111.098 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.52 26.03 61.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.603 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.418 ' HG3' HG21 ' A' ' 130' ' ' ILE . 1.8 ttm105 -81.33 137.92 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.4 ' N ' ' HA2' ' A' ' 151' ' ' GLY . 9.5 t -71.31 137.38 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -108.38 163.9 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.454 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -57.24 -34.8 68.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.25 -36.26 83.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.0 m-20 -64.24 -48.01 77.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.48 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 39.2 mm -52.87 -54.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.544 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -56.56 -39.02 72.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.15 88.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.409 ' CZ3' ' O ' ' A' ' 148' ' ' LEU . 49.6 t-105 -58.72 -57.05 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.419 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.4 mt -61.13 -26.56 67.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.213 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.159 -179.865 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.476 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.0 mp . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.284 0.564 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.12 147.05 3.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 5.9 mtp -57.38 155.11 20.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.737 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.9 -24.23 78.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.548 2.165 . . . . 0.0 112.303 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 -36.21 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.425 HG13 HG13 ' A' ' 158' ' ' VAL . 47.3 t -64.69 -44.26 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.358 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -29.99 54.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 109.727 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -40.48 41.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.974 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.501 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.3 t80 -65.47 -48.03 74.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.081 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.4 -45.18 80.88 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -54.88 -31.84 60.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.057 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.43 -37.54 21.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.425 ' HE3' ' CE1' ' A' ' 138' ' ' TYR . 18.1 mmtp -84.46 25.36 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.748 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.8 21.17 21.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.412 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 53.6 t -109.51 143.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -116.17 130.62 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.123 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.469 HD11 HG22 ' A' ' 146' ' ' ILE . 33.9 mm -50.77 -22.65 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.198 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -63.68 -35.76 81.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.059 0.457 . . . . 0.0 110.32 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.96 -0.43 56.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.993 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.96 130.86 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 111.268 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 101.43 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.607 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -65.03 129.24 34.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.943 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.44 25.99 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.325 . . . . 0.0 110.697 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.86 123.52 7.78 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.259 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt 56.5 -84.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -113.09 37.0 3.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.675 0.274 . . . . 0.0 111.484 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 89.39 26.19 26.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.768 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.476 ' HG3' HG21 ' A' ' 130' ' ' ILE . 2.6 ttt180 -81.61 142.93 32.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.507 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 8.3 t -82.63 128.0 39.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.168 0.508 . . . . 0.0 110.728 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 15.8 mt -100.55 165.86 11.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.66 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -57.61 -32.78 67.54 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.51 -36.63 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.3 m-20 -64.26 -49.02 73.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.591 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.501 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 39.6 mm -52.96 -54.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.608 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.63 -39.56 71.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.86 83.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 148' ' ' LEU . 42.9 t-105 -59.77 -57.06 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.555 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.412 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.1 mt -65.26 -31.15 72.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.187 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.425 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.843 0.354 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -164.56 151.42 11.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.219 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.92 157.34 11.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.888 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.45 -24.6 78.36 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.581 2.187 . . . . 0.0 112.133 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.0 p -90.95 -30.37 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.995 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.9 t -66.73 -47.02 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 37.9 mtp85 -54.67 -30.04 54.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -40.37 42.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.179 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.9 t80 -66.39 -48.14 71.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.978 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.406 ' HB1' ' CD1' ' A' ' 163' ' ' ILE . . . -65.34 -46.16 81.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.98 -31.83 61.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.38 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -84.44 -37.22 21.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HB3' ' CD1' ' A' ' 167' ' ' LEU . 45.4 mmtt -84.19 25.06 0.88 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.721 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 22.41 19.59 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.523 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.402 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 46.7 t -111.5 143.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.992 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -116.19 130.01 56.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.942 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.416 HG22 ' HB ' ' A' ' 158' ' ' VAL . 20.7 mm -51.86 -22.15 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -63.77 -33.99 76.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.006 0.431 . . . . 0.0 110.299 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.97 -4.69 59.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 6.1 t -110.97 147.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.264 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.8 99.6 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.684 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.402 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -59.09 126.93 43.95 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.688 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.0 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.631 0.253 . . . . 0.0 111.01 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.45 141.76 16.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.986 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.28 -91.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -114.19 24.23 12.16 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.634 0.254 . . . . 0.0 111.477 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 103.71 26.1 6.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.878 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.425 ' HG3' HG21 ' A' ' 130' ' ' ILE . 20.8 ttm105 -84.22 147.43 27.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.745 0.307 . . . . 0.0 110.825 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 146' ' ' ILE . 14.9 t -80.28 138.05 20.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.2 mt -112.06 165.09 12.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.28 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.419 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 23.4 tttt -57.01 -33.68 67.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.39 -36.95 85.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.5 m-20 -63.17 -50.51 70.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.634 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.523 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 30.7 mm -52.93 -54.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.546 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -57.59 -35.13 70.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.476 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.27 97.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.502 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.407 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 47.2 t-105 -58.73 -56.7 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.73 -29.75 70.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.069 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.289 -179.887 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.895 0.378 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.19 88.05 2.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.43 62.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.422 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 42.1 t -85.51 138.14 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.13 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.05 111.94 22.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.548 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.63 149.21 5.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.988 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.4 mtm -56.37 158.15 8.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.859 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.4 -24.89 79.05 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.496 2.131 . . . . 0.0 112.332 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 m -91.12 -31.78 16.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 158' ' ' VAL . 43.7 t -68.52 -45.2 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.6 mtp-105 -54.61 -31.82 57.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.62 -38.48 47.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.238 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.539 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.6 t80 -66.41 -48.06 71.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.011 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.23 -45.59 80.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 11.2 ttt85 -54.78 -31.67 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.402 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.36 -39.48 19.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.709 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.4 ' HB3' ' CD1' ' A' ' 167' ' ' LEU . 45.6 mmtt -80.25 9.98 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.605 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.9 8.77 64.84 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.526 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.64 143.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.986 0.422 . . . . 0.0 110.703 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -116.06 129.4 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.912 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.422 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 32.1 mm -51.04 -22.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -64.18 -34.38 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.02 0.438 . . . . 0.0 110.429 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.406 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.25 -2.14 58.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.984 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.41 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 7.4 t -115.19 139.08 43.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.9 0.381 . . . . 0.0 111.376 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -98.1 90.72 4.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.576 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.454 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -57.6 134.07 52.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.766 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.35 26.07 9.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.629 0.252 . . . . 0.0 111.009 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -105.13 127.63 9.11 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.156 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.28 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.577 0.227 . . . . 0.0 111.492 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -110.13 30.23 6.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.811 0.338 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 90.08 26.01 25.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.714 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.424 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 31.9 ttm180 -79.48 138.9 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 135' ' ' VAL . 45.7 t -72.07 132.68 33.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 111.425 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.1 mt -105.66 162.5 13.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.756 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -55.74 -31.42 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.99 -37.59 86.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -61.69 -49.98 74.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.664 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.539 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 35.0 mm -52.69 -54.8 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.473 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.88 -38.61 73.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.46 89.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.568 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.406 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 51.6 t-105 -58.4 -57.01 14.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.4 ' CD1' ' HB3' ' A' ' 142' ' ' LYS . 1.9 mt -65.58 -27.35 68.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.066 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.94 31.1 2.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.294 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 168.41 -76.86 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.51 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.343 -1.254 . . . . 0.0 112.467 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.826 0.346 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 137.7 51.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.722 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -176.71 -38.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.053 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 37.6 t -72.52 135.28 28.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.272 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.05 111.93 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.414 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -161.28 150.39 16.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.344 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.5 mtp -59.98 159.59 19.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.785 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.4 -26.27 82.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.569 2.179 . . . . 0.0 112.157 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 p -91.04 -29.58 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.4 t -70.06 -48.82 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.382 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -54.58 -30.03 53.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -40.07 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.119 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.17 -48.15 71.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.067 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -66.22 -45.35 81.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -54.83 -31.82 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.133 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.49 -37.54 21.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.853 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -84.03 26.1 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.862 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.0 18.71 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.557 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.425 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 54.4 t -112.26 141.06 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.05 0.452 . . . . 0.0 110.944 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -116.21 131.23 57.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.624 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.437 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 32.6 mm -50.82 -23.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.628 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.405 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -65.12 -31.96 73.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.932 0.396 . . . . 0.0 110.287 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.44 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.5 mt -86.07 -7.66 58.45 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.658 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.3 t -111.08 145.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 120.974 0.416 . . . . 0.0 111.435 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.71 88.48 2.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.197 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.43 137.09 39.71 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.049 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.38 26.06 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.754 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.79 121.76 6.77 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.402 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.52 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' GLY . 17.0 m-80 -114.08 36.86 3.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.18 26.08 34.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.617 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -82.06 142.5 32.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.94 137.95 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.477 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.5 mt -110.41 161.38 15.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.702 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -55.43 -31.8 62.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.774 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -64.61 -38.05 89.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.7 m-20 -62.16 -49.94 73.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.737 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.517 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 37.9 mm -52.69 -55.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.66 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.79 -37.3 68.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.89 92.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.855 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.44 ' CZ2' ' HB3' ' A' ' 148' ' ' LEU . 55.3 t-105 -58.34 -57.1 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -63.34 -31.33 72.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.953 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.95 -25.08 64.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.21 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.78 -65.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.521 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.454 -1.192 . . . . 0.0 112.508 179.956 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.855 0.36 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -36.62 7.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.58 171.98 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.815 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -82.33 157.05 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.004 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp -90.79 111.93 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.063 0.458 . . . . 0.0 111.139 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -165.53 149.12 8.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.4 mtm -61.8 160.06 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.13 -25.91 72.92 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.651 2.234 . . . . 0.0 112.231 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.5 p -90.97 -31.01 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.038 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.84 -47.35 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.37 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -54.66 -30.09 54.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.462 . . . . 0.0 109.892 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -77.7 -41.12 39.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.165 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.499 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.0 t80 -65.5 -48.17 73.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.02 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.9 -45.44 81.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -54.91 -31.84 60.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.096 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.52 -37.58 21.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.947 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.416 ' HE3' ' CE1' ' A' ' 138' ' ' TYR . 19.1 mmtp -84.13 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.814 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.14 18.61 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.66 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.59 143.66 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.046 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -116.19 131.32 56.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.016 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.7 mm -50.88 -23.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.226 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -63.96 -34.86 78.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.046 0.451 . . . . 0.0 110.469 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.412 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -89.52 -0.07 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.981 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 3.3 t -118.85 113.28 41.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.88 0.372 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.31 105.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.188 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.437 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -66.28 128.87 31.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.753 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 26.08 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.637 0.256 . . . . 0.0 110.96 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.24 126.42 8.08 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.309 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.49 -89.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.09 21.73 14.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.555 0.217 . . . . 0.0 111.464 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 110.61 26.14 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.809 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.2 ttp-105 -85.72 146.94 26.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.425 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 12.5 t -83.61 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.093 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.0 mt -107.87 165.05 11.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.39 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 1.6 tttt -57.5 -34.37 69.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.29 -36.09 82.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.3 m-20 -64.94 -48.65 73.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.499 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 41.5 mm -52.87 -54.79 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.13 -40.81 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.677 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.65 83.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.412 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 45.9 t-105 -58.82 -57.12 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.44 -33.59 76.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.942 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -99.43 27.97 4.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -114.62 -27.78 3.19 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.279 -1.289 . . . . 0.0 112.479 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.842 0.353 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -143.94 -46.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.86 177.38 5.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 48.8 t -93.74 144.97 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.05 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.413 ' CG2' ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -130.12 111.9 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.674 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.411 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -170.11 147.77 3.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.945 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.1 mtm -54.54 148.91 23.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.991 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.77 -26.6 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.659 2.239 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -89.76 -28.18 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.23 -45.86 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.52 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 11.5 mtp-105 -54.67 -32.01 58.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.145 0.498 . . . . 0.0 109.735 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -40.14 41.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.1 t80 -65.67 -48.15 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.12 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.55 -45.08 80.55 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -54.91 -31.94 60.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.022 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -84.42 -38.13 20.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.952 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -83.46 24.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.805 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.38 21.73 20.87 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.497 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.422 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 49.6 t -109.95 142.89 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.907 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -116.1 129.98 56.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.066 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.426 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 31.0 mm -51.73 -21.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.239 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -64.45 -34.45 78.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.405 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.91 -1.11 57.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.928 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -115.1 151.0 16.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 0.6 OUTLIER -111.59 96.59 6.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -67.82 135.31 30.42 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.963 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.33 26.01 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.635 0.255 . . . . 0.0 110.946 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.0 131.14 10.5 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.102 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.04 -87.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.605 0.241 . . . . 0.0 111.375 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.04 29.13 8.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.777 0.323 . . . . 0.0 111.012 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 96.87 18.26 30.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.697 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HA ' ' CG2' ' A' ' 130' ' ' ILE . 3.2 ttm180 -73.0 138.98 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 110.971 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.42 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 31.9 t -71.26 138.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.185 0.517 . . . . 0.0 111.551 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.1 mt -109.84 161.74 15.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.53 -32.44 62.94 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.742 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -64.33 -37.38 87.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.267 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.9 m-20 -62.57 -50.03 72.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.76 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.514 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 33.8 mm -52.74 -55.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.654 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.16 -38.97 71.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.726 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.09 84.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.545 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.41 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 44.8 t-105 -60.19 -57.03 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.422 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.1 mt -64.55 -30.19 71.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.76 30.99 1.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 137.11 -79.76 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.609 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.349 -1.25 . . . . 0.0 112.473 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 -42.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.68 142.9 57.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.77 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 55.5 t -86.25 134.66 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.217 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.01 111.92 22.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.425 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -161.63 149.11 14.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.355 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.37 150.82 62.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.08 -26.81 15.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.526 2.151 . . . . 0.0 112.352 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 -29.64 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.072 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.32 -50.27 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.385 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 10.3 mtt180 -54.64 -30.18 54.33 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -77.67 -39.63 44.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.142 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.515 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 47.5 t80 -66.9 -48.11 69.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.165 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.92 77.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.89 -31.98 60.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.033 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.41 -36.97 22.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.992 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.584 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -82.19 19.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.733 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.5 19.88 49.45 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.977 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.406 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 50.0 t -110.75 143.56 20.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 111.022 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -116.23 130.56 56.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.947 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.434 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 34.6 mm -51.0 -23.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -63.33 -34.27 77.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.542 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.42 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -86.62 -6.46 58.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.971 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.1 t -107.82 152.33 9.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.88 0.372 . . . . 0.0 111.142 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.85 97.51 7.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.813 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.93 128.77 48.48 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.99 26.02 9.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.697 0.284 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -122.03 150.27 17.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.687 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 47.97 -97.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -114.19 37.02 3.47 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.91 26.09 23.03 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.413 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 34.0 ttm180 -81.97 146.73 29.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 162' ' ' ASP . 40.0 t -81.52 134.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.14 0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.7 mt -105.25 161.32 14.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -55.63 -32.34 63.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.0 -37.51 87.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -62.5 -50.07 72.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.638 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.515 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 37.0 mm -52.66 -54.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.49 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.0 -35.08 68.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.92 95.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.601 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.42 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 47.3 t-105 -58.38 -56.48 21.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.406 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -65.94 -34.95 79.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.993 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.0 -25.01 59.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.25 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -87.16 -32.25 14.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.385 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.443 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.726 0.298 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -70.23 -37.88 75.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.833 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -61.4 177.81 0.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.436 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 75.0 t -125.53 136.73 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 111.292 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.6 mp -130.13 111.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.389 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -166.66 152.81 8.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.318 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.48 151.86 58.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.737 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.42 -27.58 32.18 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.468 2.112 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.9 -29.23 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.365 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 HG13 ' A' ' 158' ' ' VAL . 86.0 t -68.0 -48.55 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -54.63 -29.3 51.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -77.69 -39.91 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.97 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.8 t80 -66.38 -48.02 71.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.05 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.0 -45.32 82.0 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.89 -31.87 60.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.102 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.44 -37.38 21.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.847 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -84.08 23.5 1.04 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.836 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.53 20.92 25.86 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.446 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 49.1 t -109.0 143.53 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.968 0.413 . . . . 0.0 110.943 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.062 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.436 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 30.4 mm -52.31 -21.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.089 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -63.76 -34.29 77.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.05 0.452 . . . . 0.0 110.218 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.412 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.05 -3.92 58.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.867 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.9 t -116.8 129.38 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.322 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.29 94.85 10.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.287 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -59.91 134.83 50.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.011 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.17 25.99 9.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 110.652 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.46 103.94 3.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.965 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.94 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.657 0.265 . . . . 0.0 111.489 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.2 m-80 -95.85 35.18 1.42 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 111.109 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 75.3 26.11 66.81 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.502 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.425 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 27.7 ttm180 -79.24 139.16 37.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.214 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.457 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 38.2 t -74.6 133.79 30.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.199 0.523 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.7 mt -104.8 160.97 14.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.001 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -55.81 -31.55 62.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.97 -37.45 86.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -61.78 -50.0 74.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.593 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.513 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 35.6 mm -52.66 -55.18 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.558 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -55.55 -40.55 72.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.655 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.14 82.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.636 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.412 ' CZ2' ' HB3' ' A' ' 148' ' ' LEU . 41.9 t-105 -59.47 -57.01 14.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.481 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.446 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.1 mt -63.59 -31.56 72.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.939 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.61 -25.0 63.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.227 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -101.31 -48.27 1.45 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.499 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.385 -1.23 . . . . 0.0 112.466 179.961 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.3 t30 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.9 40.1 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.7 mtt85 -124.22 31.21 5.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 40.3 t -138.01 141.85 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.07 111.89 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.625 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.428 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -163.92 153.95 14.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.46 160.1 54.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.37 -28.17 83.97 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 112.258 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.1 p -91.13 -29.46 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.92 -48.33 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.448 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 65.5 mtt-85 -54.63 -29.37 51.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.061 0.458 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.71 -41.14 38.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.198 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.608 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 44.3 t80 -66.4 -48.26 70.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.911 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -64.31 -47.18 80.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 16.8 tpt180 -54.97 -31.92 61.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.72 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.69 -38.61 19.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.221 0.534 . . . . 0.0 111.192 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 138' ' ' TYR . 26.6 mmmt -82.38 24.71 0.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.831 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.23 21.88 27.49 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.445 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.417 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 54.6 t -112.33 142.25 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -116.18 129.97 56.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.453 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 34.2 mm -51.39 -22.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -63.98 -34.0 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.987 0.423 . . . . 0.0 110.384 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.96 -4.22 58.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.916 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 5.4 t -113.92 134.98 55.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.107 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.28 93.4 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -57.87 129.37 49.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.586 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 26.09 9.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 0.0 111.1 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.76 140.53 16.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.984 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.41 -91.0 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.462 0.172 . . . . 0.0 111.441 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -114.1 34.38 4.7 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.871 0.367 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 90.0 21.06 40.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.454 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.428 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 41.7 ttm180 -78.36 145.11 35.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.424 HG11 ' HB2' ' A' ' 162' ' ' ASP . 38.5 t -77.18 135.94 25.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.164 0.507 . . . . 0.0 111.322 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.2 mt -107.51 162.04 14.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.006 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -55.66 -32.05 62.89 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.821 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -65.24 -37.33 86.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.5 m-20 -62.77 -50.14 72.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.73 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.54 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 34.7 mm -52.67 -55.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -56.82 -36.58 70.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.545 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.407 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 42.2 t-105 -59.75 -54.84 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.549 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.417 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -68.85 -26.82 65.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.135 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.36 31.1 1.55 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.622 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.42 -53.56 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.595 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.509 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.782 0.325 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.8 ttm-85 59.89 66.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.951 0.405 . . . . 0.0 110.914 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -113.71 -35.2 5.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.039 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 146' ' ' ILE . 2.7 t -137.94 158.57 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.185 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.405 HG21 ' HG3' ' A' ' 157' ' ' ARG . 28.0 mt -88.9 118.48 34.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 110.99 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.08 146.31 3.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.17 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.69 146.96 79.48 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.71 -24.42 17.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.555 2.17 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 m -91.06 -37.32 13.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.085 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 158' ' ' VAL . 47.9 t -63.44 -44.13 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.65 -30.44 55.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.64 -39.45 45.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.084 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.512 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.9 t80 -66.3 -48.04 71.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.114 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.25 81.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -31.87 60.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.172 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.39 -37.47 21.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.854 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -84.27 25.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.727 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.65 20.72 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.525 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 53.7 t -111.5 143.78 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -116.17 130.21 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.786 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.41 HG22 ' HB ' ' A' ' 158' ' ' VAL . 29.7 mm -49.99 -23.7 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.383 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.41 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.8 OUTLIER -64.3 -37.02 86.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.907 0.384 . . . . 0.0 110.367 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.0 OUTLIER -81.42 -5.63 58.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.642 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.6 t -112.82 137.19 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.332 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.57 100.01 12.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -63.41 126.14 35.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.901 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 26.03 9.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.644 0.259 . . . . 0.0 110.794 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -101.71 122.05 7.43 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.349 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.69 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.6 OUTLIER -106.93 27.47 8.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.761 0.315 . . . . 0.0 111.293 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.52 26.17 21.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.8 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.408 ' HG3' ' HA ' ' A' ' 131' ' ' ALA . 27.3 ttm105 -82.19 151.99 26.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.705 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 135' ' ' VAL . 9.5 t -86.64 136.18 23.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.173 0.511 . . . . 0.0 111.117 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 27.9 mt -107.26 164.45 12.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.48 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -33.18 67.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.45 -36.47 84.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.2 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -63.65 -48.51 76.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.746 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.512 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 36.1 mm -52.9 -54.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.62 -39.2 73.21 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.621 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.4 80.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.529 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 148' ' ' LEU . 52.0 t-105 -60.53 -56.97 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.87 -33.06 75.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.04 58.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.276 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.06 -50.54 64.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.528 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.819 0.342 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -67.91 -36.44 80.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -101.65 -173.98 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 53.6 t -94.26 136.02 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.438 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.4 mp -130.08 111.88 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.706 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 157' ' ' ARG . . . -168.57 158.12 9.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.314 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.2 154.39 82.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.828 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.32 -27.53 58.05 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.639 2.226 . . . . 0.0 112.35 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -90.02 -32.11 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.07 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.415 HG13 HG13 ' A' ' 158' ' ' VAL . 97.5 t -65.53 -48.06 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.354 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 24.4 mtt180 -54.57 -28.78 48.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -77.67 -39.86 43.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.942 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.503 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.8 t80 -66.83 -48.02 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.059 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 3.4 tpt180 -54.92 -31.99 60.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.054 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.32 -36.62 22.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.067 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.1 OUTLIER -83.61 21.64 1.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.61 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.48 19.78 42.65 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.421 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 49.0 t -110.36 143.05 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.0 110.913 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -116.27 130.19 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.053 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 32.8 mm -52.38 -21.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -63.58 -34.21 77.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.058 0.456 . . . . 0.0 110.25 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.56 -4.16 58.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.859 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.57 139.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.383 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.428 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 3.8 pt20 -102.73 97.48 7.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.355 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.436 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -71.7 143.29 34.99 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.165 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.32 113.76 4.46 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.965 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.95 -85.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.372 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -105.72 37.01 2.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.83 0.347 . . . . 0.0 111.108 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 83.68 26.13 43.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.577 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.438 ' HG3' HG21 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -75.87 136.82 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.749 0.309 . . . . 0.0 111.003 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.429 ' HA ' ' CA ' ' A' ' 151' ' ' GLY . 30.5 t -73.56 132.24 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.105 0.479 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.4 mt -102.87 161.13 14.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.196 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.408 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 3.8 tttt -55.45 -31.7 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.32 -37.83 88.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.0 m-20 -61.66 -50.48 72.33 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.626 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.503 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 31.5 mm -52.79 -54.97 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.43 -39.04 72.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.541 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.22 84.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.634 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.413 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 48.1 t-105 -60.38 -57.08 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.421 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -64.92 -32.52 74.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.934 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.82 -9.92 58.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -95.26 29.51 9.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.512 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.462 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.866 0.365 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.23 154.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.23 -71.37 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 57.8 t -138.13 135.57 44.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.333 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.435 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.4 mp -130.09 111.86 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.508 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.444 ' N ' ' HG3' ' A' ' 157' ' ' ARG . . . -166.94 154.77 9.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.6 mtt -60.47 160.02 20.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.34 -25.78 80.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.462 2.108 . . . . 0.0 112.202 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -30.49 16.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' A' ' 158' ' ' VAL . 76.3 t -68.28 -47.82 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -54.68 -29.89 54.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -77.7 -39.89 43.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.059 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.16 -48.18 71.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.928 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.77 -45.89 80.84 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.81 -31.8 59.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.348 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -84.49 -37.56 21.18 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.923 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HE2' ' CE1' ' A' ' 138' ' ' TYR . 38.5 mmtt -84.58 25.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.728 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 22.05 19.29 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.697 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.435 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 51.1 t -111.18 142.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.001 0.429 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -116.16 130.21 56.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.197 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.439 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 31.0 mm -52.61 -21.26 2.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -64.0 -34.97 79.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 110.094 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.414 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.52 -1.27 57.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.855 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.07 133.39 66.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.88 0.371 . . . . 0.0 111.485 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -95.89 97.31 9.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -71.37 144.03 36.71 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.059 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.75 10.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.334 . . . . 0.0 110.629 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -87.12 107.1 3.22 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.814 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.31 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 111.332 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.8 p30 -99.32 33.26 2.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.343 . . . . 0.0 111.02 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.66 25.96 44.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -76.4 138.72 40.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.717 0.294 . . . . 0.0 111.094 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.418 ' HA ' ' CA ' ' A' ' 151' ' ' GLY . 24.6 t -72.86 137.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 111.19 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -109.42 161.33 15.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.226 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -55.97 -31.06 62.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -65.58 -37.31 86.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -62.38 -50.55 71.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.784 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.508 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 30.0 mm -52.77 -55.0 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.695 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.1 -40.16 73.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.673 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.25 87.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.87 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.414 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 52.3 t-105 -58.94 -57.25 13.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.435 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.1 mt -63.45 -32.33 73.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.83 -25.07 48.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.67 46.85 1.12 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.517 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.385 -1.231 . . . . 0.0 112.501 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.823 0.344 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.38 117.69 26.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.35 -45.85 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 68.9 t -119.66 143.82 30.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.042 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.05 111.91 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.608 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.41 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -169.87 151.26 4.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.4 mtp -58.98 149.64 65.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.87 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.35 -26.62 11.98 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -91.08 -29.23 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 99.5 t -68.09 -51.18 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.421 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 1.8 mtt-85 -54.59 -29.95 53.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -77.68 -38.8 46.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.157 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.527 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 45.8 t80 -67.54 -48.11 67.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.053 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.23 76.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 1.2 tmt_? -54.92 -32.03 60.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.036 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -84.3 -36.68 22.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.059 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.4 OUTLIER -83.47 22.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.678 -179.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.28 20.73 37.41 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.255 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.425 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 51.1 t -112.1 142.83 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -116.14 130.7 56.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.054 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.432 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 34.9 mm -51.49 -23.09 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -63.09 -34.12 76.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.496 . . . . 0.0 110.36 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.411 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.5 -6.71 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.951 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.1 t -110.87 129.62 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.891 0.376 . . . . 0.0 111.322 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.21 92.46 8.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.452 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -57.97 130.35 50.88 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.757 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.44 26.1 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.59 0.233 . . . . 0.0 111.038 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -104.6 125.2 8.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.513 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.82 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -114.08 31.36 6.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 92.62 26.08 18.64 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.721 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.41 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 40.3 ttp180 -81.01 149.61 29.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.045 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.0 t -83.51 135.45 24.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.21 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.5 mt -106.2 160.93 14.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.955 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -55.63 -32.38 63.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.664 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -65.12 -37.28 86.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -62.14 -49.91 73.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.762 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.527 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 34.8 mm -52.69 -55.02 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.524 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -57.35 -36.24 70.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.626 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.98 99.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.646 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.411 ' CZ3' ' O ' ' A' ' 148' ' ' LEU . 54.9 t-105 -57.22 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.482 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -64.21 -31.77 73.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.912 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.9 -25.11 64.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.06 31.34 17.61 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.512 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.493 -179.978 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.781 0.324 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.43 90.15 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.1 -174.65 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.972 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 146' ' ' ILE . 2.5 t -120.09 157.86 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.404 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.2 mp -87.16 111.9 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.115 0.484 . . . . 0.0 111.079 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.411 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -165.55 149.82 8.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.425 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 1.7 mmt -64.67 154.53 84.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.716 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.72 -33.71 94.47 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.708 2.272 . . . . 0.0 112.531 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.83 -33.21 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.104 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 53.6 t -69.08 -45.76 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.308 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 8.1 mtm180 -54.62 -31.44 57.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -38.81 46.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.078 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.492 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.9 t80 -66.49 -47.91 71.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.94 -45.7 77.01 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.71 -32.08 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.128 178.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.47 -37.58 21.17 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.593 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -81.86 20.39 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.725 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.01 48.73 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.13 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.51 144.3 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 110.941 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -116.28 130.73 56.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.123 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 146' ' ' ILE . 33.4 mm -49.98 -23.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.162 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -63.71 -35.99 82.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.005 0.431 . . . . 0.0 110.545 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.36 -0.52 56.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.093 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.6 t -116.51 131.53 68.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.65 106.14 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -69.0 129.71 24.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.72 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.04 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.608 0.242 . . . . 0.0 111.003 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.91 143.35 17.41 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.894 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt 49.67 -91.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -114.2 22.95 13.32 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.593 0.235 . . . . 0.0 111.444 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 26.05 6.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.759 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HG3' ' HA ' ' A' ' 131' ' ' ALA . 38.3 ttm180 -83.28 143.07 30.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.681 0.276 . . . . 0.0 111.006 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.422 HG13 HG13 ' A' ' 135' ' ' VAL . 13.8 t -78.88 134.79 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 111.112 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 15.2 mt -107.1 165.81 11.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.54 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -34.39 68.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -36.36 83.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.4 m-20 -64.6 -48.57 74.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.75 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.492 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 38.3 mm -52.92 -54.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.575 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -56.85 -38.84 73.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.568 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.69 -38.19 84.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.489 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.413 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 48.6 t-105 -60.03 -57.08 14.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.601 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -32.39 73.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.909 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.03 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.56 58.99 1.38 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.345 -1.253 . . . . 0.0 112.518 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.792 0.33 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -132.47 30.48 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -139.57 -64.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.42 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 55.9 t -137.95 136.13 45.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.308 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.08 111.86 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.252 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.13 154.61 9.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.166 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 mtp -61.34 151.23 77.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.15 -26.01 24.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.2 . . . . 0.0 112.42 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 p -91.04 -30.36 16.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.409 ' CG1' HG13 ' A' ' 158' ' ' VAL . 58.9 t -67.24 -47.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.533 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 1.4 mtp-105 -54.68 -30.02 54.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 0.0 109.887 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -77.59 -40.39 42.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.198 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.522 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.01 -48.11 72.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.049 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.08 -45.56 80.83 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.82 -31.75 59.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.16 178.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.39 -37.46 21.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.901 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.421 ' HE3' ' CE1' ' A' ' 138' ' ' TYR . 19.0 mmtp -84.3 25.26 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.761 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.09 21.78 18.93 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.532 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.418 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 54.8 t -110.66 142.29 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.902 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.42 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 29.3 mm -51.22 -22.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 -62.7 -33.7 75.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.33 -7.16 57.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.846 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.2 t -111.15 140.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.848 0.356 . . . . 0.0 111.334 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.29 90.8 4.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.4 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -61.64 135.33 47.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.878 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.98 9.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.591 0.234 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.79 127.08 9.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.107 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt 57.02 -86.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.548 0.213 . . . . 0.0 111.509 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.28 29.71 7.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.218 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 94.46 26.12 14.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.416 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 33.9 ttm180 -83.38 137.71 33.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 110.841 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.409 HG13 ' CG1' ' A' ' 135' ' ' VAL . 39.1 t -70.87 138.03 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.191 0.52 . . . . 0.0 111.467 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.2 mt -111.88 162.91 14.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.824 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -56.01 -31.59 63.22 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.42 -36.47 84.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -63.48 -49.97 71.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.673 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.522 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 34.4 mm -52.76 -54.92 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.704 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -55.91 -39.88 72.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.664 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.01 80.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.691 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.41 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 45.2 t-105 -60.74 -57.02 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.574 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.418 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -64.8 -32.51 74.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.79 -24.99 44.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.314 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.81 29.01 55.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.42 -1.211 . . . . 0.0 112.416 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.875 0.369 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 78.12 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -155.4 160.89 41.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 41.2 t -121.74 140.25 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.08 111.89 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.646 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.436 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -165.64 148.88 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.015 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -57.41 159.96 7.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.717 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.84 -25.92 82.12 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.578 2.185 . . . . 0.0 112.248 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -91.05 -29.46 17.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.45 HG13 HG13 ' A' ' 158' ' ' VAL . 62.1 t -70.18 -47.53 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.396 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -54.53 -31.25 55.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.64 -38.76 47.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.213 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.2 t80 -66.77 -48.09 70.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.056 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.31 -45.73 79.33 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -54.88 -31.81 60.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -84.43 -37.6 21.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -83.98 25.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.737 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.43 20.08 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.506 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.427 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 49.4 t -111.48 143.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.984 0.421 . . . . 0.0 110.972 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -116.21 130.85 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.429 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 28.1 mm -52.35 -22.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mmm-85 -64.11 -33.93 76.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.939 0.399 . . . . 0.0 110.439 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.18 -4.01 59.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.076 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 10.8 t -111.54 146.75 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.878 0.37 . . . . 0.0 111.186 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.4 95.43 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.5 128.6 48.0 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.709 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.16 26.12 9.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 0.0 111.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.81 143.83 18.03 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.001 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 49.28 -91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -114.01 29.9 7.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.741 0.305 . . . . 0.0 111.322 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.68 26.04 12.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.659 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.436 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 38.5 ttm180 -82.63 145.93 29.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.731 0.3 . . . . 0.0 110.905 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.45 HG13 HG13 ' A' ' 135' ' ' VAL . 41.1 t -79.31 134.63 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.275 0.559 . . . . 0.0 111.279 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.6 mt -106.35 162.01 14.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.972 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -31.7 62.38 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -37.76 87.93 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.1 m-20 -62.16 -50.15 72.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.742 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.519 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 34.5 mm -52.73 -54.93 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.639 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.11 -36.01 67.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.661 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.24 90.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.407 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 38.9 t-105 -59.67 -56.71 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.559 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.427 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -64.83 -31.42 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.01 64.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 125.17 -28.92 4.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.437 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.472 -179.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.92 74.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.31 -33.62 5.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 53.4 t -117.26 147.26 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.229 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.07 111.79 22.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.651 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.19 154.28 4.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.89 147.63 78.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.695 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.45 -25.53 14.33 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.572 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.7 p -91.01 -28.96 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.66 -47.61 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.468 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.9 mtp180 -54.71 -30.68 56.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -77.63 -39.24 45.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.126 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.5 t80 -66.48 -48.21 70.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.49 -45.47 79.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 3.5 tpt180 -54.8 -31.71 59.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.267 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.47 -38.21 20.41 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.924 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -82.99 26.45 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.885 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.84 22.25 18.54 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.471 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.417 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 54.1 t -111.68 144.01 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 111.044 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -116.29 131.1 57.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.97 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 35.0 mm -52.4 -22.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -64.58 -33.61 76.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.982 0.42 . . . . 0.0 110.421 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.411 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.93 -1.4 57.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.961 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.7 t -114.64 146.11 19.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -104.65 108.5 19.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' CA ' HG21 ' A' ' 158' ' ' VAL . . . -66.96 126.1 25.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.764 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.26 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.716 0.293 . . . . 0.0 111.016 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.23 142.31 17.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.12 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.406 ' CE ' ' HA ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER 49.87 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -114.02 31.72 6.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.69 0.281 . . . . 0.0 111.326 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.13 17.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.721 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -84.29 148.09 26.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.711 0.291 . . . . 0.0 110.742 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.408 HG21 ' CA ' ' A' ' 151' ' ' GLY . 10.1 t -81.63 137.99 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 111.223 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.9 mt -110.35 161.92 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.345 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -55.64 -32.65 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.3 -37.38 87.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.277 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -62.39 -48.5 79.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.701 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.502 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 39.4 mm -52.83 -54.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.502 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.94 -35.29 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.526 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.14 89.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.504 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.411 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 39.9 t-105 -59.93 -57.01 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.417 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -64.81 -32.06 73.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.03 64.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.251 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -119.0 27.97 6.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.457 -1.191 . . . . 0.0 112.51 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 p30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.784 0.326 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -124.95 175.32 7.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.0 169.51 9.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 26.3 t -138.01 149.74 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.132 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.06 111.94 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.618 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.403 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -169.99 151.2 3.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.31 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.404 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 1.4 mtp -58.27 148.47 62.92 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.12 -25.32 22.58 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.562 2.174 . . . . 0.0 112.506 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.2 m -90.94 -34.0 15.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 92.7 t -62.79 -47.56 92.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.4 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 37.7 mtp85 -54.66 -28.1 44.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.035 0.445 . . . . 0.0 110.002 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -41.57 37.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.928 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.613 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 40.4 t80 -66.3 -48.29 70.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.816 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.15 85.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.4 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.95 -32.11 61.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.5 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -84.69 -38.42 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 111.104 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 138' ' ' TYR . 27.0 mmmt -82.19 25.48 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.976 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 23.65 23.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.342 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.65 142.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.06 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -116.24 131.86 56.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.702 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.466 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 32.9 mm -50.29 -23.77 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.712 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.413 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.4 OUTLIER -66.31 -33.19 75.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.893 0.378 . . . . 0.0 110.377 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.413 ' CD2' ' HG3' ' A' ' 147' ' ' ARG . 1.4 mt -85.52 -1.86 57.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.412 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 5.0 t -115.56 127.21 73.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.81 0.338 . . . . 0.0 111.475 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.01 92.4 7.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.425 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -57.38 129.13 49.03 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.981 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.12 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.727 0.299 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -100.06 117.03 5.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 153' ' ' GLY . 4.1 p30 -101.73 31.31 3.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.62 26.16 43.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.677 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.403 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 43.7 ttm180 -80.13 150.91 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 146' ' ' ILE . 21.9 t -84.67 133.73 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 21.0 mt -106.83 162.41 13.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.66 -33.18 63.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -62.87 -48.48 78.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.785 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.527 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 32.5 mm -52.76 -53.82 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.428 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.74 -38.36 75.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.523 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.84 86.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.412 ' CZ3' ' O ' ' A' ' 148' ' ' LEU . 50.8 t-105 -59.2 -57.06 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.24 -33.68 76.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.27 -25.08 59.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.229 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.66 67.91 1.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.559 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.474 179.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.795 0.331 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.11 -44.73 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -167.73 1.87 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.8 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 55.8 t -137.58 138.53 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.985 0.421 . . . . 0.0 111.173 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.03 111.79 22.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.47 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.423 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.2 152.02 7.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.163 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.3 mtp -58.7 160.04 11.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.22 -25.8 81.22 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 m -91.03 -30.92 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.457 HG13 HG13 ' A' ' 158' ' ' VAL . 45.1 t -69.11 -47.15 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.541 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.5 mtp180 -54.61 -31.22 56.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.69 -38.21 47.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.82 -48.09 70.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.077 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.38 -45.42 80.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.77 59.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.285 178.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -84.45 -37.78 20.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.905 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -83.61 25.85 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.728 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.03 21.8 18.53 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.381 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.418 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 55.9 t -111.12 142.42 23.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.009 0.433 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.21 130.47 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.426 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 34.8 mm -50.7 -23.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtp-105 -63.8 -35.74 81.6 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.7 OUTLIER -85.51 -4.07 59.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 8.6 t -113.46 149.2 15.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 111.241 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -107.29 102.55 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.403 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -62.39 129.73 43.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.0 9.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.712 0.291 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.2 141.57 17.09 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.077 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.61 -91.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -113.98 34.33 4.7 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.735 0.302 . . . . 0.0 111.271 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 89.93 26.09 25.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.763 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.423 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 22.6 ttm180 -82.55 142.63 31.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.854 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.457 HG13 HG13 ' A' ' 135' ' ' VAL . 37.5 t -76.75 133.32 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.231 0.538 . . . . 0.0 111.196 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.3 mt -107.86 163.9 12.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.075 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.45 -32.4 62.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.93 -37.72 88.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -62.18 -50.52 71.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.753 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.523 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 29.9 mm -52.74 -55.04 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.733 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.43 -38.46 69.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.636 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.89 89.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 148' ' ' LEU . 46.1 t-105 -59.16 -57.15 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.418 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.1 mt -64.45 -30.24 71.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.023 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.99 -24.95 64.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.09 -27.81 43.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.556 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.427 -1.207 . . . . 0.0 112.462 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.0 p30 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.814 0.34 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 124.57 28.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.35 56.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.2 156.84 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.418 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.4 mp -88.85 111.95 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.21 0.529 . . . . 0.0 111.211 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -168.68 143.69 3.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.1 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.416 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 9.9 mmt -55.55 150.28 25.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.45 -29.78 70.43 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.04 -33.46 21.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 93.3 t -66.36 -46.81 86.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.304 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 42.0 mtp180 -54.64 -28.88 50.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.027 0.442 . . . . 0.0 109.867 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -77.67 -41.61 37.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.055 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.48 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.4 t80 -65.2 -47.99 74.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.44 82.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.8 tpt85 -54.71 -31.84 58.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.3 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.46 -37.54 21.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 167' ' ' LEU . 47.6 mmtt -84.14 22.35 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.797 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.3 19.06 31.13 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.594 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.419 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 65.3 t -104.96 143.24 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.3 t0 -116.16 129.09 56.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.934 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 146' ' ' ILE . 35.5 mm -50.66 -22.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.25 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -64.32 -33.71 76.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.99 0.424 . . . . 0.0 110.595 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.409 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.2 OUTLIER -91.37 1.73 56.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 4.0 t -119.09 120.12 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.71 96.23 8.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.4 ' HA2' ' N ' ' A' ' 158' ' ' VAL . . . -68.85 134.78 27.85 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.114 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.18 26.02 9.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 110.695 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.12 112.74 4.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.935 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.2 -85.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 153' ' ' GLY . 69.9 m-80 -97.75 33.66 2.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.769 0.319 . . . . 0.0 111.098 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.52 26.03 61.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.603 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.418 ' HG3' HG21 ' A' ' 130' ' ' ILE . 1.8 ttm105 -81.33 137.92 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.4 ' N ' ' HA2' ' A' ' 151' ' ' GLY . 9.5 t -71.31 137.38 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -108.38 163.9 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.454 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -57.24 -34.8 68.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.25 -36.26 83.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.0 m-20 -64.24 -48.01 77.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.48 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 39.2 mm -52.87 -54.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.544 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -56.56 -39.02 72.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.15 88.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.409 ' CZ3' ' O ' ' A' ' 148' ' ' LEU . 49.6 t-105 -58.72 -57.05 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.419 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.4 mt -61.13 -26.56 67.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.213 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.87 -24.97 64.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.159 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.16 34.92 6.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.564 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.434 -1.203 . . . . 0.0 112.457 179.909 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.815 0.34 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.01 173.39 6.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.36 116.54 3.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.001 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.4 ' CG1' ' CG2' ' A' ' 146' ' ' ILE . 2.9 t -93.36 157.42 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.793 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.476 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.0 mp -83.44 111.81 20.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.284 0.564 . . . . 0.0 111.192 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.12 147.05 3.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 5.9 mtp -57.38 155.11 20.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.737 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.9 -24.23 78.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.548 2.165 . . . . 0.0 112.303 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 -36.21 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.425 HG13 HG13 ' A' ' 158' ' ' VAL . 47.3 t -64.69 -44.26 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.358 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -29.99 54.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 109.727 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -40.48 41.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.974 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.501 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.3 t80 -65.47 -48.03 74.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.081 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.4 -45.18 80.88 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -54.88 -31.84 60.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.057 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.43 -37.54 21.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.425 ' HE3' ' CE1' ' A' ' 138' ' ' TYR . 18.1 mmtp -84.46 25.36 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.748 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.8 21.17 21.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.412 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 53.6 t -109.51 143.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -116.17 130.62 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.123 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.469 HD11 HG22 ' A' ' 146' ' ' ILE . 33.9 mm -50.77 -22.65 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.198 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -63.68 -35.76 81.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.059 0.457 . . . . 0.0 110.32 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.96 -0.43 56.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.993 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.96 130.86 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 111.268 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 101.43 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.607 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -65.03 129.24 34.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.943 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.44 25.99 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.325 . . . . 0.0 110.697 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.86 123.52 7.78 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.259 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt 56.5 -84.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -113.09 37.0 3.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.675 0.274 . . . . 0.0 111.484 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 89.39 26.19 26.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.768 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.476 ' HG3' HG21 ' A' ' 130' ' ' ILE . 2.6 ttt180 -81.61 142.93 32.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.507 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 8.3 t -82.63 128.0 39.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.168 0.508 . . . . 0.0 110.728 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 15.8 mt -100.55 165.86 11.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.66 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -57.61 -32.78 67.54 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.51 -36.63 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.3 m-20 -64.26 -49.02 73.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.591 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.501 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 39.6 mm -52.96 -54.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.608 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.63 -39.56 71.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.86 83.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 148' ' ' LEU . 42.9 t-105 -59.77 -57.06 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.555 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.412 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.1 mt -65.26 -31.15 72.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.98 64.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.187 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.67 29.97 11.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.52 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.806 0.336 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -81.38 116.59 21.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -105.26 -29.64 10.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 42.5 t -96.73 135.16 31.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 111.413 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.425 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.6 mp -130.04 111.9 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.428 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -164.56 151.42 11.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.219 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.92 157.34 11.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.888 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.45 -24.6 78.36 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.581 2.187 . . . . 0.0 112.133 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.0 p -90.95 -30.37 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.995 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.9 t -66.73 -47.02 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 37.9 mtp85 -54.67 -30.04 54.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -40.37 42.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.179 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.9 t80 -66.39 -48.14 71.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.978 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.406 ' HB1' ' CD1' ' A' ' 163' ' ' ILE . . . -65.34 -46.16 81.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.98 -31.83 61.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.38 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -84.44 -37.22 21.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HB3' ' CD1' ' A' ' 167' ' ' LEU . 45.4 mmtt -84.19 25.06 0.88 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.721 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 22.41 19.59 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.523 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.402 ' CG2' ' HG ' ' A' ' 167' ' ' LEU . 46.7 t -111.5 143.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.992 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -116.19 130.01 56.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.942 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.432 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 20.7 mm -51.86 -22.15 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -63.77 -33.99 76.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.006 0.431 . . . . 0.0 110.299 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.97 -4.69 59.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 162' ' ' ASP . 6.1 t -110.97 147.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.264 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.8 99.6 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.684 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.402 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -59.09 126.93 43.95 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.688 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.0 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.631 0.253 . . . . 0.0 111.01 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.45 141.76 16.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.986 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.28 -91.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -114.19 24.23 12.16 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.634 0.254 . . . . 0.0 111.477 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 103.71 26.1 6.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.878 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.425 ' HG3' HG21 ' A' ' 130' ' ' ILE . 20.8 ttm105 -84.22 147.43 27.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.745 0.307 . . . . 0.0 110.825 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 146' ' ' ILE . 14.9 t -80.28 138.05 20.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.2 mt -112.06 165.09 12.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.28 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.419 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 23.4 tttt -57.01 -33.68 67.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.39 -36.95 85.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.5 m-20 -63.17 -50.51 70.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.634 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.523 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 30.7 mm -52.93 -54.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.546 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -57.59 -35.13 70.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.476 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.27 97.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.502 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.407 ' CH2' ' O ' ' A' ' 148' ' ' LEU . 47.2 t-105 -58.73 -56.7 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.73 -29.75 70.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.069 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.66 31.08 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.289 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.08 80.72 0.1 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.522 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.483 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.2 mp . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 121.087 0.47 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.63 149.21 5.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.988 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.4 mtm -56.37 158.15 8.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.4 -24.89 79.05 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.496 2.131 . . . . 0.0 112.332 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 m -91.12 -31.78 16.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.698 HG11 HG12 ' A' ' 158' ' ' VAL . 43.7 t -68.52 -45.2 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.6 mtp-105 -54.61 -31.82 57.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.62 -38.48 47.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.238 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.545 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.6 t80 -66.41 -48.06 71.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.011 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.006 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.23 -45.59 80.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 11.2 ttt85 -54.78 -31.67 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.402 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.36 -39.48 19.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.709 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.591 ' HB3' HD11 ' A' ' 167' ' ' LEU . 45.6 mmtt -80.25 9.98 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.605 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.9 8.77 64.84 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.526 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 167' ' ' LEU . 48.8 t -96.64 143.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.986 0.422 . . . . 0.0 110.703 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 22.4 t0 -116.06 129.4 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.912 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.822 HG23 HG21 ' A' ' 158' ' ' VAL . 32.1 mm -51.04 -22.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -64.18 -34.38 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.02 0.438 . . . . 0.0 110.429 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.3 OUTLIER -88.25 -2.14 58.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.984 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 162' ' ' ASP . 7.4 t -115.19 139.08 43.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.9 0.381 . . . . 0.0 111.376 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -98.1 90.72 4.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.576 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.6 134.07 52.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.766 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.35 26.07 9.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.629 0.252 . . . . 0.0 111.009 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -105.13 127.63 9.11 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.156 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.28 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.577 0.227 . . . . 0.0 111.492 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -110.13 30.23 6.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.811 0.338 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.08 26.01 25.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.714 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.619 ' HA ' HG22 ' A' ' 130' ' ' ILE . 31.9 ttm180 -79.48 138.9 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.822 HG21 HG23 ' A' ' 146' ' ' ILE . 45.7 t -72.07 132.68 33.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 111.425 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.1 mt -105.66 162.5 13.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.756 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -55.74 -31.42 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.99 -37.59 86.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB3' HG11 ' A' ' 149' ' ' VAL . 4.7 m-20 -61.69 -49.98 74.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.664 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.006 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.0 mm -52.69 -54.8 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.473 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.88 -38.61 73.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.46 89.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.568 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.564 ' HD1' HG22 ' A' ' 144' ' ' VAL . 51.6 t-105 -58.4 -57.01 14.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.636 HD21 HG23 ' A' ' 144' ' ' VAL . 1.9 mt -65.58 -27.35 68.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.066 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.294 -179.81 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.556 HG22 ' CB ' ' A' ' 157' ' ' ARG . 3.8 mp . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.929 0.395 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' ' 136' ' ' ARG . . . -161.28 150.39 16.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.344 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.5 mtp -59.98 159.59 19.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.785 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.4 -26.27 82.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.569 2.179 . . . . 0.0 112.157 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 p -91.04 -29.58 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.727 HG11 HG12 ' A' ' 158' ' ' VAL . 61.4 t -70.06 -48.82 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.382 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.445 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 42.2 mtt-85 -54.58 -30.03 53.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -40.07 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.119 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.17 -48.15 71.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.067 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.989 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.22 -45.35 81.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -54.83 -31.82 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.133 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.49 -37.54 21.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.853 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.779 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.4 mmtt -84.03 26.1 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.862 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.0 18.71 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.557 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.555 HG22 ' HD1' ' A' ' 166' ' ' TRP . 54.4 t -112.26 141.06 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.05 0.452 . . . . 0.0 110.944 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -116.21 131.23 57.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.624 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.834 HG23 HG21 ' A' ' 158' ' ' VAL . 32.6 mm -50.82 -23.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.628 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -65.12 -31.96 73.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.932 0.396 . . . . 0.0 110.287 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.5 mt -86.07 -7.66 58.45 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.658 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.3 t -111.08 145.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 120.974 0.416 . . . . 0.0 111.435 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.71 88.48 2.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.197 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -64.43 137.09 39.71 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.049 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.38 26.06 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.754 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.79 121.76 6.77 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.402 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.52 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' GLY . 17.0 m-80 -114.08 36.86 3.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.18 26.08 34.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.617 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.556 ' CB ' HG22 ' A' ' 130' ' ' ILE . 18.1 ttm180 -82.06 142.5 32.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.834 HG21 HG23 ' A' ' 146' ' ' ILE . 38.6 t -75.94 137.95 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.477 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.5 mt -110.41 161.38 15.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.702 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -55.43 -31.8 62.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.774 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -64.61 -38.05 89.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.501 ' HB3' HG11 ' A' ' 149' ' ' VAL . 6.7 m-20 -62.16 -49.94 73.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.737 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.989 HD12 ' HB2' ' A' ' 139' ' ' ALA . 37.9 mm -52.69 -55.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.66 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.79 -37.3 68.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.89 92.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.855 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.555 ' HD1' HG22 ' A' ' 144' ' ' VAL . 55.3 t-105 -58.34 -57.1 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -63.34 -31.33 72.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.953 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.21 179.893 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.063 0.458 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.559 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -165.53 149.12 8.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.4 mtm -61.8 160.06 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.13 -25.91 72.92 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.651 2.234 . . . . 0.0 112.231 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.5 p -90.97 -31.01 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.038 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.762 HG11 HG12 ' A' ' 158' ' ' VAL . 60.5 t -68.84 -47.35 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.37 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.559 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 26.1 mtp180 -54.66 -30.09 54.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.462 . . . . 0.0 109.892 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -77.7 -41.12 39.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.165 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.521 ' CD2' HG21 ' A' ' 163' ' ' ILE . 52.0 t80 -65.5 -48.17 73.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.02 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.9 -45.44 81.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -54.91 -31.84 60.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.096 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.52 -37.58 21.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.947 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.768 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.1 mmtp -84.13 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.814 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.14 18.61 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.66 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.554 HG23 HD21 ' A' ' 167' ' ' LEU . 52.4 t -110.59 143.66 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.046 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -116.19 131.32 56.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.016 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' A' ' 131' ' ' ALA . 41.7 mm -50.88 -23.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.226 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -63.96 -34.86 78.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.046 0.451 . . . . 0.0 110.469 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.412 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -89.52 -0.07 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.981 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' A' ' 158' ' ' VAL . 3.3 t -118.85 113.28 41.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.88 0.372 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.31 105.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.188 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -66.28 128.87 31.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.753 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 26.08 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.637 0.256 . . . . 0.0 110.96 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.24 126.42 8.08 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.309 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.49 -89.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.09 21.73 14.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.555 0.217 . . . . 0.0 111.464 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 110.61 26.14 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.809 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.592 ' HA ' HG22 ' A' ' 130' ' ' ILE . 18.2 ttp-105 -85.72 146.94 26.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.762 HG12 HG11 ' A' ' 135' ' ' VAL . 12.5 t -83.61 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.093 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.0 mt -107.87 165.05 11.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.39 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.416 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 1.6 tttt -57.5 -34.37 69.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.29 -36.09 82.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.3 m-20 -64.94 -48.65 73.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 139' ' ' ALA . 41.5 mm -52.87 -54.79 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.13 -40.81 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.677 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.65 83.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.524 ' HD1' HG22 ' A' ' 144' ' ' VAL . 45.9 t-105 -58.82 -57.12 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.768 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.44 -33.59 76.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.942 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.184 0.516 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -170.11 147.77 3.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.945 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.1 mtm -54.54 148.91 23.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.991 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.77 -26.6 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.659 2.239 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -89.76 -28.18 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.803 HG11 HG12 ' A' ' 158' ' ' VAL . 48.7 t -71.23 -45.86 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.52 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 11.5 mtp-105 -54.67 -32.01 58.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.145 0.498 . . . . 0.0 109.735 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -40.14 41.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.1 t80 -65.67 -48.15 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.12 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.947 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.55 -45.08 80.55 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 15.4 tpt180 -54.91 -31.94 60.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.022 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -84.42 -38.13 20.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.952 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.741 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.2 mmtt -83.46 24.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.805 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.38 21.73 20.87 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.497 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.545 HG23 HD21 ' A' ' 167' ' ' LEU . 49.6 t -109.95 142.89 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.907 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -116.1 129.98 56.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.066 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 158' ' ' VAL . 31.0 mm -51.73 -21.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.239 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -64.45 -34.45 78.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.405 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.91 -1.11 57.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.928 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.1 t -115.1 151.0 16.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 0.6 OUTLIER -111.59 96.59 6.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -67.82 135.31 30.42 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.963 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.33 26.01 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.635 0.255 . . . . 0.0 110.946 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.0 131.14 10.5 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.102 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.04 -87.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.605 0.241 . . . . 0.0 111.375 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.04 29.13 8.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.777 0.323 . . . . 0.0 111.012 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 96.87 18.26 30.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.697 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.66 ' HA ' HG22 ' A' ' 130' ' ' ILE . 3.2 ttm180 -73.0 138.98 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 110.971 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.803 HG12 HG11 ' A' ' 135' ' ' VAL . 31.9 t -71.26 138.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.185 0.517 . . . . 0.0 111.551 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.1 mt -109.84 161.74 15.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.53 -32.44 62.94 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.742 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -64.33 -37.38 87.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.267 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.486 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.9 m-20 -62.57 -50.03 72.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.76 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.947 HD12 ' HB2' ' A' ' 139' ' ' ALA . 33.8 mm -52.74 -55.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.654 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.16 -38.97 71.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.726 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.09 84.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.545 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.542 ' HD1' HG22 ' A' ' 144' ' ' VAL . 44.8 t-105 -60.19 -57.03 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.741 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -64.55 -30.19 71.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.858 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.528 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -161.63 149.11 14.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.355 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -59.37 150.82 62.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.08 -26.81 15.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.526 2.151 . . . . 0.0 112.352 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 -29.64 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.072 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.562 HG11 HG12 ' A' ' 158' ' ' VAL . 86.1 t -68.32 -50.27 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.385 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.653 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 10.3 mtt180 -54.64 -30.18 54.33 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -77.67 -39.63 44.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.142 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.521 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 47.5 t80 -66.9 -48.11 69.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.165 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.018 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.5 -45.92 77.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.89 -31.98 60.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.033 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.41 -36.97 22.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.992 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.73 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -82.19 19.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.733 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.5 19.88 49.45 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.977 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.563 HG22 ' HD1' ' A' ' 166' ' ' TRP . 50.0 t -110.75 143.56 20.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 111.022 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 59.7 t0 -116.23 130.56 56.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.947 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.777 HG23 HG21 ' A' ' 158' ' ' VAL . 34.6 mm -51.0 -23.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -63.33 -34.27 77.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.542 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.42 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -86.62 -6.46 58.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.971 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 162' ' ' ASP . 7.1 t -107.82 152.33 9.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.88 0.372 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.85 97.51 7.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.813 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -58.93 128.77 48.48 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.559 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.99 26.02 9.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.697 0.284 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -122.03 150.27 17.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.687 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 47.97 -97.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -114.19 37.02 3.47 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.91 26.09 23.03 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.528 ' CB ' HG22 ' A' ' 130' ' ' ILE . 34.0 ttm180 -81.97 146.73 29.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.777 HG21 HG23 ' A' ' 146' ' ' ILE . 40.0 t -81.52 134.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.14 0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.7 mt -105.25 161.32 14.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -55.63 -32.34 63.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.0 -37.51 87.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.521 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -62.5 -50.07 72.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.638 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.018 HD12 ' HB2' ' A' ' 139' ' ' ALA . 37.0 mm -52.66 -54.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.49 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.0 -35.08 68.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.92 95.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.601 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.563 ' HD1' HG22 ' A' ' 144' ' ' VAL . 47.3 t-105 -58.38 -56.48 21.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.94 -34.95 79.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.993 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.25 179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.449 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -166.66 152.81 8.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.318 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -59.48 151.86 58.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.737 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.42 -27.58 32.18 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.468 2.112 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.9 -29.23 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.365 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 158' ' ' VAL . 86.0 t -68.0 -48.55 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.406 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 3.5 mtt180 -54.63 -29.3 51.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -77.69 -39.91 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.97 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.8 t80 -66.38 -48.02 71.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.05 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.983 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.0 -45.32 82.0 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.89 -31.87 60.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.102 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.44 -37.38 21.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.847 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.724 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.6 mmtt -84.08 23.5 1.04 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.836 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.53 20.92 25.86 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.57 HG23 HD21 ' A' ' 167' ' ' LEU . 49.1 t -109.0 143.53 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.968 0.413 . . . . 0.0 110.943 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.062 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.843 HG23 HG21 ' A' ' 158' ' ' VAL . 30.4 mm -52.31 -21.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.089 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -63.76 -34.29 77.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.05 0.452 . . . . 0.0 110.218 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.05 -3.92 58.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.867 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.9 t -116.8 129.38 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.322 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.29 94.85 10.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.287 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -59.91 134.83 50.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.011 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.17 25.99 9.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 110.652 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.46 103.94 3.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.965 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.94 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.657 0.265 . . . . 0.0 111.489 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.2 m-80 -95.85 35.18 1.42 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 111.109 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 75.3 26.11 66.81 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.502 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.675 ' HA ' HG22 ' A' ' 130' ' ' ILE . 27.7 ttm180 -79.24 139.16 37.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.214 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.843 HG21 HG23 ' A' ' 146' ' ' ILE . 38.2 t -74.6 133.79 30.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.199 0.523 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.7 mt -104.8 160.97 14.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.001 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -55.81 -31.55 62.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.97 -37.45 86.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -61.78 -50.0 74.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.593 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.983 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.6 mm -52.66 -55.18 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.558 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -55.55 -40.55 72.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.655 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.14 82.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.636 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.483 ' HD1' HG22 ' A' ' 144' ' ' VAL . 41.9 t-105 -59.47 -57.01 14.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.481 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -63.59 -31.56 72.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.939 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.227 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.517 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.3 mp . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 121.009 0.433 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -163.92 153.95 14.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -64.46 160.1 54.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.37 -28.17 83.97 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 112.258 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.1 p -91.13 -29.46 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 158' ' ' VAL . 95.9 t -68.92 -48.33 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.448 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.438 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 65.5 mtt-85 -54.63 -29.37 51.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.061 0.458 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.71 -41.14 38.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.198 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.617 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 44.3 t80 -66.4 -48.26 70.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.911 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.053 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.31 -47.18 80.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 16.8 tpt180 -54.97 -31.92 61.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.72 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.69 -38.61 19.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.221 0.534 . . . . 0.0 111.192 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.799 ' O ' HD21 ' A' ' 167' ' ' LEU . 26.6 mmmt -82.38 24.71 0.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.831 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.23 21.88 27.49 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.445 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.644 HG23 HD21 ' A' ' 167' ' ' LEU . 54.6 t -112.33 142.25 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -116.18 129.97 56.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.804 HG23 HG21 ' A' ' 158' ' ' VAL . 34.2 mm -51.39 -22.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -63.98 -34.0 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.987 0.423 . . . . 0.0 110.384 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.96 -4.22 58.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.916 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' A' ' 162' ' ' ASP . 5.4 t -113.92 134.98 55.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.107 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.28 93.4 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.417 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.87 129.37 49.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.586 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 26.09 9.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 0.0 111.1 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.76 140.53 16.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.984 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.41 -91.0 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.462 0.172 . . . . 0.0 111.441 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -114.1 34.38 4.7 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.871 0.367 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.0 21.06 40.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.454 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.517 ' HA ' HG22 ' A' ' 130' ' ' ILE . 41.7 ttm180 -78.36 145.11 35.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.804 HG21 HG23 ' A' ' 146' ' ' ILE . 38.5 t -77.18 135.94 25.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.164 0.507 . . . . 0.0 111.322 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.2 mt -107.51 162.04 14.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.006 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -55.66 -32.05 62.89 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.821 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -65.24 -37.33 86.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.514 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.5 m-20 -62.77 -50.14 72.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.73 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.053 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.7 mm -52.67 -55.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -56.82 -36.58 70.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.545 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.587 ' HD1' HG22 ' A' ' 144' ' ' VAL . 42.2 t-105 -59.75 -54.84 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.549 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -68.85 -26.82 65.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.135 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.622 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.598 HG22 ' CB ' ' A' ' 157' ' ' ARG . 28.0 mt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.013 0.435 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.462 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -170.08 146.31 3.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.17 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -59.69 146.96 79.48 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.71 -24.42 17.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.555 2.17 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 m -91.06 -37.32 13.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.085 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.619 HG11 HG12 ' A' ' 158' ' ' VAL . 47.9 t -63.44 -44.13 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.2 OUTLIER -54.65 -30.44 55.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.64 -39.45 45.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.084 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.9 t80 -66.3 -48.04 71.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.114 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.11 -45.25 81.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -54.88 -31.87 60.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.172 178.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.39 -37.47 21.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.854 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.754 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.2 mmtt -84.27 25.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.727 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.65 20.72 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.525 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.551 HG23 HD21 ' A' ' 167' ' ' LEU . 53.7 t -111.5 143.78 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.403 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 15.9 t0 -116.17 130.21 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.786 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 131' ' ' ALA . 29.7 mm -49.99 -23.7 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.383 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.81 ' HG3' HD23 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -64.3 -37.02 86.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.907 0.384 . . . . 0.0 110.367 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.81 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.0 OUTLIER -81.42 -5.63 58.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.642 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 162' ' ' ASP . 4.6 t -112.82 137.19 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.332 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.57 100.01 12.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -63.41 126.14 35.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.901 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 26.03 9.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.644 0.259 . . . . 0.0 110.794 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -101.71 122.05 7.43 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.349 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.69 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.6 OUTLIER -106.93 27.47 8.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.761 0.315 . . . . 0.0 111.293 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.52 26.17 21.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.8 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.598 ' CB ' HG22 ' A' ' 130' ' ' ILE . 27.3 ttm105 -82.19 151.99 26.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.705 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.619 HG12 HG11 ' A' ' 135' ' ' VAL . 9.5 t -86.64 136.18 23.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.173 0.511 . . . . 0.0 111.117 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 27.9 mt -107.26 164.45 12.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.48 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -33.18 67.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.45 -36.47 84.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.2 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -63.65 -48.51 76.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.746 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 139' ' ' ALA . 36.1 mm -52.9 -54.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.62 -39.2 73.21 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.621 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.4 80.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.529 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.515 ' HD1' HG22 ' A' ' 144' ' ' VAL . 52.0 t-105 -60.53 -56.97 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.754 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.87 -33.06 75.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.888 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.276 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.776 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.046 0.45 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.544 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.57 158.12 9.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.314 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -64.2 154.39 82.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.828 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.32 -27.53 58.05 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.639 2.226 . . . . 0.0 112.35 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -90.02 -32.11 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.07 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 158' ' ' VAL . 97.5 t -65.53 -48.06 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.354 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 24.4 mtt180 -54.57 -28.78 48.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -77.67 -39.86 43.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.942 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.8 t80 -66.83 -48.02 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.059 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.979 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 3.4 tpt180 -54.92 -31.99 60.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.054 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.32 -36.62 22.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.067 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.727 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -83.61 21.64 1.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.61 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.48 19.78 42.65 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.554 HG23 HD21 ' A' ' 167' ' ' LEU . 49.0 t -110.36 143.05 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.0 110.913 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -116.27 130.19 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.053 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.855 HG23 HG21 ' A' ' 158' ' ' VAL . 32.8 mm -52.38 -21.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -63.58 -34.21 77.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.058 0.456 . . . . 0.0 110.25 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.56 -4.16 58.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.859 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.8 t -116.57 139.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.383 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.428 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 3.8 pt20 -102.73 97.48 7.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.355 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -71.7 143.29 34.99 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.165 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.32 113.76 4.46 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.965 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.95 -85.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.372 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -105.72 37.01 2.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.83 0.347 . . . . 0.0 111.108 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 83.68 26.13 43.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.577 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.776 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -75.87 136.82 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.749 0.309 . . . . 0.0 111.003 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.855 HG21 HG23 ' A' ' 146' ' ' ILE . 30.5 t -73.56 132.24 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.105 0.479 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.4 mt -102.87 161.13 14.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.196 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -55.45 -31.7 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.32 -37.83 88.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.0 m-20 -61.66 -50.48 72.33 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.626 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.979 HD12 ' HB2' ' A' ' 139' ' ' ALA . 31.5 mm -52.79 -54.97 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.43 -39.04 72.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.541 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.22 84.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.634 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.548 ' HD1' HG22 ' A' ' 144' ' ' VAL . 48.1 t-105 -60.38 -57.08 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.727 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.92 -32.52 74.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.934 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.899 0.38 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -166.94 154.77 9.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.6 mtt -60.47 160.02 20.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.34 -25.78 80.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.462 2.108 . . . . 0.0 112.202 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -30.49 16.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 158' ' ' VAL . 76.3 t -68.28 -47.82 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 9.7 mtt180 -54.68 -29.89 54.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -77.7 -39.89 43.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.059 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.16 -48.18 71.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.928 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.964 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.77 -45.89 80.84 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -54.81 -31.8 59.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.348 178.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -84.49 -37.56 21.18 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.923 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.755 ' O ' HD21 ' A' ' 167' ' ' LEU . 38.5 mmtt -84.58 25.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.728 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 22.05 19.29 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.697 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.544 HG23 HD21 ' A' ' 167' ' ' LEU . 51.1 t -111.18 142.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.001 0.429 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -116.16 130.21 56.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.197 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.904 HG23 HG21 ' A' ' 158' ' ' VAL . 31.0 mm -52.61 -21.26 2.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -64.0 -34.97 79.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 110.094 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.414 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.52 -1.27 57.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.855 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.4 t -120.07 133.39 66.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.88 0.371 . . . . 0.0 111.485 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -95.89 97.31 9.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -71.37 144.03 36.71 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.059 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.75 10.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.334 . . . . 0.0 110.629 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -87.12 107.1 3.22 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.814 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.31 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 111.332 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.8 p30 -99.32 33.26 2.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.343 . . . . 0.0 111.02 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.66 25.96 44.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.705 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -76.4 138.72 40.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.717 0.294 . . . . 0.0 111.094 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.904 HG21 HG23 ' A' ' 146' ' ' ILE . 24.6 t -72.86 137.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 111.19 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -109.42 161.33 15.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.226 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -55.97 -31.06 62.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -65.58 -37.31 86.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -62.38 -50.55 71.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.784 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.964 HD12 ' HB2' ' A' ' 139' ' ' ALA . 30.0 mm -52.77 -55.0 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.695 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.1 -40.16 73.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.673 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.25 87.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.87 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.522 ' HD1' HG22 ' A' ' 144' ' ' VAL . 52.3 t-105 -58.94 -57.25 13.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.755 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -63.45 -32.33 73.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.515 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.9 mp . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.039 0.447 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.546 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.87 151.26 4.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.55 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.4 mtp -58.98 149.64 65.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.87 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.35 -26.62 11.98 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -91.08 -29.23 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.55 HG23 ' HB2' ' A' ' 132' ' ' MET . 99.5 t -68.09 -51.18 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 1.8 mtt-85 -54.59 -29.95 53.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -77.68 -38.8 46.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.157 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.532 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 45.8 t80 -67.54 -48.11 67.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.053 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.011 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.64 -46.23 76.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 1.2 tmt_? -54.92 -32.03 60.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.036 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -84.3 -36.68 22.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.059 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.776 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -83.47 22.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.678 -179.18 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.28 20.73 37.41 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.255 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.552 HG23 HD21 ' A' ' 167' ' ' LEU . 51.1 t -112.1 142.83 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -116.14 130.7 56.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.054 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 158' ' ' VAL . 34.9 mm -51.49 -23.09 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -63.09 -34.12 76.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.496 . . . . 0.0 110.36 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.411 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.5 -6.71 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.951 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.1 t -110.87 129.62 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.891 0.376 . . . . 0.0 111.322 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.21 92.46 8.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.462 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.97 130.35 50.88 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.757 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.44 26.1 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.59 0.233 . . . . 0.0 111.038 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -104.6 125.2 8.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.513 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.82 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -114.08 31.36 6.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 92.62 26.08 18.64 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.721 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.515 ' HG3' HG22 ' A' ' 130' ' ' ILE . 40.3 ttp180 -81.01 149.61 29.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.045 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.784 HG21 HG23 ' A' ' 146' ' ' ILE . 32.0 t -83.51 135.45 24.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.21 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.5 mt -106.2 160.93 14.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.955 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -55.63 -32.38 63.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.664 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -65.12 -37.28 86.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.49 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -62.14 -49.91 73.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.762 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.8 mm -52.69 -55.02 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.524 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -57.35 -36.24 70.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.626 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.98 99.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.646 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.541 ' HD1' HG22 ' A' ' 144' ' ' VAL . 54.9 t-105 -57.22 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.482 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.776 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.21 -31.77 73.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.912 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.2 mp . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.115 0.484 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.647 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -165.55 149.82 8.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.7 mmt -64.67 154.53 84.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.716 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.72 -33.71 94.47 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.708 2.272 . . . . 0.0 112.531 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.83 -33.21 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.104 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.629 HG11 HG12 ' A' ' 158' ' ' VAL . 53.6 t -69.08 -45.76 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.308 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.647 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 8.1 mtm180 -54.62 -31.44 57.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -38.81 46.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.078 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.503 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.9 t80 -66.49 -47.91 71.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.059 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.94 -45.7 77.01 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.71 -32.08 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.128 178.692 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.47 -37.58 21.17 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.682 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -81.86 20.39 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.725 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.01 48.73 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.13 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.604 HG23 HD21 ' A' ' 167' ' ' LEU . 52.8 t -109.51 144.3 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 110.941 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -116.28 130.73 56.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.123 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 131' ' ' ALA . 33.4 mm -49.98 -23.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.162 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -63.71 -35.99 82.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.005 0.431 . . . . 0.0 110.545 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.36 -0.52 56.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.093 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' A' ' 158' ' ' VAL . 5.6 t -116.51 131.53 68.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.65 106.14 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -69.0 129.71 24.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.72 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.04 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.608 0.242 . . . . 0.0 111.003 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.91 143.35 17.41 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.894 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt 49.67 -91.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -114.2 22.95 13.32 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.593 0.235 . . . . 0.0 111.444 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 26.05 6.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.759 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 130' ' ' ILE . 38.3 ttm180 -83.28 143.07 30.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.681 0.276 . . . . 0.0 111.006 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.629 HG12 HG11 ' A' ' 135' ' ' VAL . 13.8 t -78.88 134.79 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 111.112 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.469 ' HA ' HG21 ' A' ' 135' ' ' VAL . 15.2 mt -107.1 165.81 11.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.54 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -34.39 68.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -36.36 83.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.4 m-20 -64.6 -48.57 74.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.75 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.059 HD12 ' HB2' ' A' ' 139' ' ' ALA . 38.3 mm -52.92 -54.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.575 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -56.85 -38.84 73.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.568 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.69 -38.19 84.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.489 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.521 ' HD1' HG22 ' A' ' 144' ' ' VAL . 48.6 t-105 -60.03 -57.08 14.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.601 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.682 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -66.43 -32.39 73.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.909 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.983 0.42 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.512 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.13 154.61 9.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.166 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 135' ' ' VAL . 7.4 mtp -61.34 151.23 77.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.929 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.15 -26.01 24.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.2 . . . . 0.0 112.42 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 p -91.04 -30.36 16.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.807 HG11 HG12 ' A' ' 158' ' ' VAL . 58.9 t -67.24 -47.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.533 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 1.4 mtp-105 -54.68 -30.02 54.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 0.0 109.887 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -77.59 -40.39 42.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.198 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.528 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.01 -48.11 72.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.049 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.972 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.08 -45.56 80.83 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.82 -31.75 59.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.16 178.697 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.39 -37.46 21.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.901 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.746 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.0 mmtp -84.3 25.26 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.761 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.09 21.78 18.93 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.532 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.565 HG23 HD21 ' A' ' 167' ' ' LEU . 54.8 t -110.66 142.29 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.902 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.837 HG23 HG21 ' A' ' 158' ' ' VAL . 29.3 mm -51.22 -22.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 -62.7 -33.7 75.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.33 -7.16 57.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.846 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 162' ' ' ASP . 4.2 t -111.15 140.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.848 0.356 . . . . 0.0 111.334 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.29 90.8 4.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -61.64 135.33 47.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.878 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.98 9.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.591 0.234 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.79 127.08 9.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.107 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt 57.02 -86.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.548 0.213 . . . . 0.0 111.509 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.28 29.71 7.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.218 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 94.46 26.12 14.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.627 ' HA ' HG22 ' A' ' 130' ' ' ILE . 33.9 ttm180 -83.38 137.71 33.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 110.841 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.837 HG21 HG23 ' A' ' 146' ' ' ILE . 39.1 t -70.87 138.03 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.191 0.52 . . . . 0.0 111.467 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.2 mt -111.88 162.91 14.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.824 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -56.01 -31.59 63.22 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.42 -36.47 84.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.492 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -63.48 -49.97 71.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.673 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.972 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.4 mm -52.76 -54.92 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.704 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -55.91 -39.88 72.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.664 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.01 80.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.691 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.51 ' HD1' HG22 ' A' ' 144' ' ' VAL . 45.2 t-105 -60.74 -57.02 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.574 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.746 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.8 -32.51 74.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.314 -179.872 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.504 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.1 mp . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.033 0.444 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -165.64 148.88 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.015 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.523 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -57.41 159.96 7.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.717 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.84 -25.92 82.12 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.578 2.185 . . . . 0.0 112.248 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -91.05 -29.46 17.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.617 HG11 HG12 ' A' ' 158' ' ' VAL . 62.1 t -70.18 -47.53 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.396 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 13.2 mtt180 -54.53 -31.25 55.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.64 -38.76 47.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.213 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.525 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.2 t80 -66.77 -48.09 70.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.056 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.983 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.31 -45.73 79.33 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.1 tpm_? -54.88 -31.81 60.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -84.43 -37.6 21.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.773 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.2 mmtt -83.98 25.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.737 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.43 20.08 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.506 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.552 HG23 HD21 ' A' ' 167' ' ' LEU . 49.4 t -111.48 143.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.984 0.421 . . . . 0.0 110.972 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -116.21 130.85 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.774 HG23 HG21 ' A' ' 158' ' ' VAL . 28.1 mm -52.35 -22.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mmm-85 -64.11 -33.93 76.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.939 0.399 . . . . 0.0 110.439 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.18 -4.01 59.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.076 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.542 HG11 ' HB3' ' A' ' 162' ' ' ASP . 10.8 t -111.54 146.75 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.878 0.37 . . . . 0.0 111.186 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.4 95.43 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -58.5 128.6 48.0 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.709 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.16 26.12 9.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 0.0 111.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.81 143.83 18.03 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.001 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 49.28 -91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -114.01 29.9 7.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.741 0.305 . . . . 0.0 111.322 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 95.68 26.04 12.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.659 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.504 ' CB ' HG22 ' A' ' 130' ' ' ILE . 38.5 ttm180 -82.63 145.93 29.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.731 0.3 . . . . 0.0 110.905 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.774 HG21 HG23 ' A' ' 146' ' ' ILE . 41.1 t -79.31 134.63 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.275 0.559 . . . . 0.0 111.279 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.6 mt -106.35 162.01 14.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.972 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -31.7 62.38 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -37.76 87.93 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.1 m-20 -62.16 -50.15 72.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.742 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.983 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.5 mm -52.73 -54.93 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.639 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.11 -36.01 67.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.661 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.24 90.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.537 ' HD1' HG22 ' A' ' 144' ' ' VAL . 38.9 t-105 -59.67 -56.71 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.559 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.773 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.83 -31.42 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.8 mp . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.969 0.414 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -170.19 154.28 4.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.538 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -59.89 147.63 78.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.695 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.45 -25.53 14.33 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.572 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.7 p -91.01 -28.96 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.794 HG11 HG12 ' A' ' 158' ' ' VAL . 62.0 t -68.66 -47.61 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.468 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.9 mtp180 -54.71 -30.68 56.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -77.63 -39.24 45.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.126 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.5 t80 -66.48 -48.21 70.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.044 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.49 -45.47 79.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 3.5 tpt180 -54.8 -31.71 59.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.267 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.47 -38.21 20.41 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.924 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.76 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.4 mmtt -82.99 26.45 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.885 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.84 22.25 18.54 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.471 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.546 HG23 HD21 ' A' ' 167' ' ' LEU . 54.1 t -111.68 144.01 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 111.044 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.401 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.2 t0 -116.29 131.1 57.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.97 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.53 HG23 HG21 ' A' ' 158' ' ' VAL . 35.0 mm -52.4 -22.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -64.58 -33.61 76.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.982 0.42 . . . . 0.0 110.421 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.93 -1.4 57.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.961 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 162' ' ' ASP . 13.7 t -114.64 146.11 19.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -104.65 108.5 19.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -66.96 126.1 25.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.764 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.26 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.716 0.293 . . . . 0.0 111.016 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.23 142.31 17.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.12 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER 49.87 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -114.02 31.72 6.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.69 0.281 . . . . 0.0 111.326 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.13 17.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.721 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.523 ' HA ' HG22 ' A' ' 130' ' ' ILE . 6.1 ttm180 -84.29 148.09 26.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.711 0.291 . . . . 0.0 110.742 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.794 HG12 HG11 ' A' ' 135' ' ' VAL . 10.1 t -81.63 137.99 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 111.223 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.9 mt -110.35 161.92 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.345 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -55.64 -32.65 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.3 -37.38 87.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.277 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -62.39 -48.5 79.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.701 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.044 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.4 mm -52.83 -54.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.502 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.94 -35.29 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.526 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.14 89.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.504 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.524 ' HD1' HG22 ' A' ' 144' ' ' VAL . 39.9 t-105 -59.93 -57.01 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.76 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.81 -32.06 73.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.251 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.908 0.385 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.518 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.99 151.2 3.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.31 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.4 mtp -58.27 148.47 62.92 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.12 -25.32 22.58 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.562 2.174 . . . . 0.0 112.506 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.2 m -90.94 -34.0 15.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.65 HG11 HG12 ' A' ' 158' ' ' VAL . 92.7 t -62.79 -47.56 92.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 37.7 mtp85 -54.66 -28.1 44.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.035 0.445 . . . . 0.0 110.002 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -41.57 37.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.928 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.619 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 40.4 t80 -66.3 -48.29 70.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.816 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.132 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.19 -46.15 85.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.95 -32.11 61.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.5 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -84.69 -38.42 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 111.104 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.819 ' O ' HD21 ' A' ' 167' ' ' LEU . 27.0 mmmt -82.19 25.48 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.976 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 23.65 23.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.342 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.584 HG23 HD21 ' A' ' 167' ' ' LEU . 53.7 t -114.65 142.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.06 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -116.24 131.86 56.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.702 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.497 HG23 HG21 ' A' ' 158' ' ' VAL . 32.9 mm -50.29 -23.77 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.712 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.4 OUTLIER -66.31 -33.19 75.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.893 0.378 . . . . 0.0 110.377 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.433 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.4 mt -85.52 -1.86 57.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.487 ' HB ' HG21 ' A' ' 158' ' ' VAL . 5.0 t -115.56 127.21 73.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.81 0.338 . . . . 0.0 111.475 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.01 92.4 7.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.425 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -57.38 129.13 49.03 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.981 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.12 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.727 0.299 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -100.06 117.03 5.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 153' ' ' GLY . 3.9 p-10 -101.73 31.31 3.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.62 26.16 43.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.677 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.509 ' HG3' HG22 ' A' ' 130' ' ' ILE . 43.7 ttm180 -80.13 150.91 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.65 HG12 HG11 ' A' ' 135' ' ' VAL . 21.9 t -84.67 133.73 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 21.0 mt -106.83 162.41 13.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.66 -33.18 63.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -62.87 -48.48 78.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.785 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.132 HD12 ' HB2' ' A' ' 139' ' ' ALA . 32.5 mm -52.76 -53.82 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.428 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.74 -38.36 75.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.523 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.84 86.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.573 ' HD1' HG22 ' A' ' 144' ' ' VAL . 50.8 t-105 -59.2 -57.06 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.819 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -66.24 -33.68 76.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.914 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.229 -179.922 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.603 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.006 0.431 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.443 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.2 152.02 7.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.163 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.515 ' HB2' HG23 ' A' ' 135' ' ' VAL . 6.3 mtp -58.7 160.04 11.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.22 -25.8 81.22 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 m -91.03 -30.92 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.702 HG11 HG12 ' A' ' 158' ' ' VAL . 45.1 t -69.11 -47.15 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.541 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.5 mtp180 -54.61 -31.22 56.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.69 -38.21 47.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.82 -48.09 70.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.077 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.38 -45.42 80.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.77 59.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.285 178.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -84.45 -37.78 20.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.905 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.734 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.4 mmtt -83.61 25.85 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.728 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.03 21.8 18.53 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.381 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.564 HG23 HD21 ' A' ' 167' ' ' LEU . 55.9 t -111.12 142.42 23.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.009 0.433 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.21 130.47 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 158' ' ' VAL . 34.8 mm -50.7 -23.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtp-105 -63.8 -35.74 81.6 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.7 OUTLIER -85.51 -4.07 59.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' A' ' 162' ' ' ASP . 8.6 t -113.46 149.2 15.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 111.241 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -107.29 102.55 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -62.39 129.73 43.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.0 9.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.712 0.291 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.2 141.57 17.09 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.077 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.61 -91.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -113.98 34.33 4.7 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.735 0.302 . . . . 0.0 111.271 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 89.93 26.09 25.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.763 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.603 ' HA ' HG22 ' A' ' 130' ' ' ILE . 22.6 ttm180 -82.55 142.63 31.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.854 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.8 HG21 HG23 ' A' ' 146' ' ' ILE . 37.5 t -76.75 133.32 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.231 0.538 . . . . 0.0 111.196 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.3 mt -107.86 163.9 12.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.075 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.45 -32.4 62.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.93 -37.72 88.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.536 ' HB3' HG11 ' A' ' 149' ' ' VAL . 4.7 m-20 -62.18 -50.52 71.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.753 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 139' ' ' ALA . 29.9 mm -52.74 -55.04 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.733 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.43 -38.46 69.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.636 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.89 89.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.535 ' HD1' HG22 ' A' ' 144' ' ' VAL . 46.1 t-105 -59.16 -57.15 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.734 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -64.45 -30.24 71.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.023 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.21 0.529 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -168.68 143.69 3.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.1 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.509 ' HB2' HG23 ' A' ' 135' ' ' VAL . 9.9 mmt -55.55 150.28 25.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.45 -29.78 70.43 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.04 -33.46 21.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 158' ' ' VAL . 93.3 t -66.36 -46.81 86.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.304 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 42.0 mtp180 -54.64 -28.88 50.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.027 0.442 . . . . 0.0 109.867 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -77.67 -41.61 37.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.055 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.486 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.4 t80 -65.2 -47.99 74.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.078 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.68 -45.44 82.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.8 tpt85 -54.71 -31.84 58.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.3 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.46 -37.54 21.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.738 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.6 mmtt -84.14 22.35 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.797 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.3 19.06 31.13 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.594 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.508 HG23 HD21 ' A' ' 167' ' ' LEU . 65.3 t -104.96 143.24 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.3 t0 -116.16 129.09 56.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.934 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.467 HG21 ' HB2' ' A' ' 131' ' ' ALA . 35.5 mm -50.66 -22.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.25 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -64.32 -33.71 76.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.99 0.424 . . . . 0.0 110.595 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.409 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.2 OUTLIER -91.37 1.73 56.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.538 ' HB ' HG21 ' A' ' 158' ' ' VAL . 4.0 t -119.09 120.12 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.71 96.23 8.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -68.85 134.78 27.85 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.114 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.18 26.02 9.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 110.695 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.12 112.74 4.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.935 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.2 -85.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 153' ' ' GLY . 35.6 m120 -97.75 33.66 2.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.769 0.319 . . . . 0.0 111.098 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.52 26.03 61.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.603 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.627 ' HA ' HG22 ' A' ' 130' ' ' ILE . 1.8 ttm105 -81.33 137.92 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.72 HG12 HG11 ' A' ' 135' ' ' VAL . 9.5 t -71.31 137.38 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -108.38 163.9 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.454 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -57.24 -34.8 68.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.25 -36.26 83.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.0 m-20 -64.24 -48.01 77.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.078 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.2 mm -52.87 -54.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.544 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -56.56 -39.02 72.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.15 88.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.409 ' CZ3' ' O ' ' A' ' 148' ' ' LEU . 49.6 t-105 -58.72 -57.05 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.4 mt -61.13 -26.56 67.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.213 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.159 -179.865 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.0 mp . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.284 0.564 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -170.12 147.05 3.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' VAL . 5.9 mtp -57.38 155.11 20.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.737 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.9 -24.23 78.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.548 2.165 . . . . 0.0 112.303 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 -36.21 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 158' ' ' VAL . 47.3 t -64.69 -44.26 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.358 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.513 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -54.71 -29.99 54.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 109.727 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -40.48 41.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.974 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.3 t80 -65.47 -48.03 74.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.081 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.014 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.4 -45.18 80.88 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -54.88 -31.84 60.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.057 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.43 -37.54 21.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.736 ' O ' HD21 ' A' ' 167' ' ' LEU . 18.1 mmtp -84.46 25.36 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.748 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.8 21.17 21.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.577 HG23 HD21 ' A' ' 167' ' ' LEU . 53.6 t -109.51 143.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -116.17 130.62 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.123 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 131' ' ' ALA . 33.9 mm -50.77 -22.65 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.198 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -63.68 -35.76 81.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.059 0.457 . . . . 0.0 110.32 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.96 -0.43 56.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.993 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.45 ' HB ' HG21 ' A' ' 158' ' ' VAL . 3.9 t -118.96 130.86 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 111.268 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 101.43 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.607 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -65.03 129.24 34.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.943 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.44 25.99 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.325 . . . . 0.0 110.697 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.86 123.52 7.78 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.259 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt 56.5 -84.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -113.09 37.0 3.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.675 0.274 . . . . 0.0 111.484 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 89.39 26.19 26.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.768 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.753 ' HA ' HG22 ' A' ' 130' ' ' ILE . 2.6 ttt180 -81.61 142.93 32.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 135' ' ' VAL . 8.3 t -82.63 128.0 39.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.168 0.508 . . . . 0.0 110.728 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.526 ' HA ' HG21 ' A' ' 135' ' ' VAL . 15.8 mt -100.55 165.86 11.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.66 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -57.61 -32.78 67.54 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.51 -36.63 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.3 m-20 -64.26 -49.02 73.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.591 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.014 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.6 mm -52.96 -54.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.608 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.63 -39.56 71.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.86 83.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.523 ' HD1' HG22 ' A' ' 144' ' ' VAL . 42.9 t-105 -59.77 -57.06 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.555 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.736 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -65.26 -31.15 72.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.187 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.46 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.843 0.354 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -164.56 151.42 11.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.219 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.535 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -56.92 157.34 11.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.888 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.45 -24.6 78.36 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.581 2.187 . . . . 0.0 112.133 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.0 p -90.95 -30.37 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.995 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.79 HG11 HG12 ' A' ' 158' ' ' VAL . 63.9 t -66.73 -47.02 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 37.9 mtp85 -54.67 -30.04 54.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -40.37 42.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.179 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.9 t80 -66.39 -48.14 71.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.978 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.94 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.34 -46.16 81.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.98 -31.83 61.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.38 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -84.44 -37.22 21.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.767 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.4 mmtt -84.19 25.06 0.88 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.721 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 22.41 19.59 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.523 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG22 ' HD1' ' A' ' 166' ' ' TRP . 46.7 t -111.5 143.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.992 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -116.19 130.01 56.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.942 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.761 HG23 HG21 ' A' ' 158' ' ' VAL . 20.7 mm -51.86 -22.15 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -63.77 -33.99 76.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.006 0.431 . . . . 0.0 110.299 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.97 -4.69 59.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.574 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.1 t -110.97 147.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.264 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.8 99.6 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.684 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -59.09 126.93 43.95 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.688 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.0 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.631 0.253 . . . . 0.0 111.01 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.45 141.76 16.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.986 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.28 -91.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -114.19 24.23 12.16 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.634 0.254 . . . . 0.0 111.477 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 103.71 26.1 6.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.878 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.46 ' CB ' HG22 ' A' ' 130' ' ' ILE . 20.8 ttm105 -84.22 147.43 27.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.745 0.307 . . . . 0.0 110.825 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.79 HG12 HG11 ' A' ' 135' ' ' VAL . 14.9 t -80.28 138.05 20.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.2 mt -112.06 165.09 12.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.28 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 23.4 tttt -57.01 -33.68 67.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.39 -36.95 85.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.574 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.5 m-20 -63.17 -50.51 70.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.634 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.94 HD12 ' HB2' ' A' ' 139' ' ' ALA . 30.7 mm -52.93 -54.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.546 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -57.59 -35.13 70.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.476 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.27 97.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.502 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.561 ' HD1' HG22 ' A' ' 144' ' ' VAL . 47.2 t-105 -58.73 -56.7 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.767 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.73 -29.75 70.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.069 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.289 -179.887 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.579 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.895 0.378 . . . . 0.0 111.214 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.19 88.05 2.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.43 62.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.787 HG13 ' HB ' ' A' ' 146' ' ' ILE . 42.1 t -85.51 138.14 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.13 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.2 mp -130.05 111.94 22.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.548 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.63 149.21 5.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.988 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.4 mtm -56.37 158.15 8.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.4 -24.89 79.05 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.496 2.131 . . . . 0.0 112.332 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 m -91.12 -31.78 16.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.698 HG11 HG12 ' A' ' 158' ' ' VAL . 43.7 t -68.52 -45.2 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.6 mtp-105 -54.61 -31.82 57.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.62 -38.48 47.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.238 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.545 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.6 t80 -66.41 -48.06 71.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.011 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.006 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.23 -45.59 80.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 11.2 ttt85 -54.78 -31.67 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.402 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.36 -39.48 19.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.709 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.591 ' HB3' HD11 ' A' ' 167' ' ' LEU . 45.6 mmtt -80.25 9.98 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.605 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.9 8.77 64.84 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.526 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 167' ' ' LEU . 48.8 t -96.64 143.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.986 0.422 . . . . 0.0 110.703 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 22.4 t0 -116.06 129.4 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.912 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.822 HG23 HG21 ' A' ' 158' ' ' VAL . 32.1 mm -51.04 -22.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.403 ' HG3' HG22 ' A' ' 129' ' ' VAL . 2.9 mtp85 -64.18 -34.38 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.02 0.438 . . . . 0.0 110.429 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.3 OUTLIER -88.25 -2.14 58.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.984 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 162' ' ' ASP . 7.4 t -115.19 139.08 43.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.9 0.381 . . . . 0.0 111.376 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -98.1 90.72 4.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.576 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.6 134.07 52.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.766 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.35 26.07 9.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.629 0.252 . . . . 0.0 111.009 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -105.13 127.63 9.11 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.156 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.28 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.577 0.227 . . . . 0.0 111.492 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -110.13 30.23 6.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.811 0.338 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.08 26.01 25.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.714 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.619 ' HA ' HG22 ' A' ' 130' ' ' ILE . 31.9 ttm180 -79.48 138.9 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.822 HG21 HG23 ' A' ' 146' ' ' ILE . 45.7 t -72.07 132.68 33.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 111.425 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.1 mt -105.66 162.5 13.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.756 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -55.74 -31.42 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.99 -37.59 86.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB3' HG11 ' A' ' 149' ' ' VAL . 4.7 m-20 -61.69 -49.98 74.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.664 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.006 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.0 mm -52.69 -54.8 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.473 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.88 -38.61 73.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.46 89.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.568 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.564 ' HD1' HG22 ' A' ' 144' ' ' VAL . 51.6 t-105 -58.4 -57.01 14.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.636 HD21 HG23 ' A' ' 144' ' ' VAL . 1.9 mt -65.58 -27.35 68.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.066 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.94 31.1 2.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.294 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 168.41 -76.86 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.51 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.343 -1.254 . . . . 0.0 112.467 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.826 0.346 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 137.7 51.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.722 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.492 ' O ' HD12 ' A' ' 130' ' ' ILE . 16.1 ttp180 -176.71 -38.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.053 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.716 HG13 ' HB ' ' A' ' 146' ' ' ILE . 37.6 t -72.52 135.28 28.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.272 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.556 HG22 ' CB ' ' A' ' 157' ' ' ARG . 3.8 mp -130.05 111.93 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.414 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' ' 136' ' ' ARG . . . -161.28 150.39 16.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.344 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.5 mtp -59.98 159.59 19.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.785 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.4 -26.27 82.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.569 2.179 . . . . 0.0 112.157 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 p -91.04 -29.58 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.727 HG11 HG12 ' A' ' 158' ' ' VAL . 61.4 t -70.06 -48.82 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.382 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.445 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 42.2 mtt-85 -54.58 -30.03 53.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -40.07 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.119 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.17 -48.15 71.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.067 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.989 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.22 -45.35 81.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -54.83 -31.82 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.133 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.49 -37.54 21.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.853 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.779 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.4 mmtt -84.03 26.1 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.862 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.0 18.71 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.557 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.555 HG22 ' HD1' ' A' ' 166' ' ' TRP . 54.4 t -112.26 141.06 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.05 0.452 . . . . 0.0 110.944 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -116.21 131.23 57.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.624 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.834 HG23 HG21 ' A' ' 158' ' ' VAL . 32.6 mm -50.82 -23.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.628 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -65.12 -31.96 73.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.932 0.396 . . . . 0.0 110.287 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.5 mt -86.07 -7.66 58.45 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.658 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.3 t -111.08 145.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 120.974 0.416 . . . . 0.0 111.435 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.71 88.48 2.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.197 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -64.43 137.09 39.71 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.049 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.38 26.06 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.754 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.79 121.76 6.77 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.402 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.52 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' GLY . 17.0 m-80 -114.08 36.86 3.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.18 26.08 34.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.617 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.556 ' CB ' HG22 ' A' ' 130' ' ' ILE . 18.1 ttm180 -82.06 142.5 32.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.834 HG21 HG23 ' A' ' 146' ' ' ILE . 38.6 t -75.94 137.95 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.477 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.5 mt -110.41 161.38 15.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.702 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -55.43 -31.8 62.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.774 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -64.61 -38.05 89.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.501 ' HB3' HG11 ' A' ' 149' ' ' VAL . 6.7 m-20 -62.16 -49.94 73.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.737 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.989 HD12 ' HB2' ' A' ' 139' ' ' ALA . 37.9 mm -52.69 -55.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.66 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.79 -37.3 68.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.89 92.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.855 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.555 ' HD1' HG22 ' A' ' 144' ' ' VAL . 55.3 t-105 -58.34 -57.1 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -63.34 -31.33 72.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.953 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.95 -25.08 64.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.21 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.78 -65.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.521 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.454 -1.192 . . . . 0.0 112.508 179.956 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.855 0.36 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -36.62 7.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.58 171.98 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.815 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.477 ' CG1' HG22 ' A' ' 146' ' ' ILE . 1.9 t -82.33 157.05 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.004 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -90.79 111.93 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.063 0.458 . . . . 0.0 111.139 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.559 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -165.53 149.12 8.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.4 mtm -61.8 160.06 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.13 -25.91 72.92 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.651 2.234 . . . . 0.0 112.231 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.5 p -90.97 -31.01 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.038 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.762 HG11 HG12 ' A' ' 158' ' ' VAL . 60.5 t -68.84 -47.35 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.37 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.559 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 26.1 mtp180 -54.66 -30.09 54.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.462 . . . . 0.0 109.892 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -77.7 -41.12 39.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.165 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.521 ' CD2' HG21 ' A' ' 163' ' ' ILE . 52.0 t80 -65.5 -48.17 73.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.02 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.9 -45.44 81.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -54.91 -31.84 60.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.096 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.52 -37.58 21.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.947 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.768 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.1 mmtp -84.13 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.814 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.14 18.61 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.66 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.554 HG23 HD21 ' A' ' 167' ' ' LEU . 52.4 t -110.59 143.66 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.046 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -116.19 131.32 56.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.016 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.477 HG22 ' CG1' ' A' ' 129' ' ' VAL . 41.7 mm -50.88 -23.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.226 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -63.96 -34.86 78.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.046 0.451 . . . . 0.0 110.469 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.412 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -89.52 -0.07 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.981 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' A' ' 158' ' ' VAL . 3.3 t -118.85 113.28 41.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.88 0.372 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.31 105.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.188 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -66.28 128.87 31.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.753 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 26.08 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.637 0.256 . . . . 0.0 110.96 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.24 126.42 8.08 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.309 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.49 -89.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.09 21.73 14.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.555 0.217 . . . . 0.0 111.464 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 110.61 26.14 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.809 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.592 ' HA ' HG22 ' A' ' 130' ' ' ILE . 18.2 ttp-105 -85.72 146.94 26.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.762 HG12 HG11 ' A' ' 135' ' ' VAL . 12.5 t -83.61 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.093 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.0 mt -107.87 165.05 11.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.39 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.416 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 1.6 tttt -57.5 -34.37 69.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.29 -36.09 82.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.3 m-20 -64.94 -48.65 73.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 139' ' ' ALA . 41.5 mm -52.87 -54.79 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.13 -40.81 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.677 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.65 83.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.524 ' HD1' HG22 ' A' ' 144' ' ' VAL . 45.9 t-105 -58.82 -57.12 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.768 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.44 -33.59 76.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.942 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -99.43 27.97 4.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -114.62 -27.78 3.19 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.279 -1.289 . . . . 0.0 112.479 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.842 0.353 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -143.94 -46.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.86 177.38 5.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.754 HG13 ' HB ' ' A' ' 146' ' ' ILE . 48.8 t -93.74 144.97 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.05 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -130.12 111.9 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.674 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -170.11 147.77 3.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.945 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.1 mtm -54.54 148.91 23.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.991 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.77 -26.6 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.659 2.239 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -89.76 -28.18 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.803 HG11 HG12 ' A' ' 158' ' ' VAL . 48.7 t -71.23 -45.86 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.52 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 11.5 mtp-105 -54.67 -32.01 58.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.145 0.498 . . . . 0.0 109.735 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -40.14 41.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.1 t80 -65.67 -48.15 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.12 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.947 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.55 -45.08 80.55 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 15.4 tpt180 -54.91 -31.94 60.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.022 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -84.42 -38.13 20.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.952 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.741 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.2 mmtt -83.46 24.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.805 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.38 21.73 20.87 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.497 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.545 HG23 HD21 ' A' ' 167' ' ' LEU . 49.6 t -109.95 142.89 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.907 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -116.1 129.98 56.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.066 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 158' ' ' VAL . 31.0 mm -51.73 -21.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.239 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -64.45 -34.45 78.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.405 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.91 -1.11 57.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.928 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.1 t -115.1 151.0 16.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 0.6 OUTLIER -111.59 96.59 6.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -67.82 135.31 30.42 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.963 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.33 26.01 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.635 0.255 . . . . 0.0 110.946 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.0 131.14 10.5 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.102 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.04 -87.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.605 0.241 . . . . 0.0 111.375 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.04 29.13 8.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.777 0.323 . . . . 0.0 111.012 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 96.87 18.26 30.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.697 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.66 ' HA ' HG22 ' A' ' 130' ' ' ILE . 3.2 ttm180 -73.0 138.98 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 110.971 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.803 HG12 HG11 ' A' ' 135' ' ' VAL . 31.9 t -71.26 138.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.185 0.517 . . . . 0.0 111.551 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.1 mt -109.84 161.74 15.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.53 -32.44 62.94 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.742 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -64.33 -37.38 87.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.267 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.486 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.9 m-20 -62.57 -50.03 72.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.76 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.947 HD12 ' HB2' ' A' ' 139' ' ' ALA . 33.8 mm -52.74 -55.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.654 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.16 -38.97 71.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.726 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.09 84.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.545 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.542 ' HD1' HG22 ' A' ' 144' ' ' VAL . 44.8 t-105 -60.19 -57.03 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.741 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -64.55 -30.19 71.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.76 30.99 1.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 137.11 -79.76 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.609 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.349 -1.25 . . . . 0.0 112.473 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 -42.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.68 142.9 57.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.77 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.75 HG13 ' HB ' ' A' ' 146' ' ' ILE . 55.5 t -86.25 134.66 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.217 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.528 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp -130.01 111.92 22.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.425 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -161.63 149.11 14.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.355 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -59.37 150.82 62.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.08 -26.81 15.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.526 2.151 . . . . 0.0 112.352 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 -29.64 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.072 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.562 HG11 HG12 ' A' ' 158' ' ' VAL . 86.1 t -68.32 -50.27 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.385 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.653 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 10.3 mtt180 -54.64 -30.18 54.33 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -77.67 -39.63 44.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.142 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.521 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 47.5 t80 -66.9 -48.11 69.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.165 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.018 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.5 -45.92 77.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.89 -31.98 60.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.033 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.41 -36.97 22.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.992 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.73 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -82.19 19.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.733 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.5 19.88 49.45 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.977 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.563 HG22 ' HD1' ' A' ' 166' ' ' TRP . 50.0 t -110.75 143.56 20.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 111.022 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 59.7 t0 -116.23 130.56 56.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.947 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.777 HG23 HG21 ' A' ' 158' ' ' VAL . 34.6 mm -51.0 -23.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -63.33 -34.27 77.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.542 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.42 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -86.62 -6.46 58.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.971 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 162' ' ' ASP . 7.1 t -107.82 152.33 9.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.88 0.372 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.85 97.51 7.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.813 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -58.93 128.77 48.48 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.559 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.99 26.02 9.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.697 0.284 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -122.03 150.27 17.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.687 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 47.97 -97.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -114.19 37.02 3.47 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.91 26.09 23.03 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.528 ' CB ' HG22 ' A' ' 130' ' ' ILE . 34.0 ttm180 -81.97 146.73 29.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.777 HG21 HG23 ' A' ' 146' ' ' ILE . 40.0 t -81.52 134.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.14 0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.7 mt -105.25 161.32 14.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -55.63 -32.34 63.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.0 -37.51 87.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.521 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -62.5 -50.07 72.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.638 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.018 HD12 ' HB2' ' A' ' 139' ' ' ALA . 37.0 mm -52.66 -54.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.49 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.0 -35.08 68.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.92 95.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.601 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.563 ' HD1' HG22 ' A' ' 144' ' ' VAL . 47.3 t-105 -58.38 -56.48 21.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.94 -34.95 79.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.993 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.0 -25.01 59.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.25 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -87.16 -32.25 14.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.385 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.443 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.726 0.298 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -70.23 -37.88 75.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.833 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -61.4 177.81 0.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.855 HG13 ' HB ' ' A' ' 146' ' ' ILE . 75.0 t -125.53 136.73 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 111.292 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp -130.13 111.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.389 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.449 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -166.66 152.81 8.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.318 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -59.48 151.86 58.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.737 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.42 -27.58 32.18 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.468 2.112 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.9 -29.23 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.365 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 158' ' ' VAL . 86.0 t -68.0 -48.55 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.406 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 3.5 mtt180 -54.63 -29.3 51.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -77.69 -39.91 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.97 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.8 t80 -66.38 -48.02 71.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.05 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.983 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.0 -45.32 82.0 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.89 -31.87 60.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.102 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.44 -37.38 21.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.847 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.724 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.6 mmtt -84.08 23.5 1.04 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.836 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.53 20.92 25.86 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.57 HG23 HD21 ' A' ' 167' ' ' LEU . 49.1 t -109.0 143.53 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.968 0.413 . . . . 0.0 110.943 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.062 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.855 ' HB ' HG13 ' A' ' 129' ' ' VAL . 30.4 mm -52.31 -21.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.089 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -63.76 -34.29 77.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.05 0.452 . . . . 0.0 110.218 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.05 -3.92 58.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.867 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.9 t -116.8 129.38 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.322 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.29 94.85 10.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.287 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -59.91 134.83 50.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.011 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.17 25.99 9.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 110.652 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.46 103.94 3.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.965 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.94 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.657 0.265 . . . . 0.0 111.489 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.2 m-80 -95.85 35.18 1.42 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 111.109 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 75.3 26.11 66.81 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.502 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.675 ' HA ' HG22 ' A' ' 130' ' ' ILE . 27.7 ttm180 -79.24 139.16 37.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.214 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.843 HG21 HG23 ' A' ' 146' ' ' ILE . 38.2 t -74.6 133.79 30.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.199 0.523 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.7 mt -104.8 160.97 14.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.001 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -55.81 -31.55 62.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.97 -37.45 86.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -61.78 -50.0 74.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.593 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.983 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.6 mm -52.66 -55.18 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.558 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -55.55 -40.55 72.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.655 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.14 82.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.636 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.483 ' HD1' HG22 ' A' ' 144' ' ' VAL . 41.9 t-105 -59.47 -57.01 14.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.481 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -63.59 -31.56 72.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.939 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.61 -25.0 63.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.227 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -101.31 -48.27 1.45 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.499 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.385 -1.23 . . . . 0.0 112.466 179.961 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.3 t30 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.9 40.1 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.7 mtt85 -124.22 31.21 5.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.732 HG13 ' HB ' ' A' ' 146' ' ' ILE . 40.3 t -138.01 141.85 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.517 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.3 mp -130.07 111.89 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.625 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -163.92 153.95 14.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -64.46 160.1 54.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.37 -28.17 83.97 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 112.258 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.1 p -91.13 -29.46 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 158' ' ' VAL . 95.9 t -68.92 -48.33 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.448 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.438 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 65.5 mtt-85 -54.63 -29.37 51.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.061 0.458 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.71 -41.14 38.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.198 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.617 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 44.3 t80 -66.4 -48.26 70.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.911 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.053 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.31 -47.18 80.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 16.8 tpt180 -54.97 -31.92 61.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.72 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.69 -38.61 19.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.221 0.534 . . . . 0.0 111.192 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.799 ' O ' HD21 ' A' ' 167' ' ' LEU . 26.6 mmmt -82.38 24.71 0.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.831 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.23 21.88 27.49 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.445 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.644 HG23 HD21 ' A' ' 167' ' ' LEU . 54.6 t -112.33 142.25 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -116.18 129.97 56.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.804 HG23 HG21 ' A' ' 158' ' ' VAL . 34.2 mm -51.39 -22.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -63.98 -34.0 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.987 0.423 . . . . 0.0 110.384 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.96 -4.22 58.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.916 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' A' ' 162' ' ' ASP . 5.4 t -113.92 134.98 55.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.107 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.28 93.4 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.417 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.87 129.37 49.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.586 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 26.09 9.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 0.0 111.1 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.76 140.53 16.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.984 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.41 -91.0 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.462 0.172 . . . . 0.0 111.441 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -114.1 34.38 4.7 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.871 0.367 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.0 21.06 40.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.454 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.517 ' HA ' HG22 ' A' ' 130' ' ' ILE . 41.7 ttm180 -78.36 145.11 35.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.804 HG21 HG23 ' A' ' 146' ' ' ILE . 38.5 t -77.18 135.94 25.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.164 0.507 . . . . 0.0 111.322 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.2 mt -107.51 162.04 14.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.006 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -55.66 -32.05 62.89 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.821 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -65.24 -37.33 86.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.514 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.5 m-20 -62.77 -50.14 72.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.73 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.053 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.7 mm -52.67 -55.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -56.82 -36.58 70.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.545 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.587 ' HD1' HG22 ' A' ' 144' ' ' VAL . 42.2 t-105 -59.75 -54.84 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.549 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -68.85 -26.82 65.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.135 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.36 31.1 1.55 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.622 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.42 -53.56 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.595 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.509 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.724 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.782 0.325 . . . . 0.0 111.235 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.8 ttm-85 59.89 66.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.951 0.405 . . . . 0.0 110.914 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -113.71 -35.2 5.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.039 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.5 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.7 t -137.94 158.57 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.185 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.598 HG22 ' CB ' ' A' ' 157' ' ' ARG . 28.0 mt -88.9 118.48 34.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 110.99 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.462 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -170.08 146.31 3.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.17 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -59.69 146.96 79.48 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.71 -24.42 17.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.555 2.17 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 m -91.06 -37.32 13.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.085 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.619 HG11 HG12 ' A' ' 158' ' ' VAL . 47.9 t -63.44 -44.13 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.2 OUTLIER -54.65 -30.44 55.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.64 -39.45 45.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.084 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.9 t80 -66.3 -48.04 71.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.114 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.11 -45.25 81.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -54.88 -31.87 60.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.172 178.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.39 -37.47 21.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.854 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.754 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.2 mmtt -84.27 25.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.727 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.65 20.72 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.525 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.551 HG23 HD21 ' A' ' 167' ' ' LEU . 53.7 t -111.5 143.78 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.403 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 15.9 t0 -116.17 130.21 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.786 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.5 HG22 ' CG1' ' A' ' 129' ' ' VAL . 29.7 mm -49.99 -23.7 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.383 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.81 ' HG3' HD23 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -64.3 -37.02 86.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.907 0.384 . . . . 0.0 110.367 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.81 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.0 OUTLIER -81.42 -5.63 58.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.642 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 162' ' ' ASP . 4.6 t -112.82 137.19 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.332 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.57 100.01 12.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -63.41 126.14 35.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.901 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 26.03 9.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.644 0.259 . . . . 0.0 110.794 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -101.71 122.05 7.43 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.349 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.69 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.6 OUTLIER -106.93 27.47 8.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.761 0.315 . . . . 0.0 111.293 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.52 26.17 21.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.8 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.598 ' CB ' HG22 ' A' ' 130' ' ' ILE . 27.3 ttm105 -82.19 151.99 26.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.705 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.619 HG12 HG11 ' A' ' 135' ' ' VAL . 9.5 t -86.64 136.18 23.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.173 0.511 . . . . 0.0 111.117 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 27.9 mt -107.26 164.45 12.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.48 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -33.18 67.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.45 -36.47 84.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.2 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -63.65 -48.51 76.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.746 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 139' ' ' ALA . 36.1 mm -52.9 -54.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.62 -39.2 73.21 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.621 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.4 80.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.529 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.515 ' HD1' HG22 ' A' ' 144' ' ' VAL . 52.0 t-105 -60.53 -56.97 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.754 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.87 -33.06 75.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.888 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.04 58.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.276 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.06 -50.54 64.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.528 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.819 0.342 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -67.91 -36.44 80.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -101.65 -173.98 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.83 HG13 ' HB ' ' A' ' 146' ' ' ILE . 53.6 t -94.26 136.02 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.776 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -130.08 111.88 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.706 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.544 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.57 158.12 9.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.314 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -64.2 154.39 82.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.828 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.32 -27.53 58.05 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.639 2.226 . . . . 0.0 112.35 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -90.02 -32.11 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.07 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 158' ' ' VAL . 97.5 t -65.53 -48.06 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.354 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 24.4 mtt180 -54.57 -28.78 48.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -77.67 -39.86 43.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.942 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.8 t80 -66.83 -48.02 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.059 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.979 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 3.4 tpt180 -54.92 -31.99 60.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.054 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.32 -36.62 22.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.067 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.727 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -83.61 21.64 1.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.61 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.48 19.78 42.65 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.554 HG23 HD21 ' A' ' 167' ' ' LEU . 49.0 t -110.36 143.05 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.0 110.913 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -116.27 130.19 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.053 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.855 HG23 HG21 ' A' ' 158' ' ' VAL . 32.8 mm -52.38 -21.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.463 ' HG2' HG22 ' A' ' 129' ' ' VAL . 2.8 mmm180 -63.58 -34.21 77.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.058 0.456 . . . . 0.0 110.25 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.56 -4.16 58.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.859 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.8 t -116.57 139.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.383 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.428 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 3.8 pt20 -102.73 97.48 7.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.355 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -71.7 143.29 34.99 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.165 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.32 113.76 4.46 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.965 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.95 -85.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.372 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -105.72 37.01 2.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.83 0.347 . . . . 0.0 111.108 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 83.68 26.13 43.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.577 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.776 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -75.87 136.82 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.749 0.309 . . . . 0.0 111.003 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.855 HG21 HG23 ' A' ' 146' ' ' ILE . 30.5 t -73.56 132.24 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.105 0.479 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.4 mt -102.87 161.13 14.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.196 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -55.45 -31.7 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.32 -37.83 88.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.0 m-20 -61.66 -50.48 72.33 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.626 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.979 HD12 ' HB2' ' A' ' 139' ' ' ALA . 31.5 mm -52.79 -54.97 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.43 -39.04 72.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.541 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.22 84.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.634 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.548 ' HD1' HG22 ' A' ' 144' ' ' VAL . 48.1 t-105 -60.38 -57.08 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.727 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.92 -32.52 74.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.934 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.82 -9.92 58.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -95.26 29.51 9.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.512 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.462 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.866 0.365 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.23 154.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.23 -71.37 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.848 HG13 ' HB ' ' A' ' 146' ' ' ILE . 57.8 t -138.13 135.57 44.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.333 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -130.09 111.86 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.508 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -166.94 154.77 9.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.6 mtt -60.47 160.02 20.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.34 -25.78 80.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.462 2.108 . . . . 0.0 112.202 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -30.49 16.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 158' ' ' VAL . 76.3 t -68.28 -47.82 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 9.7 mtt180 -54.68 -29.89 54.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -77.7 -39.89 43.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.059 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.16 -48.18 71.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.928 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.964 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.77 -45.89 80.84 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -54.81 -31.8 59.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.348 178.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -84.49 -37.56 21.18 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.923 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.755 ' O ' HD21 ' A' ' 167' ' ' LEU . 38.5 mmtt -84.58 25.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.728 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 22.05 19.29 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.697 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.544 HG23 HD21 ' A' ' 167' ' ' LEU . 51.1 t -111.18 142.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.001 0.429 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -116.16 130.21 56.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.197 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.904 HG23 HG21 ' A' ' 158' ' ' VAL . 31.0 mm -52.61 -21.26 2.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -64.0 -34.97 79.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 110.094 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.414 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.52 -1.27 57.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.855 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.4 t -120.07 133.39 66.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.88 0.371 . . . . 0.0 111.485 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -95.89 97.31 9.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -71.37 144.03 36.71 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.059 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.75 10.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.334 . . . . 0.0 110.629 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -87.12 107.1 3.22 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.814 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.31 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 111.332 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.8 p30 -99.32 33.26 2.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.343 . . . . 0.0 111.02 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.66 25.96 44.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.705 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -76.4 138.72 40.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.717 0.294 . . . . 0.0 111.094 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.904 HG21 HG23 ' A' ' 146' ' ' ILE . 24.6 t -72.86 137.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 111.19 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -109.42 161.33 15.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.226 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -55.97 -31.06 62.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -65.58 -37.31 86.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -62.38 -50.55 71.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.784 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.964 HD12 ' HB2' ' A' ' 139' ' ' ALA . 30.0 mm -52.77 -55.0 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.695 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.1 -40.16 73.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.673 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.25 87.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.87 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.522 ' HD1' HG22 ' A' ' 144' ' ' VAL . 52.3 t-105 -58.94 -57.25 13.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.755 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -63.45 -32.33 73.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.83 -25.07 48.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.67 46.85 1.12 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.517 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.385 -1.231 . . . . 0.0 112.501 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.823 0.344 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.38 117.69 26.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.35 -45.85 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.748 HG13 ' HB ' ' A' ' 146' ' ' ILE . 68.9 t -119.66 143.82 30.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.042 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.515 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.9 mp -130.05 111.91 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.608 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.546 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.87 151.26 4.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.55 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.4 mtp -58.98 149.64 65.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.87 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.35 -26.62 11.98 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -91.08 -29.23 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.55 HG23 ' HB2' ' A' ' 132' ' ' MET . 99.5 t -68.09 -51.18 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 1.8 mtt-85 -54.59 -29.95 53.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -77.68 -38.8 46.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.157 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.532 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 45.8 t80 -67.54 -48.11 67.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.053 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.011 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.64 -46.23 76.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 1.2 tmt_? -54.92 -32.03 60.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.036 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -84.3 -36.68 22.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.059 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.776 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -83.47 22.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.678 -179.18 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.28 20.73 37.41 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.255 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.552 HG23 HD21 ' A' ' 167' ' ' LEU . 51.1 t -112.1 142.83 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -116.14 130.7 56.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.054 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 158' ' ' VAL . 34.9 mm -51.49 -23.09 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -63.09 -34.12 76.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.496 . . . . 0.0 110.36 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.411 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.5 -6.71 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.951 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.1 t -110.87 129.62 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.891 0.376 . . . . 0.0 111.322 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.21 92.46 8.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.462 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.97 130.35 50.88 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.757 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.44 26.1 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.59 0.233 . . . . 0.0 111.038 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -104.6 125.2 8.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.513 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.82 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -114.08 31.36 6.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 92.62 26.08 18.64 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.721 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.515 ' HG3' HG22 ' A' ' 130' ' ' ILE . 40.3 ttp180 -81.01 149.61 29.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.045 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.784 HG21 HG23 ' A' ' 146' ' ' ILE . 32.0 t -83.51 135.45 24.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.21 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.5 mt -106.2 160.93 14.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.955 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -55.63 -32.38 63.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.664 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -65.12 -37.28 86.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.49 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -62.14 -49.91 73.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.762 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.8 mm -52.69 -55.02 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.524 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -57.35 -36.24 70.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.626 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.98 99.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.646 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.541 ' HD1' HG22 ' A' ' 144' ' ' VAL . 54.9 t-105 -57.22 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.482 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.776 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.21 -31.77 73.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.912 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.9 -25.11 64.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.06 31.34 17.61 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.512 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.493 -179.978 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.781 0.324 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.43 90.15 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.1 -174.65 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.972 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.515 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.5 t -120.09 157.86 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.2 mp -87.16 111.9 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.115 0.484 . . . . 0.0 111.079 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.647 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -165.55 149.82 8.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.7 mmt -64.67 154.53 84.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.716 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.72 -33.71 94.47 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.708 2.272 . . . . 0.0 112.531 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.83 -33.21 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.104 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.629 HG11 HG12 ' A' ' 158' ' ' VAL . 53.6 t -69.08 -45.76 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.308 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.647 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 8.1 mtm180 -54.62 -31.44 57.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -38.81 46.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.078 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.503 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.9 t80 -66.49 -47.91 71.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.059 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.94 -45.7 77.01 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.71 -32.08 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.128 178.692 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.47 -37.58 21.17 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.682 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -81.86 20.39 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.725 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.01 48.73 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.13 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.604 HG23 HD21 ' A' ' 167' ' ' LEU . 52.8 t -109.51 144.3 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 110.941 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -116.28 130.73 56.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.123 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.515 HG22 ' CG1' ' A' ' 129' ' ' VAL . 33.4 mm -49.98 -23.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.162 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -63.71 -35.99 82.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.005 0.431 . . . . 0.0 110.545 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.36 -0.52 56.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.093 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' A' ' 158' ' ' VAL . 5.6 t -116.51 131.53 68.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.65 106.14 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -69.0 129.71 24.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.72 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.04 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.608 0.242 . . . . 0.0 111.003 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.91 143.35 17.41 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.894 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt 49.67 -91.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -114.2 22.95 13.32 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.593 0.235 . . . . 0.0 111.444 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 26.05 6.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.759 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 130' ' ' ILE . 38.3 ttm180 -83.28 143.07 30.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.681 0.276 . . . . 0.0 111.006 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.629 HG12 HG11 ' A' ' 135' ' ' VAL . 13.8 t -78.88 134.79 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 111.112 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.469 ' HA ' HG21 ' A' ' 135' ' ' VAL . 15.2 mt -107.1 165.81 11.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.54 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -34.39 68.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -36.36 83.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.4 m-20 -64.6 -48.57 74.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.75 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.059 HD12 ' HB2' ' A' ' 139' ' ' ALA . 38.3 mm -52.92 -54.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.575 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -56.85 -38.84 73.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.568 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.69 -38.19 84.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.489 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.521 ' HD1' HG22 ' A' ' 144' ' ' VAL . 48.6 t-105 -60.03 -57.08 14.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.601 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.682 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -66.43 -32.39 73.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.909 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.03 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.56 58.99 1.38 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.345 -1.253 . . . . 0.0 112.518 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.792 0.33 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -132.47 30.48 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -139.57 -64.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.82 HG13 ' HB ' ' A' ' 146' ' ' ILE . 55.9 t -137.95 136.13 45.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.308 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp -130.08 111.86 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.252 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.512 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.13 154.61 9.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.166 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 135' ' ' VAL . 7.4 mtp -61.34 151.23 77.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.929 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.15 -26.01 24.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.2 . . . . 0.0 112.42 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 p -91.04 -30.36 16.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.807 HG11 HG12 ' A' ' 158' ' ' VAL . 58.9 t -67.24 -47.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.533 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 1.4 mtp-105 -54.68 -30.02 54.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 0.0 109.887 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -77.59 -40.39 42.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.198 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.528 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.01 -48.11 72.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.049 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.972 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.08 -45.56 80.83 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.82 -31.75 59.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.16 178.697 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.39 -37.46 21.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.901 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.746 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.0 mmtp -84.3 25.26 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.761 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.09 21.78 18.93 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.532 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.565 HG23 HD21 ' A' ' 167' ' ' LEU . 54.8 t -110.66 142.29 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.902 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.837 HG23 HG21 ' A' ' 158' ' ' VAL . 29.3 mm -51.22 -22.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 -62.7 -33.7 75.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.33 -7.16 57.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.846 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 162' ' ' ASP . 4.2 t -111.15 140.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.848 0.356 . . . . 0.0 111.334 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.29 90.8 4.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -61.64 135.33 47.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.878 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.98 9.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.591 0.234 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.79 127.08 9.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.107 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt 57.02 -86.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.548 0.213 . . . . 0.0 111.509 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.28 29.71 7.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.218 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 94.46 26.12 14.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.627 ' HA ' HG22 ' A' ' 130' ' ' ILE . 33.9 ttm180 -83.38 137.71 33.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 110.841 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.837 HG21 HG23 ' A' ' 146' ' ' ILE . 39.1 t -70.87 138.03 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.191 0.52 . . . . 0.0 111.467 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.2 mt -111.88 162.91 14.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.824 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -56.01 -31.59 63.22 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.42 -36.47 84.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.492 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -63.48 -49.97 71.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.673 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.972 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.4 mm -52.76 -54.92 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.704 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -55.91 -39.88 72.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.664 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.01 80.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.691 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.51 ' HD1' HG22 ' A' ' 144' ' ' VAL . 45.2 t-105 -60.74 -57.02 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.574 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.746 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.8 -32.51 74.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.79 -24.99 44.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.314 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.81 29.01 55.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.42 -1.211 . . . . 0.0 112.416 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.875 0.369 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 78.12 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -155.4 160.89 41.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.696 HG13 ' HB ' ' A' ' 146' ' ' ILE . 41.2 t -121.74 140.25 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.504 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.1 mp -130.08 111.89 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.646 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -165.64 148.88 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.015 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.523 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -57.41 159.96 7.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.717 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.84 -25.92 82.12 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.578 2.185 . . . . 0.0 112.248 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -91.05 -29.46 17.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.617 HG11 HG12 ' A' ' 158' ' ' VAL . 62.1 t -70.18 -47.53 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.396 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 13.2 mtt180 -54.53 -31.25 55.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.64 -38.76 47.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.213 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.525 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.2 t80 -66.77 -48.09 70.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.056 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.983 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.31 -45.73 79.33 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.1 tpm_? -54.88 -31.81 60.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -84.43 -37.6 21.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.773 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.2 mmtt -83.98 25.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.737 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.43 20.08 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.506 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.552 HG23 HD21 ' A' ' 167' ' ' LEU . 49.4 t -111.48 143.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.984 0.421 . . . . 0.0 110.972 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -116.21 130.85 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.774 HG23 HG21 ' A' ' 158' ' ' VAL . 28.1 mm -52.35 -22.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mmm-85 -64.11 -33.93 76.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.939 0.399 . . . . 0.0 110.439 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.18 -4.01 59.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.076 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.542 HG11 ' HB3' ' A' ' 162' ' ' ASP . 10.8 t -111.54 146.75 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.878 0.37 . . . . 0.0 111.186 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.4 95.43 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -58.5 128.6 48.0 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.709 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.16 26.12 9.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 0.0 111.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.81 143.83 18.03 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.001 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 49.28 -91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -114.01 29.9 7.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.741 0.305 . . . . 0.0 111.322 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 95.68 26.04 12.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.659 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.504 ' CB ' HG22 ' A' ' 130' ' ' ILE . 38.5 ttm180 -82.63 145.93 29.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.731 0.3 . . . . 0.0 110.905 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.774 HG21 HG23 ' A' ' 146' ' ' ILE . 41.1 t -79.31 134.63 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.275 0.559 . . . . 0.0 111.279 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.6 mt -106.35 162.01 14.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.972 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -31.7 62.38 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -37.76 87.93 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.1 m-20 -62.16 -50.15 72.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.742 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.983 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.5 mm -52.73 -54.93 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.639 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.11 -36.01 67.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.661 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.24 90.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.537 ' HD1' HG22 ' A' ' 144' ' ' VAL . 38.9 t-105 -59.67 -56.71 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.559 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.773 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.83 -31.42 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.01 64.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 125.17 -28.92 4.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.437 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.472 -179.969 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.92 74.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.31 -33.62 5.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.574 HG13 ' HB ' ' A' ' 146' ' ' ILE . 53.4 t -117.26 147.26 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.229 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.8 mp -130.07 111.79 22.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.651 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -170.19 154.28 4.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.538 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -59.89 147.63 78.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.695 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.45 -25.53 14.33 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.572 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.7 p -91.01 -28.96 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.794 HG11 HG12 ' A' ' 158' ' ' VAL . 62.0 t -68.66 -47.61 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.468 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.9 mtp180 -54.71 -30.68 56.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -77.63 -39.24 45.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.126 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.5 t80 -66.48 -48.21 70.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.044 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.49 -45.47 79.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 3.5 tpt180 -54.8 -31.71 59.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.267 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.47 -38.21 20.41 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.924 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.76 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.4 mmtt -82.99 26.45 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.885 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.84 22.25 18.54 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.471 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.546 HG23 HD21 ' A' ' 167' ' ' LEU . 54.1 t -111.68 144.01 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 111.044 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.401 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.2 t0 -116.29 131.1 57.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.97 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.574 ' HB ' HG13 ' A' ' 129' ' ' VAL . 35.0 mm -52.4 -22.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -64.58 -33.61 76.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.982 0.42 . . . . 0.0 110.421 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.93 -1.4 57.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.961 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 162' ' ' ASP . 13.7 t -114.64 146.11 19.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -104.65 108.5 19.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -66.96 126.1 25.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.764 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.26 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.716 0.293 . . . . 0.0 111.016 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.23 142.31 17.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.12 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER 49.87 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -114.02 31.72 6.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.69 0.281 . . . . 0.0 111.326 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.13 17.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.721 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.523 ' HA ' HG22 ' A' ' 130' ' ' ILE . 6.1 ttm180 -84.29 148.09 26.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.711 0.291 . . . . 0.0 110.742 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.794 HG12 HG11 ' A' ' 135' ' ' VAL . 10.1 t -81.63 137.99 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 111.223 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.9 mt -110.35 161.92 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.345 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -55.64 -32.65 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.3 -37.38 87.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.277 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -62.39 -48.5 79.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.701 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.044 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.4 mm -52.83 -54.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.502 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.94 -35.29 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.526 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.14 89.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.504 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.524 ' HD1' HG22 ' A' ' 144' ' ' VAL . 39.9 t-105 -59.93 -57.01 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.76 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.81 -32.06 73.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.03 64.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.251 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -119.0 27.97 6.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.457 -1.191 . . . . 0.0 112.51 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 p30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.784 0.326 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -124.95 175.32 7.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.0 169.51 9.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.541 HG13 ' HB ' ' A' ' 146' ' ' ILE . 26.3 t -138.01 149.74 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.132 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.6 mp -130.06 111.94 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.618 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.518 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.99 151.2 3.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.31 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.4 mtp -58.27 148.47 62.92 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.12 -25.32 22.58 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.562 2.174 . . . . 0.0 112.506 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.2 m -90.94 -34.0 15.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.65 HG11 HG12 ' A' ' 158' ' ' VAL . 92.7 t -62.79 -47.56 92.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 37.7 mtp85 -54.66 -28.1 44.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.035 0.445 . . . . 0.0 110.002 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -41.57 37.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.928 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.619 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 40.4 t80 -66.3 -48.29 70.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.816 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.132 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.19 -46.15 85.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.95 -32.11 61.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.5 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -84.69 -38.42 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 111.104 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.819 ' O ' HD21 ' A' ' 167' ' ' LEU . 27.0 mmmt -82.19 25.48 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.976 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 23.65 23.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.342 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.584 HG23 HD21 ' A' ' 167' ' ' LEU . 53.7 t -114.65 142.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.06 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -116.24 131.86 56.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.702 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.541 ' HB ' HG13 ' A' ' 129' ' ' VAL . 32.9 mm -50.29 -23.77 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.712 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.4 OUTLIER -66.31 -33.19 75.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.893 0.378 . . . . 0.0 110.377 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.433 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.4 mt -85.52 -1.86 57.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.487 ' HB ' HG21 ' A' ' 158' ' ' VAL . 5.0 t -115.56 127.21 73.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.81 0.338 . . . . 0.0 111.475 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.01 92.4 7.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.425 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -57.38 129.13 49.03 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.981 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.12 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.727 0.299 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -100.06 117.03 5.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 153' ' ' GLY . 3.9 p-10 -101.73 31.31 3.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.62 26.16 43.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.677 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.509 ' HG3' HG22 ' A' ' 130' ' ' ILE . 43.7 ttm180 -80.13 150.91 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.65 HG12 HG11 ' A' ' 135' ' ' VAL . 21.9 t -84.67 133.73 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 21.0 mt -106.83 162.41 13.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.66 -33.18 63.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -62.87 -48.48 78.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.785 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.132 HD12 ' HB2' ' A' ' 139' ' ' ALA . 32.5 mm -52.76 -53.82 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.428 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.74 -38.36 75.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.523 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.84 86.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.573 ' HD1' HG22 ' A' ' 144' ' ' VAL . 50.8 t-105 -59.2 -57.06 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.819 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -66.24 -33.68 76.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.914 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.27 -25.08 59.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.229 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.66 67.91 1.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.559 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.474 179.933 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.795 0.331 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.11 -44.73 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -167.73 1.87 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.8 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.775 HG13 ' HB ' ' A' ' 146' ' ' ILE . 55.8 t -137.58 138.53 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.985 0.421 . . . . 0.0 111.173 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.603 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp -130.03 111.79 22.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.47 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.443 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.2 152.02 7.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.163 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.515 ' HB2' HG23 ' A' ' 135' ' ' VAL . 6.3 mtp -58.7 160.04 11.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.22 -25.8 81.22 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 m -91.03 -30.92 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.702 HG11 HG12 ' A' ' 158' ' ' VAL . 45.1 t -69.11 -47.15 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.541 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.5 mtp180 -54.61 -31.22 56.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.69 -38.21 47.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.82 -48.09 70.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.077 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.38 -45.42 80.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.77 59.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.285 178.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -84.45 -37.78 20.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.905 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.734 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.4 mmtt -83.61 25.85 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.728 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.03 21.8 18.53 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.381 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.564 HG23 HD21 ' A' ' 167' ' ' LEU . 55.9 t -111.12 142.42 23.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.009 0.433 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.21 130.47 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 158' ' ' VAL . 34.8 mm -50.7 -23.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtp-105 -63.8 -35.74 81.6 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.7 OUTLIER -85.51 -4.07 59.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' A' ' 162' ' ' ASP . 8.6 t -113.46 149.2 15.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 111.241 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -107.29 102.55 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -62.39 129.73 43.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.0 9.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.712 0.291 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.2 141.57 17.09 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.077 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.61 -91.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -113.98 34.33 4.7 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.735 0.302 . . . . 0.0 111.271 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 89.93 26.09 25.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.763 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.603 ' HA ' HG22 ' A' ' 130' ' ' ILE . 22.6 ttm180 -82.55 142.63 31.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.854 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.8 HG21 HG23 ' A' ' 146' ' ' ILE . 37.5 t -76.75 133.32 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.231 0.538 . . . . 0.0 111.196 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.3 mt -107.86 163.9 12.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.075 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.45 -32.4 62.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.93 -37.72 88.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.536 ' HB3' HG11 ' A' ' 149' ' ' VAL . 4.7 m-20 -62.18 -50.52 71.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.753 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 139' ' ' ALA . 29.9 mm -52.74 -55.04 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.733 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.43 -38.46 69.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.636 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.89 89.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.535 ' HD1' HG22 ' A' ' 144' ' ' VAL . 46.1 t-105 -59.16 -57.15 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.734 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -64.45 -30.24 71.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.023 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.99 -24.95 64.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.09 -27.81 43.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.556 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.427 -1.207 . . . . 0.0 112.462 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.0 p30 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.814 0.34 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 124.57 28.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.35 56.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.499 HG21 ' HG3' ' A' ' 147' ' ' ARG . 2.1 t -99.2 156.84 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -88.85 111.95 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.21 0.529 . . . . 0.0 111.211 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -168.68 143.69 3.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.1 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.509 ' HB2' HG23 ' A' ' 135' ' ' VAL . 9.9 mmt -55.55 150.28 25.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.45 -29.78 70.43 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.04 -33.46 21.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 158' ' ' VAL . 93.3 t -66.36 -46.81 86.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.304 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 42.0 mtp180 -54.64 -28.88 50.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.027 0.442 . . . . 0.0 109.867 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -77.67 -41.61 37.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.055 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.486 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.4 t80 -65.2 -47.99 74.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.078 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.68 -45.44 82.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.8 tpt85 -54.71 -31.84 58.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.3 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.46 -37.54 21.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.738 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.6 mmtt -84.14 22.35 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.797 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.3 19.06 31.13 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.594 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.508 HG23 HD21 ' A' ' 167' ' ' LEU . 65.3 t -104.96 143.24 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.3 t0 -116.16 129.09 56.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.934 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.473 HG22 ' CG1' ' A' ' 129' ' ' VAL . 35.5 mm -50.66 -22.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.25 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.499 ' HG3' HG21 ' A' ' 129' ' ' VAL . 10.7 mtp180 -64.32 -33.71 76.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.99 0.424 . . . . 0.0 110.595 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.409 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.2 OUTLIER -91.37 1.73 56.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.538 ' HB ' HG21 ' A' ' 158' ' ' VAL . 4.0 t -119.09 120.12 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.71 96.23 8.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -68.85 134.78 27.85 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.114 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.18 26.02 9.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 110.695 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.12 112.74 4.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.935 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.2 -85.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 153' ' ' GLY . 35.6 m120 -97.75 33.66 2.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.769 0.319 . . . . 0.0 111.098 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.52 26.03 61.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.603 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.627 ' HA ' HG22 ' A' ' 130' ' ' ILE . 1.8 ttm105 -81.33 137.92 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.72 HG12 HG11 ' A' ' 135' ' ' VAL . 9.5 t -71.31 137.38 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -108.38 163.9 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.454 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -57.24 -34.8 68.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.25 -36.26 83.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.0 m-20 -64.24 -48.01 77.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.078 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.2 mm -52.87 -54.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.544 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -56.56 -39.02 72.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.15 88.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.409 ' CZ3' ' O ' ' A' ' 148' ' ' LEU . 49.6 t-105 -58.72 -57.05 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.4 mt -61.13 -26.56 67.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.213 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.87 -24.97 64.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.159 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.16 34.92 6.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.564 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.434 -1.203 . . . . 0.0 112.457 179.909 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.815 0.34 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.01 173.39 6.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.36 116.54 3.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.001 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.595 HG21 ' HG2' ' A' ' 147' ' ' ARG . 2.9 t -93.36 157.42 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.793 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.0 mp -83.44 111.81 20.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.284 0.564 . . . . 0.0 111.192 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -170.12 147.05 3.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' VAL . 5.9 mtp -57.38 155.11 20.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.737 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.9 -24.23 78.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.548 2.165 . . . . 0.0 112.303 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 -36.21 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 158' ' ' VAL . 47.3 t -64.69 -44.26 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.358 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.513 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -54.71 -29.99 54.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 109.727 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -40.48 41.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.974 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.3 t80 -65.47 -48.03 74.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.081 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.014 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.4 -45.18 80.88 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -54.88 -31.84 60.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.057 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.43 -37.54 21.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.736 ' O ' HD21 ' A' ' 167' ' ' LEU . 18.1 mmtp -84.46 25.36 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.748 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.8 21.17 21.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.577 HG23 HD21 ' A' ' 167' ' ' LEU . 53.6 t -109.51 143.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -116.17 130.62 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.123 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.504 HG22 ' CG1' ' A' ' 129' ' ' VAL . 33.9 mm -50.77 -22.65 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.198 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.595 ' HG2' HG21 ' A' ' 129' ' ' VAL . 8.4 mmm180 -63.68 -35.76 81.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.059 0.457 . . . . 0.0 110.32 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.96 -0.43 56.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.993 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.45 ' HB ' HG21 ' A' ' 158' ' ' VAL . 3.9 t -118.96 130.86 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 111.268 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 101.43 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.607 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -65.03 129.24 34.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.943 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.44 25.99 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.325 . . . . 0.0 110.697 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.86 123.52 7.78 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.259 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt 56.5 -84.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -113.09 37.0 3.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.675 0.274 . . . . 0.0 111.484 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 89.39 26.19 26.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.768 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.753 ' HA ' HG22 ' A' ' 130' ' ' ILE . 2.6 ttt180 -81.61 142.93 32.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 135' ' ' VAL . 8.3 t -82.63 128.0 39.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.168 0.508 . . . . 0.0 110.728 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.526 ' HA ' HG21 ' A' ' 135' ' ' VAL . 15.8 mt -100.55 165.86 11.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.66 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -57.61 -32.78 67.54 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.51 -36.63 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.3 m-20 -64.26 -49.02 73.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.591 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.014 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.6 mm -52.96 -54.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.608 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.63 -39.56 71.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.86 83.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.523 ' HD1' HG22 ' A' ' 144' ' ' VAL . 42.9 t-105 -59.77 -57.06 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.555 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.736 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -65.26 -31.15 72.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.98 64.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.187 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.67 29.97 11.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.52 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.806 0.336 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -81.38 116.59 21.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -105.26 -29.64 10.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 146' ' ' ILE . 42.5 t -96.73 135.16 31.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 111.413 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.46 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp -130.04 111.9 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.428 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -164.56 151.42 11.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.219 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.535 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -56.92 157.34 11.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.888 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.45 -24.6 78.36 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.581 2.187 . . . . 0.0 112.133 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.0 p -90.95 -30.37 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.995 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.79 HG11 HG12 ' A' ' 158' ' ' VAL . 63.9 t -66.73 -47.02 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 37.9 mtp85 -54.67 -30.04 54.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -40.37 42.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.179 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.9 t80 -66.39 -48.14 71.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.978 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.94 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.34 -46.16 81.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.98 -31.83 61.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.38 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -84.44 -37.22 21.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.767 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.4 mmtt -84.19 25.06 0.88 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.721 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 22.41 19.59 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.523 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG22 ' HD1' ' A' ' 166' ' ' TRP . 46.7 t -111.5 143.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.992 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -116.19 130.01 56.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.942 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.761 HG23 HG21 ' A' ' 158' ' ' VAL . 20.7 mm -51.86 -22.15 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -63.77 -33.99 76.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.006 0.431 . . . . 0.0 110.299 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.97 -4.69 59.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.574 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.1 t -110.97 147.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.264 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.8 99.6 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.684 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -59.09 126.93 43.95 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.688 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.0 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.631 0.253 . . . . 0.0 111.01 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.45 141.76 16.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.986 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.28 -91.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -114.19 24.23 12.16 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.634 0.254 . . . . 0.0 111.477 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 103.71 26.1 6.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.878 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.46 ' CB ' HG22 ' A' ' 130' ' ' ILE . 20.8 ttm105 -84.22 147.43 27.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.745 0.307 . . . . 0.0 110.825 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.79 HG12 HG11 ' A' ' 135' ' ' VAL . 14.9 t -80.28 138.05 20.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.2 mt -112.06 165.09 12.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.28 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 23.4 tttt -57.01 -33.68 67.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.39 -36.95 85.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.574 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.5 m-20 -63.17 -50.51 70.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.634 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.94 HD12 ' HB2' ' A' ' 139' ' ' ALA . 30.7 mm -52.93 -54.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.546 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -57.59 -35.13 70.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.476 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.27 97.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.502 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.561 ' HD1' HG22 ' A' ' 144' ' ' VAL . 47.2 t-105 -58.73 -56.7 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.767 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.73 -29.75 70.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.069 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.66 31.08 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.289 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.08 80.72 0.1 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.522 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.483 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.2 mp . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 121.087 0.47 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.63 149.21 5.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.988 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.4 mtm -56.37 158.15 8.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.4 -24.89 79.05 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.496 2.131 . . . . 0.0 112.332 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 m -91.12 -31.78 16.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.698 HG11 HG12 ' A' ' 158' ' ' VAL . 43.7 t -68.52 -45.2 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.6 mtp-105 -54.61 -31.82 57.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.62 -38.48 47.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.238 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.545 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.6 t80 -66.41 -48.06 71.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.011 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.006 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.23 -45.59 80.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 11.2 ttt85 -54.78 -31.67 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.402 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.36 -39.48 19.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.709 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.591 ' HB3' HD11 ' A' ' 167' ' ' LEU . 45.6 mmtt -80.25 9.98 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.605 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.9 8.77 64.84 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.526 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 167' ' ' LEU . 48.8 t -96.64 143.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.986 0.422 . . . . 0.0 110.703 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 22.4 t0 -116.06 129.4 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.912 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.822 HG23 HG21 ' A' ' 158' ' ' VAL . 32.1 mm -51.04 -22.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -64.18 -34.38 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.02 0.438 . . . . 0.0 110.429 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.3 OUTLIER -88.25 -2.14 58.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.984 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 162' ' ' ASP . 7.4 t -115.19 139.08 43.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.9 0.381 . . . . 0.0 111.376 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -98.1 90.72 4.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.576 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.6 134.07 52.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.766 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.35 26.07 9.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.629 0.252 . . . . 0.0 111.009 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -105.13 127.63 9.11 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.156 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.28 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.577 0.227 . . . . 0.0 111.492 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -110.13 30.23 6.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.811 0.338 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.08 26.01 25.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.714 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.619 ' HA ' HG22 ' A' ' 130' ' ' ILE . 31.9 ttm180 -79.48 138.9 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.822 HG21 HG23 ' A' ' 146' ' ' ILE . 45.7 t -72.07 132.68 33.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 111.425 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.1 mt -105.66 162.5 13.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.756 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -55.74 -31.42 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.99 -37.59 86.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB3' HG11 ' A' ' 149' ' ' VAL . 4.7 m-20 -61.69 -49.98 74.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.664 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.006 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.0 mm -52.69 -54.8 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.473 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.88 -38.61 73.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.46 89.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.568 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.564 ' HD1' HG22 ' A' ' 144' ' ' VAL . 51.6 t-105 -58.4 -57.01 14.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.636 HD21 HG23 ' A' ' 144' ' ' VAL . 1.9 mt -65.58 -27.35 68.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.066 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.294 -179.81 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.556 HG22 ' CB ' ' A' ' 157' ' ' ARG . 3.8 mp . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.929 0.395 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' ' 136' ' ' ARG . . . -161.28 150.39 16.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.344 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.5 mtp -59.98 159.59 19.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.785 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.4 -26.27 82.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.569 2.179 . . . . 0.0 112.157 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 p -91.04 -29.58 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.727 HG11 HG12 ' A' ' 158' ' ' VAL . 61.4 t -70.06 -48.82 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.382 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.445 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 42.2 mtt-85 -54.58 -30.03 53.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -40.07 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.119 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.17 -48.15 71.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.067 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.989 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.22 -45.35 81.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -54.83 -31.82 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.133 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.49 -37.54 21.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.853 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.779 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.4 mmtt -84.03 26.1 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.862 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.0 18.71 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.557 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.555 HG22 ' HD1' ' A' ' 166' ' ' TRP . 54.4 t -112.26 141.06 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.05 0.452 . . . . 0.0 110.944 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -116.21 131.23 57.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.624 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.834 HG23 HG21 ' A' ' 158' ' ' VAL . 32.6 mm -50.82 -23.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.628 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -65.12 -31.96 73.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.932 0.396 . . . . 0.0 110.287 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.5 mt -86.07 -7.66 58.45 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.658 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.3 t -111.08 145.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 120.974 0.416 . . . . 0.0 111.435 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.71 88.48 2.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.197 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -64.43 137.09 39.71 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.049 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.38 26.06 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.754 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.79 121.76 6.77 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.402 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.52 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' GLY . 17.0 m-80 -114.08 36.86 3.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.18 26.08 34.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.617 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.556 ' CB ' HG22 ' A' ' 130' ' ' ILE . 18.1 ttm180 -82.06 142.5 32.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.834 HG21 HG23 ' A' ' 146' ' ' ILE . 38.6 t -75.94 137.95 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.477 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.5 mt -110.41 161.38 15.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.702 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -55.43 -31.8 62.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.774 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -64.61 -38.05 89.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.501 ' HB3' HG11 ' A' ' 149' ' ' VAL . 6.7 m-20 -62.16 -49.94 73.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.737 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.989 HD12 ' HB2' ' A' ' 139' ' ' ALA . 37.9 mm -52.69 -55.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.66 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.79 -37.3 68.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.89 92.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.855 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.555 ' HD1' HG22 ' A' ' 144' ' ' VAL . 55.3 t-105 -58.34 -57.1 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -63.34 -31.33 72.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.953 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.21 179.893 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.063 0.458 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.559 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -165.53 149.12 8.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.4 mtm -61.8 160.06 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.13 -25.91 72.92 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.651 2.234 . . . . 0.0 112.231 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.5 p -90.97 -31.01 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.038 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.762 HG11 HG12 ' A' ' 158' ' ' VAL . 60.5 t -68.84 -47.35 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.37 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.559 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 26.1 mtp180 -54.66 -30.09 54.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.462 . . . . 0.0 109.892 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -77.7 -41.12 39.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.165 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.521 ' CD2' HG21 ' A' ' 163' ' ' ILE . 52.0 t80 -65.5 -48.17 73.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.02 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.9 -45.44 81.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -54.91 -31.84 60.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.096 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.52 -37.58 21.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.947 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.768 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.1 mmtp -84.13 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.814 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.14 18.61 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.66 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.554 HG23 HD21 ' A' ' 167' ' ' LEU . 52.4 t -110.59 143.66 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.046 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -116.19 131.32 56.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.016 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' A' ' 131' ' ' ALA . 41.7 mm -50.88 -23.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.226 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -63.96 -34.86 78.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.046 0.451 . . . . 0.0 110.469 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.412 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -89.52 -0.07 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.981 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' A' ' 158' ' ' VAL . 3.3 t -118.85 113.28 41.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.88 0.372 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.31 105.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.188 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -66.28 128.87 31.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.753 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 26.08 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.637 0.256 . . . . 0.0 110.96 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.24 126.42 8.08 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.309 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.49 -89.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.09 21.73 14.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.555 0.217 . . . . 0.0 111.464 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 110.61 26.14 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.809 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.592 ' HA ' HG22 ' A' ' 130' ' ' ILE . 18.2 ttp-105 -85.72 146.94 26.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.762 HG12 HG11 ' A' ' 135' ' ' VAL . 12.5 t -83.61 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.093 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.0 mt -107.87 165.05 11.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.39 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.416 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 1.6 tttt -57.5 -34.37 69.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.29 -36.09 82.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.3 m-20 -64.94 -48.65 73.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 139' ' ' ALA . 41.5 mm -52.87 -54.79 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.13 -40.81 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.677 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.65 83.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.524 ' HD1' HG22 ' A' ' 144' ' ' VAL . 45.9 t-105 -58.82 -57.12 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.768 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.44 -33.59 76.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.942 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.184 0.516 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -170.11 147.77 3.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.945 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.1 mtm -54.54 148.91 23.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.991 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.77 -26.6 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.659 2.239 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -89.76 -28.18 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.803 HG11 HG12 ' A' ' 158' ' ' VAL . 48.7 t -71.23 -45.86 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.52 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 11.5 mtp-105 -54.67 -32.01 58.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.145 0.498 . . . . 0.0 109.735 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -40.14 41.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.1 t80 -65.67 -48.15 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.12 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.947 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.55 -45.08 80.55 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 15.4 tpt180 -54.91 -31.94 60.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.022 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -84.42 -38.13 20.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.952 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.741 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.2 mmtt -83.46 24.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.805 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.38 21.73 20.87 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.497 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.545 HG23 HD21 ' A' ' 167' ' ' LEU . 49.6 t -109.95 142.89 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.907 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -116.1 129.98 56.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.066 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 158' ' ' VAL . 31.0 mm -51.73 -21.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.239 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -64.45 -34.45 78.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.405 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.91 -1.11 57.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.928 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.1 t -115.1 151.0 16.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 0.6 OUTLIER -111.59 96.59 6.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -67.82 135.31 30.42 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.963 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.33 26.01 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.635 0.255 . . . . 0.0 110.946 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.0 131.14 10.5 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.102 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.04 -87.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.605 0.241 . . . . 0.0 111.375 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.04 29.13 8.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.777 0.323 . . . . 0.0 111.012 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 96.87 18.26 30.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.697 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.66 ' HA ' HG22 ' A' ' 130' ' ' ILE . 3.2 ttm180 -73.0 138.98 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 110.971 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.803 HG12 HG11 ' A' ' 135' ' ' VAL . 31.9 t -71.26 138.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.185 0.517 . . . . 0.0 111.551 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.1 mt -109.84 161.74 15.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.53 -32.44 62.94 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.742 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -64.33 -37.38 87.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.267 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.486 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.9 m-20 -62.57 -50.03 72.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.76 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.947 HD12 ' HB2' ' A' ' 139' ' ' ALA . 33.8 mm -52.74 -55.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.654 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.16 -38.97 71.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.726 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.09 84.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.545 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.542 ' HD1' HG22 ' A' ' 144' ' ' VAL . 44.8 t-105 -60.19 -57.03 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.741 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -64.55 -30.19 71.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.858 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.528 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -161.63 149.11 14.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.355 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -59.37 150.82 62.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.08 -26.81 15.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.526 2.151 . . . . 0.0 112.352 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 -29.64 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.072 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.562 HG11 HG12 ' A' ' 158' ' ' VAL . 86.1 t -68.32 -50.27 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.385 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.653 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 10.3 mtt180 -54.64 -30.18 54.33 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -77.67 -39.63 44.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.142 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.521 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 47.5 t80 -66.9 -48.11 69.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.165 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.018 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.5 -45.92 77.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.89 -31.98 60.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.033 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.41 -36.97 22.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.992 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.73 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -82.19 19.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.733 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.5 19.88 49.45 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.977 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.563 HG22 ' HD1' ' A' ' 166' ' ' TRP . 50.0 t -110.75 143.56 20.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 111.022 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 59.7 t0 -116.23 130.56 56.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.947 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.777 HG23 HG21 ' A' ' 158' ' ' VAL . 34.6 mm -51.0 -23.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -63.33 -34.27 77.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.542 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.42 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -86.62 -6.46 58.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.971 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 162' ' ' ASP . 7.1 t -107.82 152.33 9.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.88 0.372 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.85 97.51 7.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.813 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -58.93 128.77 48.48 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.559 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.99 26.02 9.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.697 0.284 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -122.03 150.27 17.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.687 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 47.97 -97.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -114.19 37.02 3.47 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.91 26.09 23.03 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.528 ' CB ' HG22 ' A' ' 130' ' ' ILE . 34.0 ttm180 -81.97 146.73 29.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.777 HG21 HG23 ' A' ' 146' ' ' ILE . 40.0 t -81.52 134.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.14 0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.7 mt -105.25 161.32 14.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -55.63 -32.34 63.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.0 -37.51 87.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.521 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -62.5 -50.07 72.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.638 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.018 HD12 ' HB2' ' A' ' 139' ' ' ALA . 37.0 mm -52.66 -54.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.49 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.0 -35.08 68.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.92 95.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.601 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.563 ' HD1' HG22 ' A' ' 144' ' ' VAL . 47.3 t-105 -58.38 -56.48 21.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.94 -34.95 79.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.993 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.25 179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 121.008 0.432 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.449 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -166.66 152.81 8.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.318 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -59.48 151.86 58.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.737 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.42 -27.58 32.18 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.468 2.112 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.9 -29.23 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.365 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 158' ' ' VAL . 86.0 t -68.0 -48.55 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.406 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 3.5 mtt180 -54.63 -29.3 51.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -77.69 -39.91 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.97 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.8 t80 -66.38 -48.02 71.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.05 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.983 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.0 -45.32 82.0 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.89 -31.87 60.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.102 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.44 -37.38 21.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.847 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.724 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.6 mmtt -84.08 23.5 1.04 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.836 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.53 20.92 25.86 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.57 HG23 HD21 ' A' ' 167' ' ' LEU . 49.1 t -109.0 143.53 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.968 0.413 . . . . 0.0 110.943 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.062 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.843 HG23 HG21 ' A' ' 158' ' ' VAL . 30.4 mm -52.31 -21.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.089 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -63.76 -34.29 77.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.05 0.452 . . . . 0.0 110.218 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.05 -3.92 58.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.867 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.9 t -116.8 129.38 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.322 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.29 94.85 10.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.287 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -59.91 134.83 50.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.011 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.17 25.99 9.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 110.652 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.46 103.94 3.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.965 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.94 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.657 0.265 . . . . 0.0 111.489 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.2 m-80 -95.85 35.18 1.42 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 111.109 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 75.3 26.11 66.81 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.502 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.675 ' HA ' HG22 ' A' ' 130' ' ' ILE . 27.7 ttm180 -79.24 139.16 37.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.214 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.843 HG21 HG23 ' A' ' 146' ' ' ILE . 38.2 t -74.6 133.79 30.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.199 0.523 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.7 mt -104.8 160.97 14.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.001 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -55.81 -31.55 62.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.97 -37.45 86.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -61.78 -50.0 74.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.593 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.983 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.6 mm -52.66 -55.18 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.558 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -55.55 -40.55 72.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.655 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.14 82.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.636 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.483 ' HD1' HG22 ' A' ' 144' ' ' VAL . 41.9 t-105 -59.47 -57.01 14.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.481 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -63.59 -31.56 72.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.939 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.227 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.517 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.3 mp . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 121.009 0.433 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -163.92 153.95 14.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -64.46 160.1 54.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.37 -28.17 83.97 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 112.258 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.1 p -91.13 -29.46 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 158' ' ' VAL . 95.9 t -68.92 -48.33 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.448 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.438 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 65.5 mtt-85 -54.63 -29.37 51.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.061 0.458 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.71 -41.14 38.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.198 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.617 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 44.3 t80 -66.4 -48.26 70.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.911 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.053 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.31 -47.18 80.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 16.8 tpt180 -54.97 -31.92 61.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.72 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.69 -38.61 19.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.221 0.534 . . . . 0.0 111.192 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.799 ' O ' HD21 ' A' ' 167' ' ' LEU . 26.6 mmmt -82.38 24.71 0.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.831 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.23 21.88 27.49 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.445 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.644 HG23 HD21 ' A' ' 167' ' ' LEU . 54.6 t -112.33 142.25 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -116.18 129.97 56.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.804 HG23 HG21 ' A' ' 158' ' ' VAL . 34.2 mm -51.39 -22.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -63.98 -34.0 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.987 0.423 . . . . 0.0 110.384 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.96 -4.22 58.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.916 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' A' ' 162' ' ' ASP . 5.4 t -113.92 134.98 55.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.107 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.28 93.4 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.417 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.87 129.37 49.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.586 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 26.09 9.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 0.0 111.1 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.76 140.53 16.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.984 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.41 -91.0 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.462 0.172 . . . . 0.0 111.441 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -114.1 34.38 4.7 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.871 0.367 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.0 21.06 40.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.454 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.517 ' HA ' HG22 ' A' ' 130' ' ' ILE . 41.7 ttm180 -78.36 145.11 35.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.804 HG21 HG23 ' A' ' 146' ' ' ILE . 38.5 t -77.18 135.94 25.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.164 0.507 . . . . 0.0 111.322 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.2 mt -107.51 162.04 14.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.006 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -55.66 -32.05 62.89 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.821 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -65.24 -37.33 86.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.514 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.5 m-20 -62.77 -50.14 72.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.73 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.053 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.7 mm -52.67 -55.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -56.82 -36.58 70.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.545 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.587 ' HD1' HG22 ' A' ' 144' ' ' VAL . 42.2 t-105 -59.75 -54.84 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.549 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -68.85 -26.82 65.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.135 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.622 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.598 HG22 ' CB ' ' A' ' 157' ' ' ARG . 28.0 mt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.013 0.435 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.462 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -170.08 146.31 3.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.17 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -59.69 146.96 79.48 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.71 -24.42 17.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.555 2.17 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 m -91.06 -37.32 13.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.085 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.619 HG11 HG12 ' A' ' 158' ' ' VAL . 47.9 t -63.44 -44.13 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.2 OUTLIER -54.65 -30.44 55.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.64 -39.45 45.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.084 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.9 t80 -66.3 -48.04 71.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.114 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.11 -45.25 81.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -54.88 -31.87 60.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.172 178.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.39 -37.47 21.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.854 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.754 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.2 mmtt -84.27 25.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.727 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.65 20.72 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.525 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.551 HG23 HD21 ' A' ' 167' ' ' LEU . 53.7 t -111.5 143.78 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.403 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 15.9 t0 -116.17 130.21 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.786 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 131' ' ' ALA . 29.7 mm -49.99 -23.7 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.383 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.81 ' HG3' HD23 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -64.3 -37.02 86.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.907 0.384 . . . . 0.0 110.367 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.81 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.0 OUTLIER -81.42 -5.63 58.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.642 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 162' ' ' ASP . 4.6 t -112.82 137.19 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.332 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.57 100.01 12.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -63.41 126.14 35.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.901 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 26.03 9.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.644 0.259 . . . . 0.0 110.794 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -101.71 122.05 7.43 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.349 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.69 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.6 OUTLIER -106.93 27.47 8.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.761 0.315 . . . . 0.0 111.293 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.52 26.17 21.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.8 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.598 ' CB ' HG22 ' A' ' 130' ' ' ILE . 27.3 ttm105 -82.19 151.99 26.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.705 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.619 HG12 HG11 ' A' ' 135' ' ' VAL . 9.5 t -86.64 136.18 23.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.173 0.511 . . . . 0.0 111.117 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 27.9 mt -107.26 164.45 12.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.48 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -33.18 67.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.45 -36.47 84.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.2 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -63.65 -48.51 76.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.746 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 139' ' ' ALA . 36.1 mm -52.9 -54.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.62 -39.2 73.21 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.621 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.4 80.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.529 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.515 ' HD1' HG22 ' A' ' 144' ' ' VAL . 52.0 t-105 -60.53 -56.97 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.754 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.87 -33.06 75.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.888 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.276 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.776 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.046 0.45 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.544 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.57 158.12 9.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.314 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -64.2 154.39 82.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.828 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.32 -27.53 58.05 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.639 2.226 . . . . 0.0 112.35 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -90.02 -32.11 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.07 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 158' ' ' VAL . 97.5 t -65.53 -48.06 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.354 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 24.4 mtt180 -54.57 -28.78 48.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -77.67 -39.86 43.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.942 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.8 t80 -66.83 -48.02 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.059 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.979 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 3.4 tpt180 -54.92 -31.99 60.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.054 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.32 -36.62 22.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.067 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.727 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -83.61 21.64 1.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.61 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.48 19.78 42.65 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.554 HG23 HD21 ' A' ' 167' ' ' LEU . 49.0 t -110.36 143.05 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.0 110.913 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -116.27 130.19 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.053 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.855 HG23 HG21 ' A' ' 158' ' ' VAL . 32.8 mm -52.38 -21.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -63.58 -34.21 77.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.058 0.456 . . . . 0.0 110.25 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.56 -4.16 58.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.859 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.8 t -116.57 139.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.383 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.428 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 3.8 pt20 -102.73 97.48 7.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.355 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -71.7 143.29 34.99 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.165 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.32 113.76 4.46 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.965 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.95 -85.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.372 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -105.72 37.01 2.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.83 0.347 . . . . 0.0 111.108 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 83.68 26.13 43.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.577 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.776 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -75.87 136.82 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.749 0.309 . . . . 0.0 111.003 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.855 HG21 HG23 ' A' ' 146' ' ' ILE . 30.5 t -73.56 132.24 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.105 0.479 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.4 mt -102.87 161.13 14.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.196 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -55.45 -31.7 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.32 -37.83 88.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.0 m-20 -61.66 -50.48 72.33 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.626 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.979 HD12 ' HB2' ' A' ' 139' ' ' ALA . 31.5 mm -52.79 -54.97 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.43 -39.04 72.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.541 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.22 84.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.634 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.548 ' HD1' HG22 ' A' ' 144' ' ' VAL . 48.1 t-105 -60.38 -57.08 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.727 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.92 -32.52 74.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.934 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.899 0.38 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -166.94 154.77 9.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.6 mtt -60.47 160.02 20.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.34 -25.78 80.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.462 2.108 . . . . 0.0 112.202 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -30.49 16.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 158' ' ' VAL . 76.3 t -68.28 -47.82 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 9.7 mtt180 -54.68 -29.89 54.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -77.7 -39.89 43.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.059 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.16 -48.18 71.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.928 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.964 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.77 -45.89 80.84 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -54.81 -31.8 59.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.348 178.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -84.49 -37.56 21.18 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.923 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.755 ' O ' HD21 ' A' ' 167' ' ' LEU . 38.5 mmtt -84.58 25.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.728 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 22.05 19.29 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.697 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.544 HG23 HD21 ' A' ' 167' ' ' LEU . 51.1 t -111.18 142.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.001 0.429 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -116.16 130.21 56.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.197 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.904 HG23 HG21 ' A' ' 158' ' ' VAL . 31.0 mm -52.61 -21.26 2.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -64.0 -34.97 79.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 110.094 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.414 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.52 -1.27 57.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.855 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.4 t -120.07 133.39 66.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.88 0.371 . . . . 0.0 111.485 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -95.89 97.31 9.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -71.37 144.03 36.71 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.059 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.75 10.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.334 . . . . 0.0 110.629 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -87.12 107.1 3.22 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.814 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.31 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 111.332 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.8 p30 -99.32 33.26 2.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.343 . . . . 0.0 111.02 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.66 25.96 44.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.705 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -76.4 138.72 40.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.717 0.294 . . . . 0.0 111.094 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.904 HG21 HG23 ' A' ' 146' ' ' ILE . 24.6 t -72.86 137.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 111.19 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -109.42 161.33 15.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.226 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -55.97 -31.06 62.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -65.58 -37.31 86.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -62.38 -50.55 71.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.784 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.964 HD12 ' HB2' ' A' ' 139' ' ' ALA . 30.0 mm -52.77 -55.0 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.695 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.1 -40.16 73.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.673 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.25 87.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.87 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.522 ' HD1' HG22 ' A' ' 144' ' ' VAL . 52.3 t-105 -58.94 -57.25 13.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.755 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -63.45 -32.33 73.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.515 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.9 mp . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.039 0.447 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.546 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.87 151.26 4.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.55 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.4 mtp -58.98 149.64 65.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.87 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.35 -26.62 11.98 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -91.08 -29.23 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.55 HG23 ' HB2' ' A' ' 132' ' ' MET . 99.5 t -68.09 -51.18 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 1.8 mtt-85 -54.59 -29.95 53.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -77.68 -38.8 46.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.157 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.532 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 45.8 t80 -67.54 -48.11 67.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.053 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.011 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.64 -46.23 76.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 1.2 tmt_? -54.92 -32.03 60.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.036 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -84.3 -36.68 22.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.059 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.776 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -83.47 22.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.678 -179.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.28 20.73 37.41 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.255 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.552 HG23 HD21 ' A' ' 167' ' ' LEU . 51.1 t -112.1 142.83 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -116.14 130.7 56.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.054 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 158' ' ' VAL . 34.9 mm -51.49 -23.09 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -63.09 -34.12 76.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.496 . . . . 0.0 110.36 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.411 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.5 -6.71 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.951 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.1 t -110.87 129.62 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.891 0.376 . . . . 0.0 111.322 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.21 92.46 8.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.462 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.97 130.35 50.88 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.757 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.44 26.1 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.59 0.233 . . . . 0.0 111.038 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -104.6 125.2 8.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.513 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.82 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -114.08 31.36 6.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 92.62 26.08 18.64 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.721 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.515 ' HG3' HG22 ' A' ' 130' ' ' ILE . 40.3 ttp180 -81.01 149.61 29.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.045 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.784 HG21 HG23 ' A' ' 146' ' ' ILE . 32.0 t -83.51 135.45 24.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.21 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.5 mt -106.2 160.93 14.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.955 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -55.63 -32.38 63.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.664 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -65.12 -37.28 86.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.49 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -62.14 -49.91 73.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.762 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.8 mm -52.69 -55.02 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.524 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -57.35 -36.24 70.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.626 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.98 99.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.646 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.541 ' HD1' HG22 ' A' ' 144' ' ' VAL . 54.9 t-105 -57.22 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.482 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.776 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.21 -31.77 73.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.912 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.2 mp . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.115 0.484 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.647 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -165.55 149.82 8.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.7 mmt -64.67 154.53 84.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.716 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.72 -33.71 94.47 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.708 2.272 . . . . 0.0 112.531 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.83 -33.21 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.104 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.629 HG11 HG12 ' A' ' 158' ' ' VAL . 53.6 t -69.08 -45.76 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.308 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.647 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 8.1 mtm180 -54.62 -31.44 57.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -38.81 46.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.078 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.503 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.9 t80 -66.49 -47.91 71.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.059 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.94 -45.7 77.01 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.71 -32.08 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.128 178.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.47 -37.58 21.17 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.682 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -81.86 20.39 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.725 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.01 48.73 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.13 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.604 HG23 HD21 ' A' ' 167' ' ' LEU . 52.8 t -109.51 144.3 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 110.941 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -116.28 130.73 56.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.123 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 131' ' ' ALA . 33.4 mm -49.98 -23.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.162 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -63.71 -35.99 82.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.005 0.431 . . . . 0.0 110.545 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.36 -0.52 56.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.093 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' A' ' 158' ' ' VAL . 5.6 t -116.51 131.53 68.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.65 106.14 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -69.0 129.71 24.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.72 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.04 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.608 0.242 . . . . 0.0 111.003 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.91 143.35 17.41 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.894 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt 49.67 -91.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -114.2 22.95 13.32 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.593 0.235 . . . . 0.0 111.444 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 26.05 6.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.759 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 130' ' ' ILE . 38.3 ttm180 -83.28 143.07 30.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.681 0.276 . . . . 0.0 111.006 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.629 HG12 HG11 ' A' ' 135' ' ' VAL . 13.8 t -78.88 134.79 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 111.112 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.469 ' HA ' HG21 ' A' ' 135' ' ' VAL . 15.2 mt -107.1 165.81 11.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.54 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -34.39 68.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -36.36 83.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.4 m-20 -64.6 -48.57 74.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.75 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.059 HD12 ' HB2' ' A' ' 139' ' ' ALA . 38.3 mm -52.92 -54.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.575 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -56.85 -38.84 73.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.568 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.69 -38.19 84.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.489 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.521 ' HD1' HG22 ' A' ' 144' ' ' VAL . 48.6 t-105 -60.03 -57.08 14.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.601 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.682 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -66.43 -32.39 73.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.909 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.983 0.42 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.512 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.13 154.61 9.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.166 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 135' ' ' VAL . 7.4 mtp -61.34 151.23 77.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.929 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.15 -26.01 24.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.2 . . . . 0.0 112.42 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 p -91.04 -30.36 16.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.807 HG11 HG12 ' A' ' 158' ' ' VAL . 58.9 t -67.24 -47.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.533 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 1.4 mtp-105 -54.68 -30.02 54.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 0.0 109.887 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -77.59 -40.39 42.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.198 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.528 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.01 -48.11 72.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.049 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.972 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.08 -45.56 80.83 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.82 -31.75 59.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.16 178.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.39 -37.46 21.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.901 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.746 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.0 mmtp -84.3 25.26 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.761 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.09 21.78 18.93 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.532 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.565 HG23 HD21 ' A' ' 167' ' ' LEU . 54.8 t -110.66 142.29 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.902 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.837 HG23 HG21 ' A' ' 158' ' ' VAL . 29.3 mm -51.22 -22.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 -62.7 -33.7 75.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.33 -7.16 57.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.846 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 162' ' ' ASP . 4.2 t -111.15 140.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.848 0.356 . . . . 0.0 111.334 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.29 90.8 4.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -61.64 135.33 47.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.878 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.98 9.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.591 0.234 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.79 127.08 9.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.107 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt 57.02 -86.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.548 0.213 . . . . 0.0 111.509 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.28 29.71 7.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.218 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 94.46 26.12 14.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.627 ' HA ' HG22 ' A' ' 130' ' ' ILE . 33.9 ttm180 -83.38 137.71 33.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 110.841 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.837 HG21 HG23 ' A' ' 146' ' ' ILE . 39.1 t -70.87 138.03 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.191 0.52 . . . . 0.0 111.467 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.2 mt -111.88 162.91 14.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.824 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -56.01 -31.59 63.22 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.42 -36.47 84.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.492 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -63.48 -49.97 71.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.673 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.972 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.4 mm -52.76 -54.92 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.704 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -55.91 -39.88 72.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.664 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.01 80.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.691 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.51 ' HD1' HG22 ' A' ' 144' ' ' VAL . 45.2 t-105 -60.74 -57.02 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.574 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.746 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.8 -32.51 74.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.314 -179.872 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.504 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.1 mp . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.033 0.444 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -165.64 148.88 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.015 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.523 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -57.41 159.96 7.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.717 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.84 -25.92 82.12 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.578 2.185 . . . . 0.0 112.248 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -91.05 -29.46 17.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.617 HG11 HG12 ' A' ' 158' ' ' VAL . 62.1 t -70.18 -47.53 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.396 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 13.2 mtt180 -54.53 -31.25 55.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.64 -38.76 47.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.213 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.525 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.2 t80 -66.77 -48.09 70.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.056 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.983 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.31 -45.73 79.33 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.1 tpm_? -54.88 -31.81 60.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -84.43 -37.6 21.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.773 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.2 mmtt -83.98 25.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.737 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.43 20.08 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.506 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.552 HG23 HD21 ' A' ' 167' ' ' LEU . 49.4 t -111.48 143.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.984 0.421 . . . . 0.0 110.972 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -116.21 130.85 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.774 HG23 HG21 ' A' ' 158' ' ' VAL . 28.1 mm -52.35 -22.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mmm-85 -64.11 -33.93 76.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.939 0.399 . . . . 0.0 110.439 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.18 -4.01 59.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.076 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.542 HG11 ' HB3' ' A' ' 162' ' ' ASP . 10.8 t -111.54 146.75 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.878 0.37 . . . . 0.0 111.186 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.4 95.43 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -58.5 128.6 48.0 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.709 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.16 26.12 9.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 0.0 111.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.81 143.83 18.03 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.001 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 49.28 -91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -114.01 29.9 7.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.741 0.305 . . . . 0.0 111.322 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 95.68 26.04 12.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.659 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.504 ' CB ' HG22 ' A' ' 130' ' ' ILE . 38.5 ttm180 -82.63 145.93 29.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.731 0.3 . . . . 0.0 110.905 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.774 HG21 HG23 ' A' ' 146' ' ' ILE . 41.1 t -79.31 134.63 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.275 0.559 . . . . 0.0 111.279 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.6 mt -106.35 162.01 14.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.972 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -31.7 62.38 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -37.76 87.93 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.1 m-20 -62.16 -50.15 72.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.742 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.983 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.5 mm -52.73 -54.93 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.639 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.11 -36.01 67.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.661 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.24 90.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.537 ' HD1' HG22 ' A' ' 144' ' ' VAL . 38.9 t-105 -59.67 -56.71 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.559 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.773 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.83 -31.42 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.8 mp . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.969 0.414 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -170.19 154.28 4.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.538 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -59.89 147.63 78.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.695 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.45 -25.53 14.33 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.572 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.7 p -91.01 -28.96 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.794 HG11 HG12 ' A' ' 158' ' ' VAL . 62.0 t -68.66 -47.61 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.468 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.9 mtp180 -54.71 -30.68 56.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -77.63 -39.24 45.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.126 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.5 t80 -66.48 -48.21 70.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.044 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.49 -45.47 79.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 3.5 tpt180 -54.8 -31.71 59.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.267 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.47 -38.21 20.41 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.924 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.76 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.4 mmtt -82.99 26.45 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.885 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.84 22.25 18.54 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.471 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.546 HG23 HD21 ' A' ' 167' ' ' LEU . 54.1 t -111.68 144.01 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 111.044 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.401 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.2 t0 -116.29 131.1 57.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.97 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.53 HG23 HG21 ' A' ' 158' ' ' VAL . 35.0 mm -52.4 -22.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -64.58 -33.61 76.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.982 0.42 . . . . 0.0 110.421 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.93 -1.4 57.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.961 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 162' ' ' ASP . 13.7 t -114.64 146.11 19.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -104.65 108.5 19.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -66.96 126.1 25.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.764 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.26 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.716 0.293 . . . . 0.0 111.016 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.23 142.31 17.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.12 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER 49.87 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -114.02 31.72 6.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.69 0.281 . . . . 0.0 111.326 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.13 17.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.721 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.523 ' HA ' HG22 ' A' ' 130' ' ' ILE . 6.1 ttm180 -84.29 148.09 26.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.711 0.291 . . . . 0.0 110.742 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.794 HG12 HG11 ' A' ' 135' ' ' VAL . 10.1 t -81.63 137.99 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 111.223 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.9 mt -110.35 161.92 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.345 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -55.64 -32.65 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.3 -37.38 87.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.277 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -62.39 -48.5 79.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.701 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.044 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.4 mm -52.83 -54.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.502 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.94 -35.29 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.526 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.14 89.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.504 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.524 ' HD1' HG22 ' A' ' 144' ' ' VAL . 39.9 t-105 -59.93 -57.01 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.76 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.81 -32.06 73.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.251 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.908 0.385 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.518 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.99 151.2 3.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.31 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.4 mtp -58.27 148.47 62.92 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.12 -25.32 22.58 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.562 2.174 . . . . 0.0 112.506 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.2 m -90.94 -34.0 15.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.65 HG11 HG12 ' A' ' 158' ' ' VAL . 92.7 t -62.79 -47.56 92.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 37.7 mtp85 -54.66 -28.1 44.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.035 0.445 . . . . 0.0 110.002 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -41.57 37.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.928 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.619 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 40.4 t80 -66.3 -48.29 70.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.816 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.132 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.19 -46.15 85.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.95 -32.11 61.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.5 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -84.69 -38.42 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 111.104 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.819 ' O ' HD21 ' A' ' 167' ' ' LEU . 27.0 mmmt -82.19 25.48 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.976 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 23.65 23.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.342 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.584 HG23 HD21 ' A' ' 167' ' ' LEU . 53.7 t -114.65 142.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.06 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -116.24 131.86 56.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.702 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.497 HG23 HG21 ' A' ' 158' ' ' VAL . 32.9 mm -50.29 -23.77 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.712 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.4 OUTLIER -66.31 -33.19 75.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.893 0.378 . . . . 0.0 110.377 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.433 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.4 mt -85.52 -1.86 57.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.487 ' HB ' HG21 ' A' ' 158' ' ' VAL . 5.0 t -115.56 127.21 73.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.81 0.338 . . . . 0.0 111.475 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.01 92.4 7.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.425 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -57.38 129.13 49.03 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.981 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.12 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.727 0.299 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -100.06 117.03 5.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 153' ' ' GLY . 4.1 p30 -101.73 31.31 3.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.62 26.16 43.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.677 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.509 ' HG3' HG22 ' A' ' 130' ' ' ILE . 43.7 ttm180 -80.13 150.91 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.65 HG12 HG11 ' A' ' 135' ' ' VAL . 21.9 t -84.67 133.73 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 21.0 mt -106.83 162.41 13.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.66 -33.18 63.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -62.87 -48.48 78.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.785 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.132 HD12 ' HB2' ' A' ' 139' ' ' ALA . 32.5 mm -52.76 -53.82 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.428 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.74 -38.36 75.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.523 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.84 86.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.573 ' HD1' HG22 ' A' ' 144' ' ' VAL . 50.8 t-105 -59.2 -57.06 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.819 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -66.24 -33.68 76.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.914 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.229 -179.922 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.603 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.006 0.431 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.443 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.2 152.02 7.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.163 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.515 ' HB2' HG23 ' A' ' 135' ' ' VAL . 6.3 mtp -58.7 160.04 11.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.22 -25.8 81.22 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 m -91.03 -30.92 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.702 HG11 HG12 ' A' ' 158' ' ' VAL . 45.1 t -69.11 -47.15 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.541 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.5 mtp180 -54.61 -31.22 56.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.69 -38.21 47.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.82 -48.09 70.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.077 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.38 -45.42 80.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.77 59.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.285 178.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -84.45 -37.78 20.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.905 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.734 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.4 mmtt -83.61 25.85 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.728 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.03 21.8 18.53 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.381 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.564 HG23 HD21 ' A' ' 167' ' ' LEU . 55.9 t -111.12 142.42 23.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.009 0.433 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.21 130.47 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 158' ' ' VAL . 34.8 mm -50.7 -23.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtp-105 -63.8 -35.74 81.6 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.7 OUTLIER -85.51 -4.07 59.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' A' ' 162' ' ' ASP . 8.6 t -113.46 149.2 15.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 111.241 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -107.29 102.55 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -62.39 129.73 43.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.0 9.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.712 0.291 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.2 141.57 17.09 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.077 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.61 -91.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -113.98 34.33 4.7 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.735 0.302 . . . . 0.0 111.271 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 89.93 26.09 25.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.763 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.603 ' HA ' HG22 ' A' ' 130' ' ' ILE . 22.6 ttm180 -82.55 142.63 31.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.854 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.8 HG21 HG23 ' A' ' 146' ' ' ILE . 37.5 t -76.75 133.32 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.231 0.538 . . . . 0.0 111.196 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.3 mt -107.86 163.9 12.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.075 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.45 -32.4 62.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.93 -37.72 88.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.536 ' HB3' HG11 ' A' ' 149' ' ' VAL . 4.7 m-20 -62.18 -50.52 71.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.753 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 139' ' ' ALA . 29.9 mm -52.74 -55.04 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.733 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.43 -38.46 69.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.636 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.89 89.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.535 ' HD1' HG22 ' A' ' 144' ' ' VAL . 46.1 t-105 -59.16 -57.15 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.734 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -64.45 -30.24 71.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.023 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.21 0.529 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -168.68 143.69 3.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.1 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.509 ' HB2' HG23 ' A' ' 135' ' ' VAL . 9.9 mmt -55.55 150.28 25.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.45 -29.78 70.43 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.04 -33.46 21.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 158' ' ' VAL . 93.3 t -66.36 -46.81 86.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.304 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 42.0 mtp180 -54.64 -28.88 50.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.027 0.442 . . . . 0.0 109.867 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -77.67 -41.61 37.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.055 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.486 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.4 t80 -65.2 -47.99 74.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.078 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.68 -45.44 82.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.8 tpt85 -54.71 -31.84 58.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.3 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.46 -37.54 21.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.738 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.6 mmtt -84.14 22.35 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.797 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.3 19.06 31.13 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.594 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.508 HG23 HD21 ' A' ' 167' ' ' LEU . 65.3 t -104.96 143.24 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.3 t0 -116.16 129.09 56.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.934 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.467 HG21 ' HB2' ' A' ' 131' ' ' ALA . 35.5 mm -50.66 -22.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.25 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -64.32 -33.71 76.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.99 0.424 . . . . 0.0 110.595 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.409 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.2 OUTLIER -91.37 1.73 56.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.538 ' HB ' HG21 ' A' ' 158' ' ' VAL . 4.0 t -119.09 120.12 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.71 96.23 8.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -68.85 134.78 27.85 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.114 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.18 26.02 9.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 110.695 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.12 112.74 4.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.935 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.401 ' HG2' ' ND2' ' A' ' 155' ' ' ASN . 1.0 OUTLIER 53.2 -85.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 153' ' ' GLY . 69.9 m-80 -97.75 33.66 2.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.769 0.319 . . . . 0.0 111.098 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.52 26.03 61.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.603 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.627 ' HA ' HG22 ' A' ' 130' ' ' ILE . 1.8 ttm105 -81.33 137.92 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.72 HG12 HG11 ' A' ' 135' ' ' VAL . 9.5 t -71.31 137.38 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -108.38 163.9 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.454 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -57.24 -34.8 68.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.25 -36.26 83.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.0 m-20 -64.24 -48.01 77.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.078 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.2 mm -52.87 -54.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.544 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -56.56 -39.02 72.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.15 88.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.409 ' CZ3' ' O ' ' A' ' 148' ' ' LEU . 49.6 t-105 -58.72 -57.05 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.4 mt -61.13 -26.56 67.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.213 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.159 -179.865 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.0 mp . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.284 0.564 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -170.12 147.05 3.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' VAL . 5.9 mtp -57.38 155.11 20.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.737 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.9 -24.23 78.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.548 2.165 . . . . 0.0 112.303 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 -36.21 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 158' ' ' VAL . 47.3 t -64.69 -44.26 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.358 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.513 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -54.71 -29.99 54.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 109.727 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -40.48 41.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.974 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.3 t80 -65.47 -48.03 74.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.081 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.014 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.4 -45.18 80.88 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -54.88 -31.84 60.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.057 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.43 -37.54 21.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.736 ' O ' HD21 ' A' ' 167' ' ' LEU . 18.1 mmtp -84.46 25.36 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.748 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.8 21.17 21.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.577 HG23 HD21 ' A' ' 167' ' ' LEU . 53.6 t -109.51 143.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -116.17 130.62 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.123 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 131' ' ' ALA . 33.9 mm -50.77 -22.65 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.198 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -63.68 -35.76 81.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.059 0.457 . . . . 0.0 110.32 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.96 -0.43 56.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.993 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.45 ' HB ' HG21 ' A' ' 158' ' ' VAL . 3.9 t -118.96 130.86 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 111.268 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 101.43 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.607 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -65.03 129.24 34.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.943 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.44 25.99 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.325 . . . . 0.0 110.697 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.86 123.52 7.78 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.259 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt 56.5 -84.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -113.09 37.0 3.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.675 0.274 . . . . 0.0 111.484 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 89.39 26.19 26.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.768 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.753 ' HA ' HG22 ' A' ' 130' ' ' ILE . 2.6 ttt180 -81.61 142.93 32.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 135' ' ' VAL . 8.3 t -82.63 128.0 39.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.168 0.508 . . . . 0.0 110.728 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.526 ' HA ' HG21 ' A' ' 135' ' ' VAL . 15.8 mt -100.55 165.86 11.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.66 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -57.61 -32.78 67.54 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.51 -36.63 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.3 m-20 -64.26 -49.02 73.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.591 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.014 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.6 mm -52.96 -54.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.608 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.63 -39.56 71.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.86 83.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.523 ' HD1' HG22 ' A' ' 144' ' ' VAL . 42.9 t-105 -59.77 -57.06 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.555 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.736 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -65.26 -31.15 72.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.187 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.46 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.843 0.354 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -164.56 151.42 11.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.219 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.535 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -56.92 157.34 11.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.888 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.45 -24.6 78.36 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.581 2.187 . . . . 0.0 112.133 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.0 p -90.95 -30.37 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.995 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.79 HG11 HG12 ' A' ' 158' ' ' VAL . 63.9 t -66.73 -47.02 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 37.9 mtp85 -54.67 -30.04 54.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -40.37 42.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.179 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.9 t80 -66.39 -48.14 71.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.978 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.94 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.34 -46.16 81.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.98 -31.83 61.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.38 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -84.44 -37.22 21.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.767 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.4 mmtt -84.19 25.06 0.88 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.721 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 22.41 19.59 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.523 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG22 ' HD1' ' A' ' 166' ' ' TRP . 46.7 t -111.5 143.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.992 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -116.19 130.01 56.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.942 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.761 HG23 HG21 ' A' ' 158' ' ' VAL . 20.7 mm -51.86 -22.15 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -63.77 -33.99 76.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.006 0.431 . . . . 0.0 110.299 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.97 -4.69 59.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.574 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.1 t -110.97 147.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.264 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.8 99.6 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.684 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -59.09 126.93 43.95 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.688 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.0 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.631 0.253 . . . . 0.0 111.01 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.45 141.76 16.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.986 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.28 -91.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -114.19 24.23 12.16 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.634 0.254 . . . . 0.0 111.477 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 103.71 26.1 6.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.878 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.46 ' CB ' HG22 ' A' ' 130' ' ' ILE . 20.8 ttm105 -84.22 147.43 27.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.745 0.307 . . . . 0.0 110.825 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.79 HG12 HG11 ' A' ' 135' ' ' VAL . 14.9 t -80.28 138.05 20.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.2 mt -112.06 165.09 12.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.28 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 23.4 tttt -57.01 -33.68 67.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.39 -36.95 85.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.574 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.5 m-20 -63.17 -50.51 70.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.634 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.94 HD12 ' HB2' ' A' ' 139' ' ' ALA . 30.7 mm -52.93 -54.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.546 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -57.59 -35.13 70.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.476 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.27 97.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.502 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.561 ' HD1' HG22 ' A' ' 144' ' ' VAL . 47.2 t-105 -58.73 -56.7 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.767 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.73 -29.75 70.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.069 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.289 -179.887 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.895 0.378 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.19 88.05 2.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.43 62.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.787 HG13 ' HB ' ' A' ' 146' ' ' ILE . 42.1 t -85.51 138.14 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.13 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.2 mp -130.05 111.94 22.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.548 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.63 149.21 5.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.988 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.4 mtm -56.37 158.15 8.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.4 -24.89 79.05 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.496 2.131 . . . . 0.0 112.332 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 m -91.12 -31.78 16.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.698 HG11 HG12 ' A' ' 158' ' ' VAL . 43.7 t -68.52 -45.2 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.6 mtp-105 -54.61 -31.82 57.75 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.62 -38.48 47.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.238 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.545 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.6 t80 -66.41 -48.06 71.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.011 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.006 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.23 -45.59 80.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 11.2 ttt85 -54.78 -31.67 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.402 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.36 -39.48 19.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.709 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.591 ' HB3' HD11 ' A' ' 167' ' ' LEU . 45.6 mmtt -80.25 9.98 5.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.605 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.9 8.77 64.84 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.526 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 167' ' ' LEU . 48.8 t -96.64 143.69 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.986 0.422 . . . . 0.0 110.703 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 22.4 t0 -116.06 129.4 56.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.912 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.822 HG23 HG21 ' A' ' 158' ' ' VAL . 32.1 mm -51.04 -22.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.403 ' HG3' HG22 ' A' ' 129' ' ' VAL . 2.9 mtp85 -64.18 -34.38 77.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.02 0.438 . . . . 0.0 110.429 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.3 OUTLIER -88.25 -2.14 58.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.984 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 162' ' ' ASP . 7.4 t -115.19 139.08 43.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.9 0.381 . . . . 0.0 111.376 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -98.1 90.72 4.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.576 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.6 134.07 52.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.766 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.35 26.07 9.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.629 0.252 . . . . 0.0 111.009 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -105.13 127.63 9.11 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.156 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.28 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.577 0.227 . . . . 0.0 111.492 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -110.13 30.23 6.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.811 0.338 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.08 26.01 25.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.714 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.619 ' HA ' HG22 ' A' ' 130' ' ' ILE . 31.9 ttm180 -79.48 138.9 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.822 HG21 HG23 ' A' ' 146' ' ' ILE . 45.7 t -72.07 132.68 33.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 111.425 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.1 mt -105.66 162.5 13.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.756 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -55.74 -31.42 62.52 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.99 -37.59 86.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB3' HG11 ' A' ' 149' ' ' VAL . 4.7 m-20 -61.69 -49.98 74.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.664 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.006 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.0 mm -52.69 -54.8 14.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.473 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.88 -38.61 73.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.46 89.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.568 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.564 ' HD1' HG22 ' A' ' 144' ' ' VAL . 51.6 t-105 -58.4 -57.01 14.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.636 HD21 HG23 ' A' ' 144' ' ' VAL . 1.9 mt -65.58 -27.35 68.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.066 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.94 31.1 2.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.294 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 168.41 -76.86 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.51 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.343 -1.254 . . . . 0.0 112.467 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.826 0.346 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 137.7 51.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.722 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.492 ' O ' HD12 ' A' ' 130' ' ' ILE . 16.1 ttp180 -176.71 -38.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.053 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.716 HG13 ' HB ' ' A' ' 146' ' ' ILE . 37.6 t -72.52 135.28 28.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.272 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.556 HG22 ' CB ' ' A' ' 157' ' ' ARG . 3.8 mp -130.05 111.93 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.414 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB3' ' CG ' ' A' ' 136' ' ' ARG . . . -161.28 150.39 16.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.344 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.5 mtp -59.98 159.59 19.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.785 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.4 -26.27 82.33 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.569 2.179 . . . . 0.0 112.157 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 p -91.04 -29.58 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.727 HG11 HG12 ' A' ' 158' ' ' VAL . 61.4 t -70.06 -48.82 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.382 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.445 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 42.2 mtt-85 -54.58 -30.03 53.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -40.07 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.119 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.17 -48.15 71.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.067 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.989 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.22 -45.35 81.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -54.83 -31.82 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.133 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -84.49 -37.54 21.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.853 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.779 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.4 mmtt -84.03 26.1 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.862 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.0 18.71 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.557 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.555 HG22 ' HD1' ' A' ' 166' ' ' TRP . 54.4 t -112.26 141.06 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.05 0.452 . . . . 0.0 110.944 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -116.21 131.23 57.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.624 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.834 HG23 HG21 ' A' ' 158' ' ' VAL . 32.6 mm -50.82 -23.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.628 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -65.12 -31.96 73.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.932 0.396 . . . . 0.0 110.287 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.5 mt -86.07 -7.66 58.45 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.658 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.3 t -111.08 145.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-O 120.974 0.416 . . . . 0.0 111.435 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.71 88.48 2.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.197 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -64.43 137.09 39.71 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.049 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.38 26.06 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.754 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.79 121.76 6.77 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.402 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.52 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' GLY . 17.0 m-80 -114.08 36.86 3.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.18 26.08 34.98 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.617 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.556 ' CB ' HG22 ' A' ' 130' ' ' ILE . 18.1 ttm180 -82.06 142.5 32.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.834 HG21 HG23 ' A' ' 146' ' ' ILE . 38.6 t -75.94 137.95 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.477 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.5 mt -110.41 161.38 15.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.702 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -55.43 -31.8 62.19 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.774 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -64.61 -38.05 89.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.501 ' HB3' HG11 ' A' ' 149' ' ' VAL . 6.7 m-20 -62.16 -49.94 73.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.737 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.989 HD12 ' HB2' ' A' ' 139' ' ' ALA . 37.9 mm -52.69 -55.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.66 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -55.79 -37.3 68.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.765 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.89 92.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.855 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.555 ' HD1' HG22 ' A' ' 144' ' ' VAL . 55.3 t-105 -58.34 -57.1 14.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -63.34 -31.33 72.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.953 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.95 -25.08 64.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.21 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.78 -65.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.521 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.454 -1.192 . . . . 0.0 112.508 179.956 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.855 0.36 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -36.62 7.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.58 171.98 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.815 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.477 ' CG1' HG22 ' A' ' 146' ' ' ILE . 1.9 t -82.33 157.05 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.004 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -90.79 111.93 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.063 0.458 . . . . 0.0 111.139 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.559 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -165.53 149.12 8.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.4 mtm -61.8 160.06 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.13 -25.91 72.92 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.651 2.234 . . . . 0.0 112.231 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.5 p -90.97 -31.01 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.038 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.762 HG11 HG12 ' A' ' 158' ' ' VAL . 60.5 t -68.84 -47.35 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.37 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.559 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 26.1 mtp180 -54.66 -30.09 54.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.069 0.462 . . . . 0.0 109.892 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -77.7 -41.12 39.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.165 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.521 ' CD2' HG21 ' A' ' 163' ' ' ILE . 52.0 t80 -65.5 -48.17 73.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.02 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.9 -45.44 81.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -54.91 -31.84 60.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.096 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.52 -37.58 21.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.947 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.768 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.1 mmtp -84.13 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.814 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.14 18.61 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.66 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.554 HG23 HD21 ' A' ' 167' ' ' LEU . 52.4 t -110.59 143.66 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.046 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -116.19 131.32 56.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.016 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.477 HG22 ' CG1' ' A' ' 129' ' ' VAL . 41.7 mm -50.88 -23.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.226 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -63.96 -34.86 78.94 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.046 0.451 . . . . 0.0 110.469 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.412 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -89.52 -0.07 57.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.981 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' A' ' 158' ' ' VAL . 3.3 t -118.85 113.28 41.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.88 0.372 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.31 105.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.188 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -66.28 128.87 31.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.753 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 26.08 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.637 0.256 . . . . 0.0 110.96 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -109.24 126.42 8.08 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.309 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.49 -89.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.09 21.73 14.52 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.555 0.217 . . . . 0.0 111.464 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 110.61 26.14 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.809 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.592 ' HA ' HG22 ' A' ' 130' ' ' ILE . 18.2 ttp-105 -85.72 146.94 26.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.762 HG12 HG11 ' A' ' 135' ' ' VAL . 12.5 t -83.61 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.093 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.0 mt -107.87 165.05 11.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.39 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.416 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 1.6 tttt -57.5 -34.37 69.01 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.29 -36.09 82.52 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.3 m-20 -64.94 -48.65 73.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 139' ' ' ALA . 41.5 mm -52.87 -54.79 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -56.13 -40.81 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.677 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.65 83.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.689 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.524 ' HD1' HG22 ' A' ' 144' ' ' VAL . 45.9 t-105 -58.82 -57.12 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.768 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.44 -33.59 76.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.942 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -99.43 27.97 4.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.187 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -114.62 -27.78 3.19 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.279 -1.289 . . . . 0.0 112.479 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.842 0.353 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -143.94 -46.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.86 177.38 5.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.937 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.754 HG13 ' HB ' ' A' ' 146' ' ' ILE . 48.8 t -93.74 144.97 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.05 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -130.12 111.9 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.674 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -170.11 147.77 3.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.945 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.1 mtm -54.54 148.91 23.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.991 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.77 -26.6 18.01 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.659 2.239 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -89.76 -28.18 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.803 HG11 HG12 ' A' ' 158' ' ' VAL . 48.7 t -71.23 -45.86 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.52 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 11.5 mtp-105 -54.67 -32.01 58.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.145 0.498 . . . . 0.0 109.735 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -40.14 41.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.1 t80 -65.67 -48.15 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.12 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.947 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.55 -45.08 80.55 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 15.4 tpt180 -54.91 -31.94 60.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.022 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -84.42 -38.13 20.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.952 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.741 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.2 mmtt -83.46 24.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.805 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.38 21.73 20.87 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.497 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.545 HG23 HD21 ' A' ' 167' ' ' LEU . 49.6 t -109.95 142.89 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.907 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -116.1 129.98 56.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.066 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 158' ' ' VAL . 31.0 mm -51.73 -21.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.239 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.2 mtp85 -64.45 -34.45 78.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.947 0.403 . . . . 0.0 110.405 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.91 -1.11 57.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.928 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.1 t -115.1 151.0 16.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 0.6 OUTLIER -111.59 96.59 6.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.552 179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -67.82 135.31 30.42 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.963 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.33 26.01 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.635 0.255 . . . . 0.0 110.946 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.0 131.14 10.5 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.102 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.04 -87.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.605 0.241 . . . . 0.0 111.375 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.04 29.13 8.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.777 0.323 . . . . 0.0 111.012 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 96.87 18.26 30.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.697 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.66 ' HA ' HG22 ' A' ' 130' ' ' ILE . 3.2 ttm180 -73.0 138.98 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 0.0 110.971 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.803 HG12 HG11 ' A' ' 135' ' ' VAL . 31.9 t -71.26 138.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.185 0.517 . . . . 0.0 111.551 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.1 mt -109.84 161.74 15.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.018 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.53 -32.44 62.94 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.742 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -64.33 -37.38 87.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.267 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.486 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.9 m-20 -62.57 -50.03 72.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.76 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.947 HD12 ' HB2' ' A' ' 139' ' ' ALA . 33.8 mm -52.74 -55.06 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.654 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.16 -38.97 71.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.726 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.09 84.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.545 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.542 ' HD1' HG22 ' A' ' 144' ' ' VAL . 44.8 t-105 -60.19 -57.03 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.741 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -64.55 -30.19 71.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.76 30.99 1.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 137.11 -79.76 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.609 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.349 -1.25 . . . . 0.0 112.473 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 -42.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.68 142.9 57.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.77 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.75 HG13 ' HB ' ' A' ' 146' ' ' ILE . 55.5 t -86.25 134.66 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.217 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.528 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp -130.01 111.92 22.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.425 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -161.63 149.11 14.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.355 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -59.37 150.82 62.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.742 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.08 -26.81 15.46 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.526 2.151 . . . . 0.0 112.352 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.3 m -91.03 -29.64 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.072 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.562 HG11 HG12 ' A' ' 158' ' ' VAL . 86.1 t -68.32 -50.27 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.385 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.653 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 10.3 mtt180 -54.64 -30.18 54.33 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -77.67 -39.63 44.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.142 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.521 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 47.5 t80 -66.9 -48.11 69.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.165 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.018 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.5 -45.92 77.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.89 -31.98 60.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.033 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.41 -36.97 22.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.992 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.73 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -82.19 19.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.733 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.5 19.88 49.45 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.977 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.563 HG22 ' HD1' ' A' ' 166' ' ' TRP . 50.0 t -110.75 143.56 20.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 111.022 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 59.7 t0 -116.23 130.56 56.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.947 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.777 HG23 HG21 ' A' ' 158' ' ' VAL . 34.6 mm -51.0 -23.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -63.33 -34.27 77.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.022 0.439 . . . . 0.0 110.542 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.42 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -86.62 -6.46 58.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.971 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 162' ' ' ASP . 7.1 t -107.82 152.33 9.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.88 0.372 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.85 97.51 7.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.813 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -58.93 128.77 48.48 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.559 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.99 26.02 9.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.697 0.284 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -122.03 150.27 17.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.687 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 47.97 -97.65 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -114.19 37.02 3.47 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.824 0.345 . . . . 0.0 111.11 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.91 26.09 23.03 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.528 ' CB ' HG22 ' A' ' 130' ' ' ILE . 34.0 ttm180 -81.97 146.73 29.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.811 0.338 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.777 HG21 HG23 ' A' ' 146' ' ' ILE . 40.0 t -81.52 134.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.14 0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.7 mt -105.25 161.32 14.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -55.63 -32.34 63.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.0 -37.51 87.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.521 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -62.5 -50.07 72.86 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.638 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.018 HD12 ' HB2' ' A' ' 139' ' ' ALA . 37.0 mm -52.66 -54.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.49 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -57.0 -35.08 68.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.92 95.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.601 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.563 ' HD1' HG22 ' A' ' 144' ' ' VAL . 47.3 t-105 -58.38 -56.48 21.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.73 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.94 -34.95 79.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.993 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.0 -25.01 59.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.25 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -87.16 -32.25 14.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.385 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.443 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.726 0.298 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -70.23 -37.88 75.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.833 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -61.4 177.81 0.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.855 HG13 ' HB ' ' A' ' 146' ' ' ILE . 75.0 t -125.53 136.73 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 111.292 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp -130.13 111.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.389 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.449 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -166.66 152.81 8.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.318 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.536 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -59.48 151.86 58.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.737 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.42 -27.58 32.18 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.468 2.112 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.9 -29.23 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.365 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 158' ' ' VAL . 86.0 t -68.0 -48.55 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.406 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 3.5 mtt180 -54.63 -29.3 51.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -77.69 -39.91 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.97 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.8 t80 -66.38 -48.02 71.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.05 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.983 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.0 -45.32 82.0 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.89 -31.87 60.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.102 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -84.44 -37.38 21.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.847 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.724 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.6 mmtt -84.08 23.5 1.04 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.836 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.53 20.92 25.86 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.498 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.57 HG23 HD21 ' A' ' 167' ' ' LEU . 49.1 t -109.0 143.53 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.968 0.413 . . . . 0.0 110.943 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.062 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.855 ' HB ' HG13 ' A' ' 129' ' ' VAL . 30.4 mm -52.31 -21.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.089 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -63.76 -34.29 77.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.05 0.452 . . . . 0.0 110.218 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.05 -3.92 58.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.867 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.9 t -116.8 129.38 73.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.322 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.29 94.85 10.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.287 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -59.91 134.83 50.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.011 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.17 25.99 9.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 110.652 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -95.46 103.94 3.05 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.965 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.94 -83.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.657 0.265 . . . . 0.0 111.489 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.2 m-80 -95.85 35.18 1.42 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 111.109 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 75.3 26.11 66.81 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.502 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.675 ' HA ' HG22 ' A' ' 130' ' ' ILE . 27.7 ttm180 -79.24 139.16 37.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.0 111.214 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.843 HG21 HG23 ' A' ' 146' ' ' ILE . 38.2 t -74.6 133.79 30.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.199 0.523 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.7 mt -104.8 160.97 14.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.001 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -55.81 -31.55 62.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.97 -37.45 86.03 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -61.78 -50.0 74.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.593 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.983 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.6 mm -52.66 -55.18 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.558 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -55.55 -40.55 72.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.655 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.14 82.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.636 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.483 ' HD1' HG22 ' A' ' 144' ' ' VAL . 41.9 t-105 -59.47 -57.01 14.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.481 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -63.59 -31.56 72.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.939 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.61 -25.0 63.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.227 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -101.31 -48.27 1.45 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.499 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.385 -1.23 . . . . 0.0 112.466 179.961 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.3 t30 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.769 0.318 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.9 40.1 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.7 mtt85 -124.22 31.21 5.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.732 HG13 ' HB ' ' A' ' 146' ' ' ILE . 40.3 t -138.01 141.85 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.517 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.3 mp -130.07 111.89 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.625 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -163.92 153.95 14.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -64.46 160.1 54.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.628 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.37 -28.17 83.97 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 112.258 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.1 p -91.13 -29.46 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 158' ' ' VAL . 95.9 t -68.92 -48.33 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.448 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.438 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 65.5 mtt-85 -54.63 -29.37 51.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.061 0.458 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.71 -41.14 38.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.198 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.617 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 44.3 t80 -66.4 -48.26 70.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.911 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.053 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.31 -47.18 80.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 16.8 tpt180 -54.97 -31.92 61.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.72 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.69 -38.61 19.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.221 0.534 . . . . 0.0 111.192 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.799 ' O ' HD21 ' A' ' 167' ' ' LEU . 26.6 mmmt -82.38 24.71 0.67 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.831 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.23 21.88 27.49 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.445 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.644 HG23 HD21 ' A' ' 167' ' ' LEU . 54.6 t -112.33 142.25 25.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.964 0.411 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -116.18 129.97 56.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.025 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.804 HG23 HG21 ' A' ' 158' ' ' VAL . 34.2 mm -51.39 -22.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.151 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -63.98 -34.0 77.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.987 0.423 . . . . 0.0 110.384 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.96 -4.22 58.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.916 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.514 HG11 ' HB3' ' A' ' 162' ' ' ASP . 5.4 t -113.92 134.98 55.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.107 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -94.28 93.4 7.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.417 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.87 129.37 49.44 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.586 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 26.09 9.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.65 0.262 . . . . 0.0 111.1 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.76 140.53 16.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.984 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.41 -91.0 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.462 0.172 . . . . 0.0 111.441 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -114.1 34.38 4.7 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.871 0.367 . . . . 0.0 111.005 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.0 21.06 40.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.454 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.517 ' HA ' HG22 ' A' ' 130' ' ' ILE . 41.7 ttm180 -78.36 145.11 35.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.804 HG21 HG23 ' A' ' 146' ' ' ILE . 38.5 t -77.18 135.94 25.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.164 0.507 . . . . 0.0 111.322 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.2 mt -107.51 162.04 14.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.006 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -55.66 -32.05 62.89 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.821 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -65.24 -37.33 86.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.514 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.5 m-20 -62.77 -50.14 72.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.73 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.053 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.7 mm -52.67 -55.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -56.82 -36.58 70.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.545 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.417 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.587 ' HD1' HG22 ' A' ' 144' ' ' VAL . 42.2 t-105 -59.75 -54.84 41.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.549 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -68.85 -26.82 65.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.135 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.36 31.1 1.55 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.622 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.42 -53.56 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.595 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.509 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.782 0.325 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.8 ttm-85 59.89 66.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.951 0.405 . . . . 0.0 110.914 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -113.71 -35.2 5.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.039 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.5 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.7 t -137.94 158.57 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.185 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.598 HG22 ' CB ' ' A' ' 157' ' ' ARG . 28.0 mt -88.9 118.48 34.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 110.99 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.462 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -170.08 146.31 3.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.17 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -59.69 146.96 79.48 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.71 -24.42 17.86 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.555 2.17 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 m -91.06 -37.32 13.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.085 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.619 HG11 HG12 ' A' ' 158' ' ' VAL . 47.9 t -63.44 -44.13 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.2 OUTLIER -54.65 -30.44 55.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.64 -39.45 45.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.084 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.9 t80 -66.3 -48.04 71.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.114 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.11 -45.25 81.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -54.88 -31.87 60.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.172 178.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.39 -37.47 21.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.854 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.754 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.2 mmtt -84.27 25.32 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.727 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.65 20.72 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.525 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.551 HG23 HD21 ' A' ' 167' ' ' LEU . 53.7 t -111.5 143.78 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.403 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 15.9 t0 -116.17 130.21 56.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.786 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.5 HG22 ' CG1' ' A' ' 129' ' ' VAL . 29.7 mm -49.99 -23.7 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.383 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.81 ' HG3' HD23 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -64.3 -37.02 86.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.907 0.384 . . . . 0.0 110.367 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.81 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.0 OUTLIER -81.42 -5.63 58.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.642 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 162' ' ' ASP . 4.6 t -112.82 137.19 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.332 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.57 100.01 12.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -63.41 126.14 35.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.901 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 26.03 9.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.644 0.259 . . . . 0.0 110.794 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -101.71 122.05 7.43 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.349 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.69 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.6 OUTLIER -106.93 27.47 8.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.761 0.315 . . . . 0.0 111.293 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.52 26.17 21.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.8 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.598 ' CB ' HG22 ' A' ' 130' ' ' ILE . 27.3 ttm105 -82.19 151.99 26.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.705 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.619 HG12 HG11 ' A' ' 135' ' ' VAL . 9.5 t -86.64 136.18 23.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.173 0.511 . . . . 0.0 111.117 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 27.9 mt -107.26 164.45 12.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.48 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -33.18 67.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.45 -36.47 84.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.2 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.4 m-20 -63.65 -48.51 76.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.746 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 139' ' ' ALA . 36.1 mm -52.9 -54.81 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.62 -39.2 73.21 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.621 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.4 80.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.529 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.515 ' HD1' HG22 ' A' ' 144' ' ' VAL . 52.0 t-105 -60.53 -56.97 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.754 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.87 -33.06 75.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.888 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.03 -25.04 58.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.276 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.06 -50.54 64.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.528 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.819 0.342 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -67.91 -36.44 80.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -101.65 -173.98 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.83 HG13 ' HB ' ' A' ' 146' ' ' ILE . 53.6 t -94.26 136.02 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.776 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -130.08 111.88 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.706 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.544 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.57 158.12 9.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.314 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -64.2 154.39 82.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.828 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.32 -27.53 58.05 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.639 2.226 . . . . 0.0 112.35 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -90.02 -32.11 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.07 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 158' ' ' VAL . 97.5 t -65.53 -48.06 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.354 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 24.4 mtt180 -54.57 -28.78 48.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -77.67 -39.86 43.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.942 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.8 t80 -66.83 -48.02 70.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.059 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.979 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 3.4 tpt180 -54.92 -31.99 60.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.054 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.32 -36.62 22.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.067 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.727 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -83.61 21.64 1.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.61 -179.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.48 19.78 42.65 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.424 -0.893 . . . . 0.0 112.142 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.554 HG23 HD21 ' A' ' 167' ' ' LEU . 49.0 t -110.36 143.05 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.987 0.422 . . . . 0.0 110.913 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -116.27 130.19 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.053 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.855 HG23 HG21 ' A' ' 158' ' ' VAL . 32.8 mm -52.38 -21.62 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.145 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.463 ' HG2' HG22 ' A' ' 129' ' ' VAL . 2.8 mmm180 -63.58 -34.21 77.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.058 0.456 . . . . 0.0 110.25 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.56 -4.16 58.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.859 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.8 t -116.57 139.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.043 0.449 . . . . 0.0 111.383 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.428 ' CG ' ' O ' ' A' ' 150' ' ' GLN . 3.8 pt20 -102.73 97.48 7.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.355 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.45 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -71.7 143.29 34.99 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.165 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.704 0.288 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.32 113.76 4.46 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.965 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.95 -85.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.372 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -105.72 37.01 2.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.83 0.347 . . . . 0.0 111.108 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 83.68 26.13 43.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.577 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.776 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -75.87 136.82 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.749 0.309 . . . . 0.0 111.003 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.855 HG21 HG23 ' A' ' 146' ' ' ILE . 30.5 t -73.56 132.24 33.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.105 0.479 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.4 mt -102.87 161.13 14.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.196 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -55.45 -31.7 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.32 -37.83 88.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.0 m-20 -61.66 -50.48 72.33 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.626 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.979 HD12 ' HB2' ' A' ' 139' ' ' ALA . 31.5 mm -52.79 -54.97 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.43 -39.04 72.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.541 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.22 84.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.634 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.548 ' HD1' HG22 ' A' ' 144' ' ' VAL . 48.1 t-105 -60.38 -57.08 14.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.727 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.92 -32.52 74.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.934 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.82 -9.92 58.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.533 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -95.26 29.51 9.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.512 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.462 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.866 0.365 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.23 154.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.23 -71.37 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.848 HG13 ' HB ' ' A' ' 146' ' ' ILE . 57.8 t -138.13 135.57 44.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.333 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -130.09 111.86 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.508 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -166.94 154.77 9.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.373 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.6 mtt -60.47 160.02 20.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.34 -25.78 80.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.462 2.108 . . . . 0.0 112.202 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.4 m -91.12 -30.49 16.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 158' ' ' VAL . 76.3 t -68.28 -47.82 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 9.7 mtt180 -54.68 -29.89 54.02 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -77.7 -39.89 43.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.059 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.16 -48.18 71.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.928 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.964 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.77 -45.89 80.84 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -54.81 -31.8 59.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.348 178.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -84.49 -37.56 21.18 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.923 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.755 ' O ' HD21 ' A' ' 167' ' ' LEU . 38.5 mmtt -84.58 25.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.728 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 22.05 19.29 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.697 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.544 HG23 HD21 ' A' ' 167' ' ' LEU . 51.1 t -111.18 142.36 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.001 0.429 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -116.16 130.21 56.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.197 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.904 HG23 HG21 ' A' ' 158' ' ' VAL . 31.0 mm -52.61 -21.26 2.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -64.0 -34.97 79.2 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 110.094 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.414 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -88.52 -1.27 57.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.855 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 162' ' ' ASP . 3.4 t -120.07 133.39 66.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.88 0.371 . . . . 0.0 111.485 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -95.89 97.31 9.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.216 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -71.37 144.03 36.71 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.059 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.75 10.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.8 0.334 . . . . 0.0 110.629 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -87.12 107.1 3.22 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.814 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.31 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.588 0.232 . . . . 0.0 111.332 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.8 p30 -99.32 33.26 2.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.343 . . . . 0.0 111.02 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.66 25.96 44.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.705 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -76.4 138.72 40.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.717 0.294 . . . . 0.0 111.094 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.904 HG21 HG23 ' A' ' 146' ' ' ILE . 24.6 t -72.86 137.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.154 0.502 . . . . 0.0 111.19 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -109.42 161.33 15.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.226 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -55.97 -31.06 62.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -65.58 -37.31 86.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -62.38 -50.55 71.09 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.784 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.964 HD12 ' HB2' ' A' ' 139' ' ' ALA . 30.0 mm -52.77 -55.0 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.695 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.1 -40.16 73.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.673 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.25 87.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.87 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.522 ' HD1' HG22 ' A' ' 144' ' ' VAL . 52.3 t-105 -58.94 -57.25 13.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.482 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.755 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -63.45 -32.33 73.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.83 -25.07 48.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.67 46.85 1.12 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.517 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.385 -1.231 . . . . 0.0 112.501 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.823 0.344 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.38 117.69 26.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.35 -45.85 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.748 HG13 ' HB ' ' A' ' 146' ' ' ILE . 68.9 t -119.66 143.82 30.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.042 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.515 HG22 ' HG3' ' A' ' 157' ' ' ARG . 3.9 mp -130.05 111.91 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.608 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.546 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.87 151.26 4.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.55 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.4 mtp -58.98 149.64 65.05 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.87 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.35 -26.62 11.98 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.643 2.229 . . . . 0.0 112.326 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -91.08 -29.23 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.55 HG23 ' HB2' ' A' ' 132' ' ' MET . 99.5 t -68.09 -51.18 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 1.8 mtt-85 -54.59 -29.95 53.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -77.68 -38.8 46.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.157 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.532 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 45.8 t80 -67.54 -48.11 67.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.053 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.011 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.64 -46.23 76.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 1.2 tmt_? -54.92 -32.03 60.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.036 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -84.3 -36.68 22.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.059 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.776 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -83.47 22.99 0.98 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.678 -179.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.28 20.73 37.41 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.255 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.552 HG23 HD21 ' A' ' 167' ' ' LEU . 51.1 t -112.1 142.83 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -116.14 130.7 56.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.054 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 158' ' ' VAL . 34.9 mm -51.49 -23.09 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -63.09 -34.12 76.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.496 . . . . 0.0 110.36 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.411 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.5 -6.71 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.951 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.1 t -110.87 129.62 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.891 0.376 . . . . 0.0 111.322 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.21 92.46 8.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.628 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.462 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -57.97 130.35 50.88 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.757 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.44 26.1 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.59 0.233 . . . . 0.0 111.038 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -104.6 125.2 8.27 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.513 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.82 -83.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -114.08 31.36 6.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.836 0.35 . . . . 0.0 111.157 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 92.62 26.08 18.64 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.721 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.515 ' HG3' HG22 ' A' ' 130' ' ' ILE . 40.3 ttp180 -81.01 149.61 29.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 0.0 111.045 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.784 HG21 HG23 ' A' ' 146' ' ' ILE . 32.0 t -83.51 135.45 24.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.21 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.5 mt -106.2 160.93 14.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.955 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -55.63 -32.38 63.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.664 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -65.12 -37.28 86.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.49 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -62.14 -49.91 73.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.762 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.011 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.8 mm -52.69 -55.02 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.524 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -57.35 -36.24 70.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.626 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.98 99.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.646 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.541 ' HD1' HG22 ' A' ' 144' ' ' VAL . 54.9 t-105 -57.22 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.482 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.776 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.21 -31.77 73.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.912 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.9 -25.11 64.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.06 31.34 17.61 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.512 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.493 -179.978 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.781 0.324 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.43 90.15 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.1 -174.65 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.972 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.515 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.5 t -120.09 157.86 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.915 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.2 mp -87.16 111.9 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.115 0.484 . . . . 0.0 111.079 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.647 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -165.55 149.82 8.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.165 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.7 mmt -64.67 154.53 84.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.716 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.72 -33.71 94.47 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.708 2.272 . . . . 0.0 112.531 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.83 -33.21 24.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.104 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.629 HG11 HG12 ' A' ' 158' ' ' VAL . 53.6 t -69.08 -45.76 79.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.308 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.647 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 8.1 mtm180 -54.62 -31.44 57.27 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -38.81 46.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.078 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.503 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.9 t80 -66.49 -47.91 71.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.059 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.94 -45.7 77.01 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.71 -32.08 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.128 178.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.47 -37.58 21.17 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.049 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.682 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -81.86 20.39 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.725 -179.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.01 48.73 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.13 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.604 HG23 HD21 ' A' ' 167' ' ' LEU . 52.8 t -109.51 144.3 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 110.941 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -116.28 130.73 56.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.123 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.515 HG22 ' CG1' ' A' ' 129' ' ' VAL . 33.4 mm -49.98 -23.88 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.162 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -63.71 -35.99 82.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.005 0.431 . . . . 0.0 110.545 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.413 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.36 -0.52 56.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.093 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' A' ' 158' ' ' VAL . 5.6 t -116.51 131.53 68.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.65 106.14 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -69.0 129.71 24.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.72 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.04 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.608 0.242 . . . . 0.0 111.003 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.91 143.35 17.41 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.894 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt 49.67 -91.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -114.2 22.95 13.32 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.593 0.235 . . . . 0.0 111.444 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.72 26.05 6.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.759 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 130' ' ' ILE . 38.3 ttm180 -83.28 143.07 30.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.681 0.276 . . . . 0.0 111.006 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.629 HG12 HG11 ' A' ' 135' ' ' VAL . 13.8 t -78.88 134.79 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 111.112 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.469 ' HA ' HG21 ' A' ' 135' ' ' VAL . 15.2 mt -107.1 165.81 11.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.54 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -34.39 68.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -36.36 83.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.4 m-20 -64.6 -48.57 74.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.75 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.059 HD12 ' HB2' ' A' ' 139' ' ' ALA . 38.3 mm -52.92 -54.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.575 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -56.85 -38.84 73.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.568 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.69 -38.19 84.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.489 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.521 ' HD1' HG22 ' A' ' 144' ' ' VAL . 48.6 t-105 -60.03 -57.08 14.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.601 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.682 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -66.43 -32.39 73.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.909 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.03 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.56 58.99 1.38 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.345 -1.253 . . . . 0.0 112.518 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.792 0.33 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -132.47 30.48 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.6 ttp85 -139.57 -64.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.82 HG13 ' HB ' ' A' ' 146' ' ' ILE . 55.9 t -137.95 136.13 45.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.308 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp -130.08 111.86 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.252 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.512 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.13 154.61 9.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.166 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 135' ' ' VAL . 7.4 mtp -61.34 151.23 77.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.929 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.15 -26.01 24.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.2 . . . . 0.0 112.42 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 p -91.04 -30.36 16.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.173 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.807 HG11 HG12 ' A' ' 158' ' ' VAL . 58.9 t -67.24 -47.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.533 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 1.4 mtp-105 -54.68 -30.02 54.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.005 0.431 . . . . 0.0 109.887 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -77.59 -40.39 42.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.198 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.528 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -66.01 -48.11 72.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.049 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.972 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.08 -45.56 80.83 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.82 -31.75 59.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.16 178.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.39 -37.46 21.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.901 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.746 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.0 mmtp -84.3 25.26 0.88 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.761 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.09 21.78 18.93 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.532 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.565 HG23 HD21 ' A' ' 167' ' ' LEU . 54.8 t -110.66 142.29 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.056 0.455 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -116.15 129.98 56.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.902 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.837 HG23 HG21 ' A' ' 158' ' ' VAL . 29.3 mm -51.22 -22.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.228 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 -62.7 -33.7 75.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.41 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.33 -7.16 57.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.846 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 162' ' ' ASP . 4.2 t -111.15 140.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.848 0.356 . . . . 0.0 111.334 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.29 90.8 4.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.462 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -61.64 135.33 47.2 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.878 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 25.98 9.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.591 0.234 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.79 127.08 9.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.107 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt 57.02 -86.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.548 0.213 . . . . 0.0 111.509 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.28 29.71 7.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.218 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 94.46 26.12 14.37 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.627 ' HA ' HG22 ' A' ' 130' ' ' ILE . 33.9 ttm180 -83.38 137.71 33.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 110.841 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.837 HG21 HG23 ' A' ' 146' ' ' ILE . 39.1 t -70.87 138.03 22.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.191 0.52 . . . . 0.0 111.467 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.2 mt -111.88 162.91 14.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.824 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -56.01 -31.59 63.22 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.42 -36.47 84.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.492 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.4 m-20 -63.48 -49.97 71.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.673 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.972 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.4 mm -52.76 -54.92 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.704 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -55.91 -39.88 72.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.664 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.01 80.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.691 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.51 ' HD1' HG22 ' A' ' 144' ' ' VAL . 45.2 t-105 -60.74 -57.02 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.574 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.746 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.8 -32.51 74.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.79 -24.99 44.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.314 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.81 29.01 55.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.42 -1.211 . . . . 0.0 112.416 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.875 0.369 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 78.12 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -155.4 160.89 41.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.696 HG13 ' HB ' ' A' ' 146' ' ' ILE . 41.2 t -121.74 140.25 46.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.504 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.1 mp -130.08 111.89 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.646 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -165.64 148.88 7.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.015 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.523 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -57.41 159.96 7.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.717 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.84 -25.92 82.12 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.578 2.185 . . . . 0.0 112.248 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -91.05 -29.46 17.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.617 HG11 HG12 ' A' ' 158' ' ' VAL . 62.1 t -70.18 -47.53 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.396 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 13.2 mtt180 -54.53 -31.25 55.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.64 -38.76 47.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.213 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.525 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.2 t80 -66.77 -48.09 70.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.056 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.983 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.31 -45.73 79.33 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.1 tpm_? -54.88 -31.81 60.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -84.43 -37.6 21.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.773 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.2 mmtt -83.98 25.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.737 -179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.97 22.43 20.08 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.506 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.552 HG23 HD21 ' A' ' 167' ' ' LEU . 49.4 t -111.48 143.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.984 0.421 . . . . 0.0 110.972 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -116.21 130.85 56.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.774 HG23 HG21 ' A' ' 158' ' ' VAL . 28.1 mm -52.35 -22.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.121 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mmm-85 -64.11 -33.93 76.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.939 0.399 . . . . 0.0 110.439 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.18 -4.01 59.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.076 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.542 HG11 ' HB3' ' A' ' 162' ' ' ASP . 10.8 t -111.54 146.75 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.878 0.37 . . . . 0.0 111.186 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.4 95.43 5.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.758 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -58.5 128.6 48.0 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.709 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.16 26.12 9.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 0.0 111.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.81 143.83 18.03 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.001 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 49.28 -91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -114.01 29.9 7.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.741 0.305 . . . . 0.0 111.322 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 95.68 26.04 12.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.659 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.504 ' CB ' HG22 ' A' ' 130' ' ' ILE . 38.5 ttm180 -82.63 145.93 29.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.731 0.3 . . . . 0.0 110.905 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.774 HG21 HG23 ' A' ' 146' ' ' ILE . 41.1 t -79.31 134.63 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.275 0.559 . . . . 0.0 111.279 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.6 mt -106.35 162.01 14.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.972 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -31.7 62.38 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -37.76 87.93 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.1 m-20 -62.16 -50.15 72.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.742 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.983 HD12 ' HB2' ' A' ' 139' ' ' ALA . 34.5 mm -52.73 -54.93 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.639 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.11 -36.01 67.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.661 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.24 90.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.514 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.537 ' HD1' HG22 ' A' ' 144' ' ' VAL . 38.9 t-105 -59.67 -56.71 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.559 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.773 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.83 -31.42 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.01 64.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 125.17 -28.92 4.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.437 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.472 -179.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.92 74.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.31 -33.62 5.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.574 HG13 ' HB ' ' A' ' 146' ' ' ILE . 53.4 t -117.26 147.26 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.229 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.8 mp -130.07 111.79 22.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.651 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -170.19 154.28 4.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.146 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.538 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -59.89 147.63 78.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.695 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.45 -25.53 14.33 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.572 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.7 p -91.01 -28.96 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.794 HG11 HG12 ' A' ' 158' ' ' VAL . 62.0 t -68.66 -47.61 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.468 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.9 mtp180 -54.71 -30.68 56.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -77.63 -39.24 45.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.126 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.5 t80 -66.48 -48.21 70.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.044 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.49 -45.47 79.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 3.5 tpt180 -54.8 -31.71 59.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.267 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -84.47 -38.21 20.41 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.924 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.76 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.4 mmtt -82.99 26.45 0.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.885 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.84 22.25 18.54 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.471 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.546 HG23 HD21 ' A' ' 167' ' ' LEU . 54.1 t -111.68 144.01 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 111.044 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.401 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.2 t0 -116.29 131.1 57.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.97 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.574 ' HB ' HG13 ' A' ' 129' ' ' VAL . 35.0 mm -52.4 -22.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -64.58 -33.61 76.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.982 0.42 . . . . 0.0 110.421 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -87.93 -1.4 57.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.961 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 162' ' ' ASP . 13.7 t -114.64 146.11 19.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -104.65 108.5 19.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -66.96 126.1 25.97 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.764 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.26 26.06 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.716 0.293 . . . . 0.0 111.016 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.23 142.31 17.53 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.12 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER 49.87 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -114.02 31.72 6.36 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.69 0.281 . . . . 0.0 111.326 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.13 17.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.721 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.523 ' HA ' HG22 ' A' ' 130' ' ' ILE . 6.1 ttm180 -84.29 148.09 26.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.711 0.291 . . . . 0.0 110.742 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.794 HG12 HG11 ' A' ' 135' ' ' VAL . 10.1 t -81.63 137.99 20.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.11 0.481 . . . . 0.0 111.223 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 18.9 mt -110.35 161.92 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.345 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -55.64 -32.65 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.3 -37.38 87.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.277 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -62.39 -48.5 79.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.701 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.044 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.4 mm -52.83 -54.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.502 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.94 -35.29 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.526 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.14 89.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.504 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.524 ' HD1' HG22 ' A' ' 144' ' ' VAL . 39.9 t-105 -59.93 -57.01 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.76 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -64.81 -32.06 73.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.03 64.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.251 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -119.0 27.97 6.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.519 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.457 -1.191 . . . . 0.0 112.51 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 p30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.784 0.326 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -124.95 175.32 7.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.0 169.51 9.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.541 HG13 ' HB ' ' A' ' 146' ' ' ILE . 26.3 t -138.01 149.74 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.132 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.6 mp -130.06 111.94 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.618 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.518 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.99 151.2 3.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.31 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.563 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.4 mtp -58.27 148.47 62.92 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.12 -25.32 22.58 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.562 2.174 . . . . 0.0 112.506 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.2 m -90.94 -34.0 15.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.65 HG11 HG12 ' A' ' 158' ' ' VAL . 92.7 t -62.79 -47.56 92.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 37.7 mtp85 -54.66 -28.1 44.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.035 0.445 . . . . 0.0 110.002 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -41.57 37.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.928 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.619 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 40.4 t80 -66.3 -48.29 70.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.816 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.132 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.19 -46.15 85.19 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.95 -32.11 61.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.5 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -84.69 -38.42 19.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 111.104 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.819 ' O ' HD21 ' A' ' 167' ' ' LEU . 27.0 mmmt -82.19 25.48 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.976 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 23.65 23.75 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.342 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.584 HG23 HD21 ' A' ' 167' ' ' LEU . 53.7 t -114.65 142.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 0.0 111.06 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -116.24 131.86 56.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.702 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.541 ' HB ' HG13 ' A' ' 129' ' ' VAL . 32.9 mm -50.29 -23.77 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.712 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.4 OUTLIER -66.31 -33.19 75.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.893 0.378 . . . . 0.0 110.377 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.433 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 1.4 mt -85.52 -1.86 57.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.663 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.487 ' HB ' HG21 ' A' ' 158' ' ' VAL . 5.0 t -115.56 127.21 73.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.81 0.338 . . . . 0.0 111.475 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.01 92.4 7.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.425 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -57.38 129.13 49.03 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.981 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.12 9.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.727 0.299 . . . . 0.0 110.703 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -100.06 117.03 5.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 -83.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 153' ' ' GLY . 4.1 p30 -101.73 31.31 3.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.62 26.16 43.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.677 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.509 ' HG3' HG22 ' A' ' 130' ' ' ILE . 43.7 ttm180 -80.13 150.91 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.65 HG12 HG11 ' A' ' 135' ' ' VAL . 21.9 t -84.67 133.73 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 21.0 mt -106.83 162.41 13.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.105 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.66 -33.18 63.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -64.63 -36.89 85.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.2 m-20 -62.87 -48.48 78.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.785 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.132 HD12 ' HB2' ' A' ' 139' ' ' ALA . 32.5 mm -52.76 -53.82 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.428 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -57.74 -38.36 75.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.523 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.84 86.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.573 ' HD1' HG22 ' A' ' 144' ' ' VAL . 50.8 t-105 -59.2 -57.06 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.481 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.819 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -66.24 -33.68 76.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.914 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.27 -25.08 59.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.229 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.66 67.91 1.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.559 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.474 179.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.795 0.331 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.11 -44.73 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -167.73 1.87 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.8 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.775 HG13 ' HB ' ' A' ' 146' ' ' ILE . 55.8 t -137.58 138.53 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.985 0.421 . . . . 0.0 111.173 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.603 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp -130.03 111.79 22.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.47 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.443 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.2 152.02 7.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.163 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.515 ' HB2' HG23 ' A' ' 135' ' ' VAL . 6.3 mtp -58.7 160.04 11.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.22 -25.8 81.22 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 m -91.03 -30.92 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.145 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.702 HG11 HG12 ' A' ' 158' ' ' VAL . 45.1 t -69.11 -47.15 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.541 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 6.5 mtp180 -54.61 -31.22 56.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.69 -38.21 47.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.7 t80 -66.82 -48.09 70.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.077 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.993 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.38 -45.42 80.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.77 59.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.285 178.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -84.45 -37.78 20.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.905 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.734 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.4 mmtt -83.61 25.85 0.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.728 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.03 21.8 18.53 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.381 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.564 HG23 HD21 ' A' ' 167' ' ' LEU . 55.9 t -111.12 142.42 23.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.009 0.433 . . . . 0.0 110.856 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.21 130.47 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.8 HG23 HG21 ' A' ' 158' ' ' VAL . 34.8 mm -50.7 -23.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.0 mtp-105 -63.8 -35.74 81.6 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.7 OUTLIER -85.51 -4.07 59.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.967 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' A' ' 162' ' ' ASP . 8.6 t -113.46 149.2 15.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.873 0.368 . . . . 0.0 111.241 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -107.29 102.55 11.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -62.39 129.73 43.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.688 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 26.0 9.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.712 0.291 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -115.2 141.57 17.09 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.077 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.61 -91.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.684 0.254 . . . . 0.0 111.684 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -113.98 34.33 4.7 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.735 0.302 . . . . 0.0 111.271 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 89.93 26.09 25.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.763 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.603 ' HA ' HG22 ' A' ' 130' ' ' ILE . 22.6 ttm180 -82.55 142.63 31.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.854 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.8 HG21 HG23 ' A' ' 146' ' ' ILE . 37.5 t -76.75 133.32 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.231 0.538 . . . . 0.0 111.196 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.3 mt -107.86 163.9 12.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.075 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.45 -32.4 62.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.93 -37.72 88.6 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.536 ' HB3' HG11 ' A' ' 149' ' ' VAL . 4.7 m-20 -62.18 -50.52 71.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.753 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 139' ' ' ALA . 29.9 mm -52.74 -55.04 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.733 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.43 -38.46 69.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.636 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.89 89.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.535 ' HD1' HG22 ' A' ' 144' ' ' VAL . 46.1 t-105 -59.16 -57.15 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.64 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.734 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -64.45 -30.24 71.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.023 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.99 -24.95 64.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.09 -27.81 43.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.556 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.427 -1.207 . . . . 0.0 112.462 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.0 p30 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.814 0.34 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 124.57 28.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.35 56.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.499 HG21 ' HG3' ' A' ' 147' ' ' ARG . 2.1 t -99.2 156.84 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -88.85 111.95 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.21 0.529 . . . . 0.0 111.211 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -168.68 143.69 3.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.1 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.509 ' HB2' HG23 ' A' ' 135' ' ' VAL . 9.9 mmt -55.55 150.28 25.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.45 -29.78 70.43 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.575 2.183 . . . . 0.0 112.281 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.04 -33.46 21.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 158' ' ' VAL . 93.3 t -66.36 -46.81 86.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.304 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 42.0 mtp180 -54.64 -28.88 50.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.027 0.442 . . . . 0.0 109.867 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -77.67 -41.61 37.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.055 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.486 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 52.4 t80 -65.2 -47.99 74.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.078 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.68 -45.44 82.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.8 tpt85 -54.71 -31.84 58.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.3 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -84.46 -37.54 21.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.738 ' O ' HD21 ' A' ' 167' ' ' LEU . 47.6 mmtt -84.14 22.35 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.797 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.3 19.06 31.13 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.594 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.508 HG23 HD21 ' A' ' 167' ' ' LEU . 65.3 t -104.96 143.24 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.3 t0 -116.16 129.09 56.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.934 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.473 HG22 ' CG1' ' A' ' 129' ' ' VAL . 35.5 mm -50.66 -22.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.25 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.499 ' HG3' HG21 ' A' ' 129' ' ' VAL . 10.7 mtp180 -64.32 -33.71 76.47 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.99 0.424 . . . . 0.0 110.595 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.409 ' O ' ' CZ3' ' A' ' 166' ' ' TRP . 0.2 OUTLIER -91.37 1.73 56.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.538 ' HB ' HG21 ' A' ' 158' ' ' VAL . 4.0 t -119.09 120.12 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 111.473 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.71 96.23 8.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -68.85 134.78 27.85 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.114 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.18 26.02 9.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.852 0.358 . . . . 0.0 110.695 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -93.12 112.74 4.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.935 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.401 ' HG2' ' ND2' ' A' ' 155' ' ' ASN . 1.0 OUTLIER 53.2 -85.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.639 0.236 . . . . 0.0 111.639 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 153' ' ' GLY . 69.9 m-80 -97.75 33.66 2.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.769 0.319 . . . . 0.0 111.098 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.52 26.03 61.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.603 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.627 ' HA ' HG22 ' A' ' 130' ' ' ILE . 1.8 ttm105 -81.33 137.92 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.898 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.72 HG12 HG11 ' A' ' 135' ' ' VAL . 9.5 t -71.31 137.38 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.074 0.464 . . . . 0.0 111.208 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -108.38 163.9 12.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.454 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -57.24 -34.8 68.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.25 -36.26 83.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.0 m-20 -64.24 -48.01 77.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.078 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.2 mm -52.87 -54.71 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.544 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -56.56 -39.02 72.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.15 88.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.409 ' CZ3' ' O ' ' A' ' 148' ' ' LEU . 49.6 t-105 -58.72 -57.05 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.4 mt -61.13 -26.56 67.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.213 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.87 -24.97 64.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.159 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.16 34.92 6.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.564 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.434 -1.203 . . . . 0.0 112.457 179.909 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.815 0.34 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.01 173.39 6.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.36 116.54 3.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.001 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.595 HG21 ' HG2' ' A' ' 147' ' ' ARG . 2.9 t -93.36 157.42 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.793 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.0 mp -83.44 111.81 20.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.284 0.564 . . . . 0.0 111.192 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -170.12 147.05 3.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' VAL . 5.9 mtp -57.38 155.11 20.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.737 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.9 -24.23 78.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.548 2.165 . . . . 0.0 112.303 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 -36.21 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 158' ' ' VAL . 47.3 t -64.69 -44.26 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.358 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.513 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -54.71 -29.99 54.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.118 0.485 . . . . 0.0 109.727 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -40.48 41.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.974 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.3 t80 -65.47 -48.03 74.05 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.081 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.014 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.4 -45.18 80.88 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -54.88 -31.84 60.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.057 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -84.43 -37.54 21.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.958 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.736 ' O ' HD21 ' A' ' 167' ' ' LEU . 18.1 mmtp -84.46 25.36 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.748 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.8 21.17 21.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.615 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.577 HG23 HD21 ' A' ' 167' ' ' LEU . 53.6 t -109.51 143.26 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -116.17 130.62 56.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.123 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.504 HG22 ' CG1' ' A' ' 129' ' ' VAL . 33.9 mm -50.77 -22.65 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.198 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.595 ' HG2' HG21 ' A' ' 129' ' ' VAL . 8.4 mmm180 -63.68 -35.76 81.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.059 0.457 . . . . 0.0 110.32 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 166' ' ' TRP . 0.3 OUTLIER -87.96 -0.43 56.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.993 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.45 ' HB ' HG21 ' A' ' 158' ' ' VAL . 3.9 t -118.96 130.86 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 111.268 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 101.43 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.607 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -65.03 129.24 34.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.943 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.44 25.99 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.325 . . . . 0.0 110.697 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.86 123.52 7.78 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.259 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt 56.5 -84.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -113.09 37.0 3.28 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.675 0.274 . . . . 0.0 111.484 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 89.39 26.19 26.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.768 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.753 ' HA ' HG22 ' A' ' 130' ' ' ILE . 2.6 ttt180 -81.61 142.93 32.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.398 . . . . 0.0 111.386 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 135' ' ' VAL . 8.3 t -82.63 128.0 39.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.168 0.508 . . . . 0.0 110.728 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.526 ' HA ' HG21 ' A' ' 135' ' ' VAL . 15.8 mt -100.55 165.86 11.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.66 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -57.61 -32.78 67.54 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.51 -36.63 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.3 m-20 -64.26 -49.02 73.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.591 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.014 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.6 mm -52.96 -54.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.608 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.63 -39.56 71.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.639 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.86 83.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.523 ' HD1' HG22 ' A' ' 144' ' ' VAL . 42.9 t-105 -59.77 -57.06 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.555 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.736 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.1 mt -65.26 -31.15 72.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.98 64.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.187 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.67 29.97 11.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.52 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.806 0.336 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -81.38 116.59 21.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.848 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -105.26 -29.64 10.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 146' ' ' ILE . 42.5 t -96.73 135.16 31.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 111.413 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.46 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp -130.04 111.9 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.428 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -164.56 151.42 11.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.219 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.535 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -56.92 157.34 11.03 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.888 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.45 -24.6 78.36 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.581 2.187 . . . . 0.0 112.133 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.0 p -90.95 -30.37 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.995 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.79 HG11 HG12 ' A' ' 158' ' ' VAL . 63.9 t -66.73 -47.02 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.295 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 37.9 mtp85 -54.67 -30.04 54.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -40.37 42.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.179 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.9 t80 -66.39 -48.14 71.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.978 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.94 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.34 -46.16 81.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.98 -31.83 61.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.38 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -84.44 -37.22 21.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.767 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.4 mmtt -84.19 25.06 0.88 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.721 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 22.41 19.59 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.523 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG22 ' HD1' ' A' ' 166' ' ' TRP . 46.7 t -111.5 143.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.992 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -116.19 130.01 56.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.942 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.761 HG23 HG21 ' A' ' 158' ' ' VAL . 20.7 mm -51.86 -22.15 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.204 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -63.77 -33.99 76.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.006 0.431 . . . . 0.0 110.299 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' ' CH2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.97 -4.69 59.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.574 HG11 ' HB3' ' A' ' 162' ' ' ASP . 6.1 t -110.97 147.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.264 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.8 99.6 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.684 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -59.09 126.93 43.95 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.688 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.0 9.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.631 0.253 . . . . 0.0 111.01 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.45 141.76 16.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.986 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 51.28 -91.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -114.19 24.23 12.16 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.634 0.254 . . . . 0.0 111.477 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 103.71 26.1 6.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.878 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.46 ' CB ' HG22 ' A' ' 130' ' ' ILE . 20.8 ttm105 -84.22 147.43 27.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.745 0.307 . . . . 0.0 110.825 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.79 HG12 HG11 ' A' ' 135' ' ' VAL . 14.9 t -80.28 138.05 20.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.2 mt -112.06 165.09 12.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.28 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 23.4 tttt -57.01 -33.68 67.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.39 -36.95 85.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.574 ' HB3' HG11 ' A' ' 149' ' ' VAL . 5.5 m-20 -63.17 -50.51 70.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.634 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.94 HD12 ' HB2' ' A' ' 139' ' ' ALA . 30.7 mm -52.93 -54.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.546 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -57.59 -35.13 70.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.476 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.27 97.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.502 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.561 ' HD1' HG22 ' A' ' 144' ' ' VAL . 47.2 t-105 -58.73 -56.7 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.767 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -65.73 -29.75 70.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.069 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.66 31.08 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.289 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.08 80.72 0.1 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.522 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.483 179.978 . . . . . . . . 0 0 . 1 stop_ save_